id	sid	tid	token	lemma	pos
bam-10675	1	1	anti	anti	ADJ
bam-10675	1	2	-	-	ADJ
bam-10675	1	3	tpo	tpo	ADJ
bam-10675	1	4	antibody	antibody	NOUN
bam-10675	1	5	and	and	CCONJ
bam-10675	1	6	thyroid	thyroid	VERB
bam-10675	1	7	hormone	hormone	NOUN
bam-10675	1	8	levels	level	NOUN
bam-10675	1	9	in	in	ADP
bam-10675	1	10	breast	breast	NOUN
bam-10675	1	11	cancer	cancer	NOUN
bam-10675	1	12	eur	eur	PROPN
bam-10675	1	13	j	j	PROPN
bam-10675	1	14	transl	transl	PROPN
bam-10675	1	15	myol	myol	ADV
bam-10675	1	16	33	33	NUM
bam-10675	1	17	(	(	PUNCT
bam-10675	1	18	1	1	NUM
bam-10675	1	19	)	)	PUNCT
bam-10675	1	20	10675	10675	NUM
bam-10675	1	21	,	,	PUNCT
bam-10675	1	22	2023	2023	NUM
bam-10675	1	23	doi	doi	NOUN
bam-10675	1	24	:	:	PUNCT
bam-10675	1	25	10.4081	10.4081	NUM
bam-10675	1	26	/	/	SYM
bam-10675	1	27	ejtm.2023.10675	ejtm.2023.10675	NOUN
bam-10675	1	28	1	1	NUM
bam-10675	1	29	anti	anti	ADJ
bam-10675	1	30	-	-	ADJ
bam-10675	1	31	tpo	tpo	ADJ
bam-10675	1	32	antibody	antibody	NOUN
bam-10675	1	33	and	and	CCONJ
bam-10675	1	34	thyroid	thyroid	VERB
bam-10675	1	35	hormone	hormone	NOUN
bam-10675	1	36	levels	level	NOUN
bam-10675	1	37	in	in	ADP
bam-10675	1	38	iranian	iranian	ADJ
bam-10675	1	39	female	female	ADJ
bam-10675	1	40	breast	breast	NOUN
bam-10675	1	41	cancer	cancer	NOUN
bam-10675	1	42	patients	patient	NOUN
bam-10675	1	43	and	and	CCONJ
bam-10675	1	44	their	their	PRON
bam-10675	1	45	association	association	NOUN
bam-10675	1	46	with	with	ADP
bam-10675	1	47	prognostic	prognostic	ADJ
bam-10675	1	48	factors	factor	NOUN
bam-10675	1	49	:	:	PUNCT
bam-10675	1	50	a	a	DET
bam-10675	1	51	case	case	NOUN
bam-10675	1	52	-	-	PUNCT
bam-10675	1	53	control	control	NOUN
bam-10675	1	54	study	study	NOUN
bam-10675	1	55	farahnaz	farahnaz	PROPN
bam-10675	1	56	ghahremanfard	ghahremanfard	PROPN
bam-10675	1	57	(	(	PUNCT
bam-10675	1	58	1	1	NUM
bam-10675	1	59	)	)	PUNCT
bam-10675	1	60	,	,	PUNCT
bam-10675	1	61	elahe	elahe	PROPN
bam-10675	1	62	jandaghi	jandaghi	PROPN
bam-10675	1	63	(	(	PUNCT
bam-10675	1	64	2,3	2,3	NUM
bam-10675	1	65	)	)	PUNCT
bam-10675	1	66	,	,	PUNCT
bam-10675	1	67	rahimi	rahimi	ADJ
bam-10675	1	68	ghobad	ghobad	NOUN
bam-10675	1	69	(	(	PUNCT
bam-10675	1	70	4	4	NUM
bam-10675	1	71	)	)	PUNCT
bam-10675	1	72	,	,	PUNCT
bam-10675	1	73	majid	majid	PROPN
bam-10675	1	74	mirmohammadkhani	mirmohammadkhani	PROPN
bam-10675	1	75	(	(	PUNCT
bam-10675	1	76	5	5	NUM
bam-10675	1	77	)	)	PUNCT
bam-10675	1	78	,	,	PUNCT
bam-10675	1	79	mohamadamir	mohamadamir	NOUN
bam-10675	1	80	sarabi	sarabi	NOUN
bam-10675	1	81	(	(	PUNCT
bam-10675	1	82	6	6	NUM
bam-10675	1	83	)	)	PUNCT
bam-10675	1	84	(	(	PUNCT
bam-10675	1	85	1	1	X
bam-10675	1	86	)	)	PUNCT
bam-10675	1	87	cancer	cancer	NOUN
bam-10675	1	88	research	research	NOUN
bam-10675	1	89	center	center	NOUN
bam-10675	1	90	(	(	PUNCT
bam-10675	1	91	crc	crc	NOUN
bam-10675	1	92	)	)	PUNCT
bam-10675	1	93	,	,	PUNCT
bam-10675	1	94	semnan	semnan	PROPN
bam-10675	1	95	university	university	PROPN
bam-10675	1	96	of	of	ADP
bam-10675	1	97	medical	medical	ADJ
bam-10675	1	98	sciences	sciences	PROPN
bam-10675	1	99	,	,	PUNCT
bam-10675	1	100	semnan	semnan	NOUN
bam-10675	1	101	,	,	PUNCT
bam-10675	1	102	iran	iran	PROPN
bam-10675	1	103	;	;	PUNCT
bam-10675	1	104	(	(	PUNCT
bam-10675	1	105	2	2	X
bam-10675	1	106	)	)	PUNCT
bam-10675	1	107	department	department	NOUN
bam-10675	1	108	of	of	ADP
bam-10675	1	109	internal	internal	ADJ
bam-10675	1	110	medicine	medicine	NOUN
bam-10675	1	111	,	,	PUNCT
bam-10675	1	112	semnan	semnan	PROPN
bam-10675	1	113	university	university	PROPN
bam-10675	1	114	of	of	ADP
bam-10675	1	115	medical	medical	ADJ
bam-10675	1	116	sciences	sciences	PROPN
bam-10675	1	117	,	,	PUNCT
bam-10675	1	118	semnan	semnan	NOUN
bam-10675	1	119	,	,	PUNCT
bam-10675	1	120	iran	iran	PROPN
bam-10675	1	121	;	;	PUNCT
bam-10675	1	122	(	(	PUNCT
bam-10675	1	123	3	3	X
bam-10675	1	124	)	)	PUNCT
bam-10675	1	125	department	department	NOUN
bam-10675	1	126	of	of	ADP
bam-10675	1	127	adult	adult	NOUN
bam-10675	1	128	rheumatology	rheumatology	NOUN
bam-10675	1	129	,	,	PUNCT
bam-10675	1	130	school	school	NOUN
bam-10675	1	131	of	of	ADP
bam-10675	1	132	medicine	medicine	NOUN
bam-10675	1	133	,	,	PUNCT
bam-10675	1	134	loghman	loghman	PROPN
bam-10675	1	135	hakim	hakim	PROPN
bam-10675	1	136	hospital	hospital	PROPN
bam-10675	1	137	,	,	PUNCT
bam-10675	1	138	shahid	shahid	PROPN
bam-10675	1	139	beheshti	beheshti	VERB
bam-10675	1	140	university	university	PROPN
bam-10675	1	141	of	of	ADP
bam-10675	1	142	medical	medical	ADJ
bam-10675	1	143	sciences	sciences	PROPN
bam-10675	1	144	,	,	PUNCT
bam-10675	1	145	tehran	tehran	PROPN
bam-10675	1	146	,	,	PUNCT
bam-10675	1	147	iran	iran	PROPN
bam-10675	1	148	;	;	PUNCT
bam-10675	1	149	(	(	PUNCT
bam-10675	1	150	4	4	X
bam-10675	1	151	)	)	PUNCT
bam-10675	1	152	department	department	NOUN
bam-10675	1	153	of	of	ADP
bam-10675	1	154	internal	internal	ADJ
bam-10675	1	155	medicine	medicine	NOUN
bam-10675	1	156	,	,	PUNCT
bam-10675	1	157	kowsar	kowsar	ADJ
bam-10675	1	158	hospital	hospital	NOUN
bam-10675	1	159	,	,	PUNCT
bam-10675	1	160	semnan	semnan	PROPN
bam-10675	1	161	university	university	PROPN
bam-10675	1	162	of	of	ADP
bam-10675	1	163	medical	medical	ADJ
bam-10675	1	164	sciences	sciences	PROPN
bam-10675	1	165	,	,	PUNCT
bam-10675	1	166	semnan	semnan	NOUN
bam-10675	1	167	,	,	PUNCT
bam-10675	1	168	iran	iran	PROPN
bam-10675	1	169	;	;	PUNCT
bam-10675	1	170	(	(	PUNCT
bam-10675	1	171	5	5	X
bam-10675	1	172	)	)	PUNCT
bam-10675	1	173	social	social	ADJ
bam-10675	1	174	determinants	determinant	NOUN
bam-10675	1	175	of	of	ADP
bam-10675	1	176	health	health	NOUN
bam-10675	1	177	research	research	NOUN
bam-10675	1	178	center	center	NOUN
bam-10675	1	179	,	,	PUNCT
bam-10675	1	180	semnan	semnan	PROPN
bam-10675	1	181	university	university	PROPN
bam-10675	1	182	of	of	ADP
bam-10675	1	183	medical	medical	ADJ
bam-10675	1	184	sciences	sciences	PROPN
bam-10675	1	185	,	,	PUNCT
bam-10675	1	186	semnan	semnan	NOUN
bam-10675	1	187	,	,	PUNCT
bam-10675	1	188	iran	iran	PROPN
bam-10675	1	189	;	;	PUNCT
bam-10675	1	190	(	(	PUNCT
bam-10675	1	191	6	6	X
bam-10675	1	192	)	)	PUNCT
bam-10675	1	193	tehran	tehran	PROPN
bam-10675	1	194	medical	medical	PROPN
bam-10675	1	195	sciences	sciences	PROPN
bam-10675	1	196	,	,	PUNCT
bam-10675	1	197	islamic	islamic	PROPN
bam-10675	1	198	azad	azad	PROPN
bam-10675	1	199	university	university	PROPN
bam-10675	1	200	,	,	PUNCT
bam-10675	1	201	tehran	tehran	PROPN
bam-10675	1	202	,	,	PUNCT
bam-10675	1	203	iran	iran	PROPN
bam-10675	1	204	.	.	PUNCT
bam-10675	2	1	this	this	DET
bam-10675	2	2	article	article	NOUN
bam-10675	2	3	is	be	AUX
bam-10675	2	4	distributed	distribute	VERB
bam-10675	2	5	under	under	ADP
bam-10675	2	6	the	the	DET
bam-10675	2	7	terms	term	NOUN
bam-10675	2	8	of	of	ADP
bam-10675	2	9	the	the	DET
bam-10675	2	10	creative	creative	ADJ
bam-10675	2	11	commons	common	NOUN
bam-10675	2	12	attribution	attribution	NOUN
bam-10675	2	13	noncommercial	noncommercial	ADJ
bam-10675	2	14	license	license	NOUN
bam-10675	2	15	(	(	PUNCT
bam-10675	2	16	cc	cc	NOUN
bam-10675	2	17	by	by	ADP
bam-10675	2	18	-	-	PUNCT
bam-10675	2	19	nc	nc	PROPN
bam-10675	2	20	4.0	4.0	NUM
bam-10675	2	21	)	)	PUNCT
bam-10675	2	22	which	which	PRON
bam-10675	2	23	permits	permit	VERB
bam-10675	2	24	any	any	DET
bam-10675	2	25	noncommercial	noncommercial	ADJ
bam-10675	2	26	use	use	NOUN
bam-10675	2	27	,	,	PUNCT
bam-10675	2	28	distribution	distribution	NOUN
bam-10675	2	29	,	,	PUNCT
bam-10675	2	30	and	and	CCONJ
bam-10675	2	31	reproduction	reproduction	NOUN
bam-10675	2	32	in	in	ADP
bam-10675	2	33	any	any	DET
bam-10675	2	34	medium	medium	NOUN
bam-10675	2	35	,	,	PUNCT
bam-10675	2	36	provided	provide	VERB
bam-10675	2	37	the	the	DET
bam-10675	2	38	original	original	ADJ
bam-10675	2	39	author(s	author(s	NOUN
bam-10675	2	40	)	)	PUNCT
bam-10675	2	41	and	and	CCONJ
bam-10675	2	42	source	source	NOUN
bam-10675	2	43	are	be	AUX
bam-10675	2	44	credited	credit	VERB
bam-10675	2	45	.	.	PUNCT
bam-10675	3	1	abstract	abstract	ADJ
bam-10675	3	2	the	the	DET
bam-10675	3	3	aim	aim	NOUN
bam-10675	3	4	of	of	ADP
bam-10675	3	5	this	this	DET
bam-10675	3	6	study	study	NOUN
bam-10675	3	7	was	be	AUX
bam-10675	3	8	to	to	PART
bam-10675	3	9	assess	assess	VERB
bam-10675	3	10	prevalence	prevalence	NOUN
bam-10675	3	11	of	of	ADP
bam-10675	3	12	anti	anti	ADJ
bam-10675	3	13	–	–	NOUN
bam-10675	3	14	thyroid	thyroid	ADJ
bam-10675	3	15	peroxidase	peroxidase	NOUN
bam-10675	3	16	(	(	PUNCT
bam-10675	3	17	anti	anti	ADJ
bam-10675	3	18	-	-	ADJ
bam-10675	3	19	tpo	tpo	NOUN
bam-10675	3	20	)	)	PUNCT
bam-10675	3	21	antibody	antibody	NOUN
bam-10675	3	22	and	and	CCONJ
bam-10675	3	23	thyroid	thyroid	NOUN
bam-10675	3	24	hormones	hormone	NOUN
bam-10675	3	25	in	in	ADP
bam-10675	3	26	iranian	iranian	ADJ
bam-10675	3	27	female	female	ADJ
bam-10675	3	28	breast	breast	NOUN
bam-10675	3	29	cancer	cancer	NOUN
bam-10675	3	30	patients	patient	NOUN
bam-10675	3	31	,	,	PUNCT
bam-10675	3	32	compare	compare	VERB
bam-10675	3	33	them	they	PRON
bam-10675	3	34	to	to	ADP
bam-10675	3	35	a	a	DET
bam-10675	3	36	control	control	NOUN
bam-10675	3	37	population	population	NOUN
bam-10675	3	38	,	,	PUNCT
bam-10675	3	39	and	and	CCONJ
bam-10675	3	40	investigate	investigate	VERB
bam-10675	3	41	their	their	PRON
bam-10675	3	42	association	association	NOUN
bam-10675	3	43	with	with	ADP
bam-10675	3	44	prognostic	prognostic	ADJ
bam-10675	3	45	factors	factor	NOUN
bam-10675	3	46	.	.	PUNCT
bam-10675	4	1	in	in	ADP
bam-10675	4	2	this	this	DET
bam-10675	4	3	case	case	NOUN
bam-10675	4	4	-	-	PUNCT
bam-10675	4	5	control	control	NOUN
bam-10675	4	6	study	study	NOUN
bam-10675	4	7	,	,	PUNCT
bam-10675	4	8	breast	breast	NOUN
bam-10675	4	9	cancer	cancer	NOUN
bam-10675	4	10	patients	patient	NOUN
bam-10675	4	11	were	be	AUX
bam-10675	4	12	selected	select	VERB
bam-10675	4	13	from	from	ADP
bam-10675	4	14	a	a	DET
bam-10675	4	15	surgery	surgery	NOUN
bam-10675	4	16	clinic	clinic	NOUN
bam-10675	4	17	in	in	ADP
bam-10675	4	18	a	a	DET
bam-10675	4	19	tertiary	tertiary	ADJ
bam-10675	4	20	hospital	hospital	NOUN
bam-10675	4	21	and	and	CCONJ
bam-10675	4	22	control	control	NOUN
bam-10675	4	23	group	group	NOUN
bam-10675	4	24	participants	participant	NOUN
bam-10675	4	25	were	be	AUX
bam-10675	4	26	enrolled	enrol	VERB
bam-10675	4	27	from	from	ADP
bam-10675	4	28	those	those	PRON
bam-10675	4	29	who	who	PRON
bam-10675	4	30	had	have	AUX
bam-10675	4	31	visited	visit	VERB
bam-10675	4	32	for	for	ADP
bam-10675	4	33	mammography	mammography	NOUN
bam-10675	4	34	screening	screening	NOUN
bam-10675	4	35	.	.	PUNCT
bam-10675	5	1	participants	participant	NOUN
bam-10675	5	2	with	with	ADP
bam-10675	5	3	any	any	DET
bam-10675	5	4	history	history	NOUN
bam-10675	5	5	of	of	ADP
bam-10675	5	6	thyroid	thyroid	NOUN
bam-10675	5	7	disease	disease	NOUN
bam-10675	5	8	,	,	PUNCT
bam-10675	5	9	or	or	CCONJ
bam-10675	5	10	thyroid	thyroid	VERB
bam-10675	5	11	related	relate	VERB
bam-10675	5	12	medication	medication	NOUN
bam-10675	5	13	were	be	AUX
bam-10675	5	14	excluded	exclude	VERB
bam-10675	5	15	from	from	ADP
bam-10675	5	16	both	both	DET
bam-10675	5	17	groups	group	NOUN
bam-10675	5	18	.	.	PUNCT
bam-10675	6	1	groups	group	NOUN
bam-10675	6	2	were	be	AUX
bam-10675	6	3	assessed	assess	VERB
bam-10675	6	4	for	for	ADP
bam-10675	6	5	levels	level	NOUN
bam-10675	6	6	of	of	ADP
bam-10675	6	7	thyroid	thyroid	NOUN
bam-10675	6	8	stimulating	stimulate	VERB
bam-10675	6	9	hormone	hormone	NOUN
bam-10675	6	10	(	(	PUNCT
bam-10675	6	11	tsh	tsh	NOUN
bam-10675	6	12	)	)	PUNCT
bam-10675	6	13	,	,	PUNCT
bam-10675	6	14	t3	t3	PROPN
bam-10675	6	15	,	,	PUNCT
bam-10675	6	16	t4	t4	PROPN
bam-10675	6	17	,	,	PUNCT
bam-10675	6	18	and	and	CCONJ
bam-10675	6	19	antitpo	antitpo	NOUN
bam-10675	6	20	.	.	PUNCT
bam-10675	7	1	in	in	ADP
bam-10675	7	2	addition	addition	NOUN
bam-10675	7	3	,	,	PUNCT
bam-10675	7	4	the	the	DET
bam-10675	7	5	status	status	NOUN
bam-10675	7	6	of	of	ADP
bam-10675	7	7	estrogen	estrogen	NOUN
bam-10675	7	8	receptors	receptor	NOUN
bam-10675	7	9	(	(	PUNCT
bam-10675	7	10	er	er	INTJ
bam-10675	7	11	)	)	PUNCT
bam-10675	7	12	,	,	PUNCT
bam-10675	7	13	progesterone	progesterone	NOUN
bam-10675	7	14	receptors	receptor	NOUN
bam-10675	7	15	(	(	PUNCT
bam-10675	7	16	pr	pr	NOUN
bam-10675	7	17	)	)	PUNCT
bam-10675	7	18	,	,	PUNCT
bam-10675	7	19	and	and	CCONJ
bam-10675	7	20	human	human	ADJ
bam-10675	7	21	epidermal	epidermal	ADJ
bam-10675	7	22	growth	growth	NOUN
bam-10675	7	23	factor	factor	NOUN
bam-10675	7	24	receptor	receptor	NOUN
bam-10675	7	25	2	2	NUM
bam-10675	7	26	(	(	PUNCT
bam-10675	7	27	her2	her2	PROPN
bam-10675	7	28	)	)	PUNCT
bam-10675	7	29	was	be	AUX
bam-10675	7	30	determined	determine	VERB
bam-10675	7	31	for	for	ADP
bam-10675	7	32	cancer	cancer	NOUN
bam-10675	7	33	patients	patient	NOUN
bam-10675	7	34	.	.	PUNCT
bam-10675	8	1	overall	overall	ADJ
bam-10675	8	2	69	69	NUM
bam-10675	8	3	participants	participant	NOUN
bam-10675	8	4	(	(	PUNCT
bam-10675	8	5	39	39	NUM
bam-10675	8	6	cancer	cancer	NOUN
bam-10675	8	7	patients	patient	NOUN
bam-10675	8	8	and	and	CCONJ
bam-10675	8	9	30	30	NUM
bam-10675	8	10	controls	control	NOUN
bam-10675	8	11	)	)	PUNCT
bam-10675	8	12	were	be	AUX
bam-10675	8	13	included	include	VERB
bam-10675	8	14	.	.	PUNCT
bam-10675	9	1	difference	difference	NOUN
bam-10675	9	2	in	in	ADP
bam-10675	9	3	serum	serum	NOUN
bam-10675	9	4	anti	anti	ADJ
bam-10675	9	5	-	-	ADJ
bam-10675	9	6	tpo	tpo	ADJ
bam-10675	9	7	levels	level	NOUN
bam-10675	9	8	between	between	ADP
bam-10675	9	9	the	the	DET
bam-10675	9	10	two	two	NUM
bam-10675	9	11	groups	group	NOUN
bam-10675	9	12	was	be	AUX
bam-10675	9	13	not	not	PART
bam-10675	9	14	statistically	statistically	ADV
bam-10675	9	15	significant	significant	ADJ
bam-10675	9	16	(	(	PUNCT
bam-10675	9	17	p	p	NOUN
bam-10675	9	18	-	-	PUNCT
bam-10675	9	19	value	value	NOUN
bam-10675	9	20	:	:	PUNCT
bam-10675	9	21	0.184	0.184	NUM
bam-10675	9	22	)	)	PUNCT
bam-10675	9	23	.	.	PUNCT
bam-10675	10	1	while	while	SCONJ
bam-10675	10	2	a	a	DET
bam-10675	10	3	significant	significant	ADJ
bam-10675	10	4	difference	difference	NOUN
bam-10675	10	5	was	be	AUX
bam-10675	10	6	observed	observe	VERB
bam-10675	10	7	for	for	ADP
bam-10675	10	8	t4	t4	PROPN
bam-10675	10	9	and	and	CCONJ
bam-10675	10	10	tsh	tsh	NOUN
bam-10675	10	11	levels	level	NOUN
bam-10675	10	12	between	between	ADP
bam-10675	10	13	groups	group	NOUN
bam-10675	10	14	(	(	PUNCT
bam-10675	10	15	p	p	NOUN
bam-10675	10	16	-	-	PUNCT
bam-10675	10	17	value	value	NOUN
bam-10675	10	18	:	:	PUNCT
bam-10675	10	19	0.034	0.034	NUM
bam-10675	10	20	and	and	CCONJ
bam-10675	10	21	<	<	X
bam-10675	10	22	0.001	0.001	NUM
bam-10675	10	23	,	,	PUNCT
bam-10675	10	24	respectively	respectively	ADV
bam-10675	10	25	)	)	PUNCT
bam-10675	10	26	,	,	PUNCT
bam-10675	10	27	t3	t3	PROPN
bam-10675	10	28	levels	level	NOUN
bam-10675	10	29	did	do	AUX
bam-10675	10	30	not	not	PART
bam-10675	10	31	reveal	reveal	VERB
bam-10675	10	32	any	any	DET
bam-10675	10	33	significant	significant	ADJ
bam-10675	10	34	difference	difference	NOUN
bam-10675	10	35	(	(	PUNCT
bam-10675	10	36	p	p	NOUN
bam-10675	10	37	-	-	PUNCT
bam-10675	10	38	value	value	NOUN
bam-10675	10	39	:	:	PUNCT
bam-10675	10	40	0.177	0.177	NUM
bam-10675	10	41	)	)	PUNCT
bam-10675	10	42	.	.	PUNCT
bam-10675	11	1	in	in	ADP
bam-10675	11	2	addition	addition	NOUN
bam-10675	11	3	,	,	PUNCT
bam-10675	11	4	er	er	INTJ
bam-10675	11	5	,	,	PUNCT
bam-10675	11	6	pr	pr	NOUN
bam-10675	11	7	,	,	PUNCT
bam-10675	11	8	and	and	CCONJ
bam-10675	11	9	her2	her2	PROPN
bam-10675	11	10	status	status	NOUN
bam-10675	11	11	were	be	AUX
bam-10675	11	12	not	not	PART
bam-10675	11	13	correlated	correlate	VERB
bam-10675	11	14	with	with	ADP
bam-10675	11	15	anti	anti	ADJ
bam-10675	11	16	-	-	ADJ
bam-10675	11	17	tpo	tpo	ADJ
bam-10675	11	18	levels	level	NOUN
bam-10675	11	19	.	.	PUNCT
bam-10675	12	1	this	this	DET
bam-10675	12	2	results	result	NOUN
bam-10675	12	3	can	can	AUX
bam-10675	12	4	serve	serve	VERB
bam-10675	12	5	as	as	ADP
bam-10675	12	6	preliminary	preliminary	ADJ
bam-10675	12	7	evidence	evidence	NOUN
bam-10675	12	8	that	that	PRON
bam-10675	12	9	thyroid	thyroid	NOUN
bam-10675	12	10	autoimmunity	autoimmunity	NOUN
bam-10675	12	11	is	be	AUX
bam-10675	12	12	not	not	PART
bam-10675	12	13	correlated	correlate	VERB
bam-10675	12	14	with	with	ADP
bam-10675	12	15	breast	breast	NOUN
bam-10675	12	16	cancer	cancer	NOUN
bam-10675	12	17	incidence	incidence	NOUN
bam-10675	12	18	in	in	ADP
bam-10675	12	19	iranian	iranian	ADJ
bam-10675	12	20	female	female	ADJ
bam-10675	12	21	population	population	NOUN
bam-10675	12	22	.	.	PUNCT
bam-10675	13	1	key	key	ADJ
bam-10675	13	2	words	word	NOUN
bam-10675	13	3	:	:	PUNCT
bam-10675	13	4	breast	breast	NOUN
bam-10675	13	5	neoplasms	neoplasm	NOUN
bam-10675	13	6	;	;	PUNCT
bam-10675	13	7	anti	anti	ADJ
bam-10675	13	8	-	-	ADJ
bam-10675	13	9	thyroid	thyroid	ADJ
bam-10675	13	10	autoantibodies	autoantibody	NOUN
bam-10675	13	11	;	;	PUNCT
bam-10675	13	12	thyroid	thyroid	NOUN
bam-10675	13	13	hormones	hormone	NOUN
bam-10675	13	14	.	.	PUNCT
bam-10675	14	1	eur	eur	PROPN
bam-10675	14	2	j	j	PROPN
bam-10675	14	3	transl	transl	PROPN
bam-10675	14	4	myol	myol	ADV
bam-10675	14	5	33	33	NUM
bam-10675	14	6	(	(	PUNCT
bam-10675	14	7	1	1	NUM
bam-10675	14	8	)	)	PUNCT
bam-10675	14	9	10675	10675	NUM
bam-10675	14	10	,	,	PUNCT
bam-10675	14	11	2023	2023	NUM
bam-10675	14	12	doi	doi	NOUN
bam-10675	14	13	:	:	PUNCT
bam-10675	14	14	10.4081	10.4081	NUM
bam-10675	14	15	/	/	SYM
bam-10675	14	16	ejtm.2023.10675	ejtm.2023.10675	NOUN
bam-10675	14	17	breast	breast	NOUN
bam-10675	14	18	cancer	cancer	NOUN
bam-10675	14	19	is	be	AUX
bam-10675	14	20	the	the	DET
bam-10675	14	21	most	most	ADV
bam-10675	14	22	prevalent	prevalent	ADJ
bam-10675	14	23	malignancy	malignancy	NOUN
bam-10675	14	24	among	among	ADP
bam-10675	14	25	women	woman	NOUN
bam-10675	14	26	and	and	CCONJ
bam-10675	14	27	it	it	PRON
bam-10675	14	28	is	be	AUX
bam-10675	14	29	the	the	DET
bam-10675	14	30	first	first	ADJ
bam-10675	14	31	cause	cause	NOUN
bam-10675	14	32	of	of	ADP
bam-10675	14	33	cancer	cancer	NOUN
bam-10675	14	34	related	relate	VERB
bam-10675	14	35	mortality	mortality	NOUN
bam-10675	14	36	in	in	ADP
bam-10675	14	37	female	female	ADJ
bam-10675	14	38	population	population	NOUN
bam-10675	14	39	in	in	ADP
bam-10675	14	40	most	most	ADJ
bam-10675	14	41	countries.1	countries.1	NOUN
bam-10675	14	42	breast	breast	NOUN
bam-10675	14	43	tumors	tumor	NOUN
bam-10675	14	44	can	can	AUX
bam-10675	14	45	be	be	AUX
bam-10675	14	46	classified	classify	VERB
bam-10675	14	47	based	base	VERB
bam-10675	14	48	on	on	ADP
bam-10675	14	49	the	the	DET
bam-10675	14	50	expression	expression	NOUN
bam-10675	14	51	of	of	ADP
bam-10675	14	52	receptors	receptor	NOUN
bam-10675	14	53	such	such	ADJ
bam-10675	14	54	as	as	ADP
bam-10675	14	55	estrogen	estrogen	NOUN
bam-10675	14	56	(	(	PUNCT
bam-10675	14	57	er	er	INTJ
bam-10675	14	58	)	)	PUNCT
bam-10675	14	59	and	and	CCONJ
bam-10675	14	60	progesterone	progesterone	NOUN
bam-10675	14	61	receptors	receptor	NOUN
bam-10675	14	62	(	(	PUNCT
bam-10675	14	63	pr	pr	NOUN
bam-10675	14	64	)	)	PUNCT
bam-10675	14	65	and	and	CCONJ
bam-10675	14	66	human	human	ADJ
bam-10675	14	67	epithelial	epithelial	ADJ
bam-10675	14	68	growth	growth	NOUN
bam-10675	14	69	factor	factor	NOUN
bam-10675	14	70	receptor	receptor	NOUN
bam-10675	14	71	2	2	NUM
bam-10675	14	72	(	(	PUNCT
bam-10675	14	73	her2	her2	PROPN
bam-10675	14	74	)	)	PUNCT
bam-10675	14	75	,	,	PUNCT
bam-10675	14	76	and	and	CCONJ
bam-10675	14	77	each	each	DET
bam-10675	14	78	type	type	NOUN
bam-10675	14	79	leads	lead	VERB
bam-10675	14	80	to	to	ADP
bam-10675	14	81	different	different	ADJ
bam-10675	14	82	prognosis	prognosis	NOUN
bam-10675	14	83	.	.	PUNCT
bam-10675	15	1	the	the	DET
bam-10675	15	2	incidence	incidence	NOUN
bam-10675	15	3	rate	rate	NOUN
bam-10675	15	4	of	of	ADP
bam-10675	15	5	breast	breast	NOUN
bam-10675	15	6	cancer	cancer	NOUN
bam-10675	15	7	in	in	ADP
bam-10675	15	8	iran	iran	PROPN
bam-10675	15	9	is	be	AUX
bam-10675	15	10	approximately	approximately	ADV
bam-10675	15	11	33	33	NUM
bam-10675	15	12	cases	case	NOUN
bam-10675	15	13	per	per	ADP
bam-10675	15	14	100,000	100,000	NUM
bam-10675	15	15	people	people	NOUN
bam-10675	15	16	with	with	ADP
bam-10675	15	17	a	a	DET
bam-10675	15	18	five	five	NUM
bam-10675	15	19	-	-	PUNCT
bam-10675	15	20	year	year	NOUN
bam-10675	15	21	overall	overall	ADJ
bam-10675	15	22	survival	survival	NOUN
bam-10675	15	23	of	of	ADP
bam-10675	15	24	72	72	NUM
bam-10675	15	25	%	%	NOUN
bam-10675	15	26	.2	.2	NUM
bam-10675	15	27	accordingly	accordingly	ADV
bam-10675	15	28	,	,	PUNCT
bam-10675	15	29	identification	identification	NOUN
bam-10675	15	30	of	of	ADP
bam-10675	15	31	its	its	PRON
bam-10675	15	32	risk	risk	NOUN
bam-10675	15	33	factors	factor	NOUN
bam-10675	15	34	is	be	AUX
bam-10675	15	35	an	an	DET
bam-10675	15	36	important	important	ADJ
bam-10675	15	37	step	step	NOUN
bam-10675	15	38	for	for	ADP
bam-10675	15	39	optimal	optimal	ADJ
bam-10675	15	40	preventing	preventing	NOUN
bam-10675	15	41	measures	measure	NOUN
bam-10675	15	42	.	.	PUNCT
bam-10675	16	1	fat	fat	ADJ
bam-10675	16	2	rich	rich	ADJ
bam-10675	16	3	diets	diet	NOUN
bam-10675	16	4	,	,	PUNCT
bam-10675	16	5	obesity	obesity	NOUN
bam-10675	16	6	,	,	PUNCT
bam-10675	16	7	oral	oral	ADJ
bam-10675	16	8	contraceptive	contraceptive	ADJ
bam-10675	16	9	use	use	NOUN
bam-10675	16	10	,	,	PUNCT
bam-10675	16	11	and	and	CCONJ
bam-10675	16	12	postmenopausal	postmenopausal	ADJ
bam-10675	16	13	hormone	hormone	NOUN
bam-10675	16	14	therapy	therapy	NOUN
bam-10675	16	15	are	be	AUX
bam-10675	16	16	some	some	PRON
bam-10675	16	17	of	of	ADP
bam-10675	16	18	the	the	DET
bam-10675	16	19	most	most	ADV
bam-10675	16	20	researched	research	VERB
bam-10675	16	21	and	and	CCONJ
bam-10675	16	22	established	establish	VERB
bam-10675	16	23	risk	risk	NOUN
bam-10675	16	24	factors.3	factors.3	PROPN
bam-10675	16	25	over	over	ADP
bam-10675	16	26	the	the	DET
bam-10675	16	27	years	year	NOUN
bam-10675	16	28	,	,	PUNCT
bam-10675	16	29	several	several	ADJ
bam-10675	16	30	studies	study	NOUN
bam-10675	16	31	have	have	AUX
bam-10675	16	32	demonstrated	demonstrate	VERB
bam-10675	16	33	an	an	DET
bam-10675	16	34	association	association	NOUN
bam-10675	16	35	between	between	ADP
bam-10675	16	36	this	this	DET
bam-10675	16	37	cancer	cancer	NOUN
bam-10675	16	38	and	and	CCONJ
bam-10675	16	39	thyroid	thyroid	NOUN
bam-10675	16	40	autoimmunity	autoimmunity	NOUN
bam-10675	16	41	,	,	PUNCT
bam-10675	16	42	regardless	regardless	ADV
bam-10675	16	43	of	of	ADP
bam-10675	16	44	clinical	clinical	ADJ
bam-10675	16	45	manifestations.4	manifestations.4	PROPN
bam-10675	16	46	-	-	SYM
bam-10675	16	47	9	9	NUM
bam-10675	16	48	however	however	ADV
bam-10675	16	49	,	,	PUNCT
bam-10675	16	50	the	the	DET
bam-10675	16	51	exact	exact	ADJ
bam-10675	16	52	causal	causal	ADJ
bam-10675	16	53	relation	relation	NOUN
bam-10675	16	54	and	and	CCONJ
bam-10675	16	55	the	the	DET
bam-10675	16	56	significance	significance	NOUN
bam-10675	16	57	of	of	ADP
bam-10675	16	58	this	this	DET
bam-10675	16	59	correlation	correlation	NOUN
bam-10675	16	60	is	be	AUX
bam-10675	16	61	not	not	PART
bam-10675	16	62	determined	determine	VERB
bam-10675	16	63	.	.	PUNCT
bam-10675	17	1	in	in	ADP
bam-10675	17	2	contrast	contrast	NOUN
bam-10675	17	3	,	,	PUNCT
bam-10675	17	4	there	there	PRON
bam-10675	17	5	are	be	VERB
bam-10675	17	6	studies	study	NOUN
bam-10675	17	7	that	that	PRON
bam-10675	17	8	have	have	AUX
bam-10675	17	9	reported	report	VERB
bam-10675	17	10	no	no	DET
bam-10675	17	11	correlation	correlation	NOUN
bam-10675	17	12	or	or	CCONJ
bam-10675	17	13	negative	negative	ADJ
bam-10675	17	14	correlation	correlation	NOUN
bam-10675	17	15	between	between	ADP
bam-10675	17	16	breast	breast	NOUN
bam-10675	17	17	cancer	cancer	NOUN
bam-10675	17	18	and	and	CCONJ
bam-10675	17	19	thyroid	thyroid	NOUN
bam-10675	17	20	autoimmunity.10	autoimmunity.10	PROPN
bam-10675	17	21	-	-	PUNCT
bam-10675	17	22	13	13	NUM
bam-10675	17	23	the	the	DET
bam-10675	17	24	current	current	ADJ
bam-10675	17	25	controversy	controversy	NOUN
bam-10675	17	26	and	and	CCONJ
bam-10675	17	27	discrepancy	discrepancy	NOUN
bam-10675	17	28	in	in	ADP
bam-10675	17	29	literature	literature	NOUN
bam-10675	17	30	justifies	justify	VERB
bam-10675	17	31	further	further	ADJ
bam-10675	17	32	investigation	investigation	NOUN
bam-10675	17	33	to	to	PART
bam-10675	17	34	determine	determine	VERB
bam-10675	17	35	the	the	DET
bam-10675	17	36	significance	significance	NOUN
bam-10675	17	37	of	of	ADP
bam-10675	17	38	thyroid	thyroid	NOUN
bam-10675	17	39	examination	examination	NOUN
bam-10675	17	40	in	in	ADP
bam-10675	17	41	breast	breast	NOUN
bam-10675	17	42	cancer	cancer	NOUN
bam-10675	17	43	prevention	prevention	NOUN
bam-10675	17	44	.	.	PUNCT
bam-10675	18	1	in	in	ADP
bam-10675	18	2	addition	addition	NOUN
bam-10675	18	3	,	,	PUNCT
bam-10675	18	4	to	to	ADP
bam-10675	18	5	the	the	DET
bam-10675	18	6	best	good	ADJ
bam-10675	18	7	of	of	ADP
bam-10675	18	8	our	our	PRON
bam-10675	18	9	knowledge	knowledge	NOUN
bam-10675	18	10	,	,	PUNCT
bam-10675	18	11	no	no	DET
bam-10675	18	12	similar	similar	ADJ
bam-10675	18	13	study	study	NOUN
bam-10675	18	14	has	have	AUX
bam-10675	18	15	been	be	AUX
bam-10675	18	16	carried	carry	VERB
bam-10675	18	17	in	in	ADP
bam-10675	18	18	iranian	iranian	ADJ
bam-10675	18	19	population	population	NOUN
bam-10675	18	20	.	.	PUNCT
bam-10675	19	1	in	in	ADP
bam-10675	19	2	this	this	DET
bam-10675	19	3	study	study	NOUN
bam-10675	19	4	we	we	PRON
bam-10675	19	5	tried	try	VERB
bam-10675	19	6	to	to	PART
bam-10675	19	7	compare	compare	VERB
bam-10675	19	8	the	the	DET
bam-10675	19	9	prevalence	prevalence	NOUN
bam-10675	19	10	of	of	ADP
bam-10675	19	11	anti	anti	ADJ
bam-10675	19	12	–	–	NOUN
bam-10675	19	13	non	non	ADJ
bam-10675	19	14	-co	-co	PROPN
bam-10675	19	15	mmerc	mmerc	PROPN
bam-10675	19	16	ial	ial	PROPN
bam-10675	20	1	us	us	PROPN
bam-10675	20	2	e	e	NOUN
bam-10675	20	3	o	o	X
bam-10675	20	4	nly	nly	ADV
bam-10675	20	5	anti	anti	ADJ
bam-10675	20	6	-	-	ADJ
bam-10675	20	7	tpo	tpo	ADJ
bam-10675	20	8	antibody	antibody	NOUN
bam-10675	20	9	and	and	CCONJ
bam-10675	20	10	thyroid	thyroid	VERB
bam-10675	20	11	hormone	hormone	NOUN
bam-10675	20	12	levels	level	NOUN
bam-10675	20	13	in	in	ADP
bam-10675	20	14	breast	breast	NOUN
bam-10675	20	15	cancer	cancer	NOUN
bam-10675	20	16	eur	eur	PROPN
bam-10675	20	17	j	j	PROPN
bam-10675	20	18	transl	transl	PROPN
bam-10675	20	19	myol	myol	ADV
bam-10675	20	20	33	33	NUM
bam-10675	20	21	(	(	PUNCT
bam-10675	20	22	1	1	NUM
bam-10675	20	23	)	)	PUNCT
bam-10675	20	24	10675	10675	NUM
bam-10675	20	25	,	,	PUNCT
bam-10675	20	26	2023	2023	NUM
bam-10675	20	27	doi	doi	NOUN
bam-10675	20	28	:	:	PUNCT
bam-10675	20	29	10.4081	10.4081	NUM
bam-10675	20	30	/	/	SYM
bam-10675	20	31	ejtm.2023.10675	ejtm.2023.10675	NOUN
bam-10675	20	32	2	2	NUM
bam-10675	20	33	thyroid	thyroid	NOUN
bam-10675	20	34	peroxidase	peroxidase	NOUN
bam-10675	20	35	(	(	PUNCT
bam-10675	20	36	anti	anti	ADJ
bam-10675	20	37	-	-	ADJ
bam-10675	20	38	tpo	tpo	NOUN
bam-10675	20	39	)	)	PUNCT
bam-10675	20	40	antibody	antibody	NOUN
bam-10675	20	41	,	,	PUNCT
bam-10675	20	42	and	and	CCONJ
bam-10675	20	43	thyroid	thyroid	NOUN
bam-10675	20	44	hormones	hormone	NOUN
bam-10675	20	45	between	between	ADP
bam-10675	20	46	breast	breast	NOUN
bam-10675	20	47	cancer	cancer	NOUN
bam-10675	20	48	and	and	CCONJ
bam-10675	20	49	control	control	NOUN
bam-10675	20	50	populations	population	NOUN
bam-10675	20	51	.	.	PUNCT
bam-10675	21	1	besides	besides	SCONJ
bam-10675	21	2	,	,	PUNCT
bam-10675	21	3	the	the	DET
bam-10675	21	4	prevalence	prevalence	NOUN
bam-10675	21	5	of	of	ADP
bam-10675	21	6	anti	anti	ADJ
bam-10675	21	7	-	-	ADJ
bam-10675	21	8	tpo	tpo	ADJ
bam-10675	21	9	antibody	antibody	NOUN
bam-10675	21	10	in	in	ADP
bam-10675	21	11	different	different	ADJ
bam-10675	21	12	tumor	tumor	NOUN
bam-10675	21	13	stages	stage	NOUN
bam-10675	21	14	and	and	CCONJ
bam-10675	21	15	different	different	ADJ
bam-10675	21	16	tumor	tumor	NOUN
bam-10675	21	17	variants	variant	NOUN
bam-10675	21	18	(	(	PUNCT
bam-10675	21	19	based	base	VERB
bam-10675	21	20	on	on	ADP
bam-10675	21	21	hormone	hormone	NOUN
bam-10675	21	22	receptors	receptor	NOUN
bam-10675	21	23	and	and	CCONJ
bam-10675	21	24	her2	her2	PROPN
bam-10675	21	25	status	status	NOUN
bam-10675	21	26	)	)	PUNCT
bam-10675	21	27	was	be	AUX
bam-10675	21	28	investigated	investigate	VERB
bam-10675	21	29	.	.	PUNCT
bam-10675	22	1	materials	material	NOUN
bam-10675	22	2	and	and	CCONJ
bam-10675	22	3	methods	method	NOUN
bam-10675	22	4	this	this	PRON
bam-10675	22	5	is	be	AUX
bam-10675	22	6	a	a	DET
bam-10675	22	7	case	case	NOUN
bam-10675	22	8	-	-	PUNCT
bam-10675	22	9	control	control	NOUN
bam-10675	22	10	study	study	NOUN
bam-10675	22	11	conducted	conduct	VERB
bam-10675	22	12	in	in	ADP
bam-10675	22	13	a	a	DET
bam-10675	22	14	tertiary	tertiary	ADJ
bam-10675	22	15	hospital	hospital	NOUN
bam-10675	22	16	(	(	PUNCT
bam-10675	22	17	affiliated	affiliate	VERB
bam-10675	22	18	with	with	ADP
bam-10675	22	19	semnan	semnan	PROPN
bam-10675	22	20	university	university	PROPN
bam-10675	22	21	of	of	ADP
bam-10675	22	22	medical	medical	ADJ
bam-10675	22	23	sciences	science	NOUN
bam-10675	22	24	)	)	PUNCT
bam-10675	22	25	on	on	ADP
bam-10675	22	26	patients	patient	NOUN
bam-10675	22	27	with	with	ADP
bam-10675	22	28	breast	breast	NOUN
bam-10675	22	29	cancer	cancer	NOUN
bam-10675	22	30	as	as	ADP
bam-10675	22	31	a	a	DET
bam-10675	22	32	case	case	NOUN
bam-10675	22	33	group	group	NOUN
bam-10675	22	34	.	.	PUNCT
bam-10675	23	1	the	the	DET
bam-10675	23	2	study	study	NOUN
bam-10675	23	3	was	be	AUX
bam-10675	23	4	conducted	conduct	VERB
bam-10675	23	5	in	in	ADP
bam-10675	23	6	concordance	concordance	NOUN
bam-10675	23	7	with	with	ADP
bam-10675	23	8	the	the	DET
bam-10675	23	9	declaration	declaration	NOUN
bam-10675	23	10	of	of	ADP
bam-10675	23	11	helsinki	helsinki	PROPN
bam-10675	23	12	and	and	CCONJ
bam-10675	23	13	its	its	PRON
bam-10675	23	14	later	later	ADJ
bam-10675	23	15	amendments	amendment	NOUN
bam-10675	23	16	.	.	PUNCT
bam-10675	24	1	the	the	DET
bam-10675	24	2	local	local	ADJ
bam-10675	24	3	ethical	ethical	PROPN
bam-10675	24	4	committee	committee	NOUN
bam-10675	24	5	approved	approve	VERB
bam-10675	24	6	the	the	DET
bam-10675	24	7	protocol	protocol	NOUN
bam-10675	24	8	,	,	PUNCT
bam-10675	24	9	and	and	CCONJ
bam-10675	24	10	all	all	DET
bam-10675	24	11	patients	patient	NOUN
bam-10675	24	12	filled	fill	VERB
bam-10675	24	13	out	out	ADP
bam-10675	24	14	informed	informed	ADJ
bam-10675	24	15	consent	consent	NOUN
bam-10675	24	16	before	before	ADP
bam-10675	24	17	entering	enter	VERB
bam-10675	24	18	the	the	DET
bam-10675	24	19	study	study	NOUN
bam-10675	24	20	(	(	PUNCT
bam-10675	24	21	irsemums.rfc.13990068	irsemums.rfc.13990068	PROPN
bam-10675	24	22	)	)	PUNCT
bam-10675	24	23	.	.	PUNCT
bam-10675	25	1	the	the	DET
bam-10675	25	2	patients	patient	NOUN
bam-10675	25	3	were	be	AUX
bam-10675	25	4	recruited	recruit	VERB
bam-10675	25	5	from	from	ADP
bam-10675	25	6	the	the	DET
bam-10675	25	7	hospital	hospital	NOUN
bam-10675	25	8	’s	’s	PART
bam-10675	25	9	surgery	surgery	NOUN
bam-10675	25	10	clinic	clinic	NOUN
bam-10675	25	11	in	in	ADP
bam-10675	25	12	2020	2020	NUM
bam-10675	25	13	and	and	CCONJ
bam-10675	25	14	2021	2021	NUM
bam-10675	25	15	.	.	PUNCT
bam-10675	26	1	we	we	PRON
bam-10675	26	2	included	include	VERB
bam-10675	26	3	consecutive	consecutive	ADJ
bam-10675	26	4	patients	patient	NOUN
bam-10675	26	5	who	who	PRON
bam-10675	26	6	came	come	VERB
bam-10675	26	7	to	to	ADP
bam-10675	26	8	the	the	DET
bam-10675	26	9	surgery	surgery	NOUN
bam-10675	26	10	clinic	clinic	NOUN
bam-10675	26	11	with	with	ADP
bam-10675	26	12	newly	newly	ADV
bam-10675	26	13	diagnosed	diagnose	VERB
bam-10675	26	14	breast	breast	NOUN
bam-10675	26	15	cancer	cancer	NOUN
bam-10675	26	16	as	as	ADP
bam-10675	26	17	our	our	PRON
bam-10675	26	18	case	case	NOUN
bam-10675	26	19	group	group	NOUN
bam-10675	26	20	.	.	PUNCT
bam-10675	27	1	control	control	PROPN
bam-10675	27	2	group	group	PROPN
bam-10675	27	3	members	member	NOUN
bam-10675	27	4	were	be	AUX
bam-10675	27	5	selected	select	VERB
bam-10675	27	6	from	from	ADP
bam-10675	27	7	those	those	PRON
bam-10675	27	8	who	who	PRON
bam-10675	27	9	came	come	VERB
bam-10675	27	10	for	for	ADP
bam-10675	27	11	screening	screen	VERB
bam-10675	27	12	mammography	mammography	NOUN
bam-10675	27	13	and	and	CCONJ
bam-10675	27	14	had	have	VERB
bam-10675	27	15	no	no	DET
bam-10675	27	16	abnormal	abnormal	ADJ
bam-10675	27	17	findings	finding	NOUN
bam-10675	27	18	.	.	PUNCT
bam-10675	28	1	the	the	DET
bam-10675	28	2	serum	serum	NOUN
bam-10675	28	3	levels	level	NOUN
bam-10675	28	4	of	of	ADP
bam-10675	28	5	anti	anti	ADJ
bam-10675	28	6	-	-	ADJ
bam-10675	28	7	tpo	tpo	NOUN
bam-10675	28	8	antibodies	antibodie	VERB
bam-10675	28	9	,	,	PUNCT
bam-10675	28	10	tsh	tsh	NOUN
bam-10675	28	11	,	,	PUNCT
bam-10675	28	12	t3	t3	NOUN
bam-10675	28	13	,	,	PUNCT
bam-10675	28	14	and	and	CCONJ
bam-10675	28	15	t4	t4	PROPN
bam-10675	28	16	were	be	AUX
bam-10675	28	17	assessed	assess	VERB
bam-10675	28	18	in	in	ADP
bam-10675	28	19	participants	participant	NOUN
bam-10675	28	20	of	of	ADP
bam-10675	28	21	both	both	DET
bam-10675	28	22	groups	group	NOUN
bam-10675	28	23	.	.	PUNCT
bam-10675	29	1	they	they	PRON
bam-10675	29	2	were	be	AUX
bam-10675	29	3	excluded	exclude	VERB
bam-10675	29	4	from	from	ADP
bam-10675	29	5	this	this	DET
bam-10675	29	6	study	study	NOUN
bam-10675	29	7	if	if	SCONJ
bam-10675	29	8	they	they	PRON
bam-10675	29	9	had	have	VERB
bam-10675	29	10	any	any	DET
bam-10675	29	11	abnormality	abnormality	NOUN
bam-10675	29	12	in	in	ADP
bam-10675	29	13	these	these	DET
bam-10675	29	14	tests	test	NOUN
bam-10675	29	15	,	,	PUNCT
bam-10675	29	16	had	have	VERB
bam-10675	29	17	a	a	DET
bam-10675	29	18	history	history	NOUN
bam-10675	29	19	of	of	ADP
bam-10675	29	20	thyroid	thyroid	NOUN
bam-10675	29	21	dysfunction	dysfunction	NOUN
bam-10675	29	22	,	,	PUNCT
bam-10675	29	23	or	or	CCONJ
bam-10675	29	24	had	have	VERB
bam-10675	29	25	a	a	DET
bam-10675	29	26	history	history	NOUN
bam-10675	29	27	of	of	ADP
bam-10675	29	28	taking	take	VERB
bam-10675	29	29	thyroid	thyroid	NOUN
bam-10675	29	30	related	relate	VERB
bam-10675	29	31	medication	medication	NOUN
bam-10675	29	32	.	.	PUNCT
bam-10675	30	1	we	we	PRON
bam-10675	30	2	gathered	gather	VERB
bam-10675	30	3	variables	variable	NOUN
bam-10675	30	4	like	like	ADP
bam-10675	30	5	age	age	NOUN
bam-10675	30	6	,	,	PUNCT
bam-10675	30	7	and	and	CCONJ
bam-10675	30	8	serum	serum	NOUN
bam-10675	30	9	levels	level	NOUN
bam-10675	30	10	of	of	ADP
bam-10675	30	11	tsh	tsh	NOUN
bam-10675	30	12	,	,	PUNCT
bam-10675	30	13	t3	t3	PROPN
bam-10675	30	14	,	,	PUNCT
bam-10675	30	15	t4	t4	PROPN
bam-10675	30	16	,	,	PUNCT
bam-10675	30	17	and	and	CCONJ
bam-10675	30	18	anti	anti	ADJ
bam-10675	30	19	-	-	ADJ
bam-10675	30	20	thyroid	thyroid	ADJ
bam-10675	30	21	peroxidase	peroxidase	NOUN
bam-10675	30	22	(	(	PUNCT
bam-10675	30	23	anti	anti	ADJ
bam-10675	30	24	-	-	NOUN
bam-10675	30	25	tpo	tpo	NOUN
bam-10675	30	26	)	)	PUNCT
bam-10675	30	27	from	from	ADP
bam-10675	30	28	both	both	DET
bam-10675	30	29	groups	group	NOUN
bam-10675	30	30	of	of	ADP
bam-10675	30	31	subjects	subject	NOUN
bam-10675	30	32	.	.	PUNCT
bam-10675	31	1	data	datum	NOUN
bam-10675	31	2	on	on	ADP
bam-10675	31	3	tumor	tumor	NOUN
bam-10675	31	4	staging	staging	NOUN
bam-10675	31	5	,	,	PUNCT
bam-10675	31	6	er	er	INTJ
bam-10675	31	7	,	,	PUNCT
bam-10675	31	8	pr	pr	NOUN
bam-10675	31	9	,	,	PUNCT
bam-10675	31	10	and	and	CCONJ
bam-10675	31	11	her-2	her-2	NUM
bam-10675	31	12	were	be	AUX
bam-10675	31	13	also	also	ADV
bam-10675	31	14	retrieved	retrieve	VERB
bam-10675	31	15	from	from	ADP
bam-10675	31	16	the	the	DET
bam-10675	31	17	case	case	NOUN
bam-10675	31	18	group	group	NOUN
bam-10675	31	19	.	.	PUNCT
bam-10675	32	1	we	we	PRON
bam-10675	32	2	used	use	VERB
bam-10675	32	3	ibm	ibm	PROPN
bam-10675	32	4	spss	spss	PROPN
bam-10675	32	5	25	25	NUM
bam-10675	32	6	to	to	PART
bam-10675	32	7	analyze	analyze	VERB
bam-10675	32	8	the	the	DET
bam-10675	32	9	data	datum	NOUN
bam-10675	32	10	(	(	PUNCT
bam-10675	32	11	ibm	ibm	PROPN
bam-10675	32	12	spss	spss	PROPN
bam-10675	32	13	statistics	statistic	NOUN
bam-10675	32	14	for	for	ADP
bam-10675	32	15	windows	window	NOUN
bam-10675	32	16	,	,	PUNCT
bam-10675	32	17	version	version	NOUN
bam-10675	32	18	25.0	25.0	NUM
bam-10675	32	19	.	.	PUNCT
bam-10675	33	1	armonk	armonk	PROPN
bam-10675	33	2	,	,	PUNCT
bam-10675	33	3	ny	ny	PROPN
bam-10675	33	4	:	:	PROPN
bam-10675	33	5	ibm	ibm	PROPN
bam-10675	33	6	corp	corp	PROPN
bam-10675	33	7	)	)	PUNCT
bam-10675	33	8	.	.	PUNCT
bam-10675	34	1	to	to	PART
bam-10675	34	2	assess	assess	VERB
bam-10675	34	3	the	the	DET
bam-10675	34	4	normality	normality	NOUN
bam-10675	34	5	of	of	ADP
bam-10675	34	6	the	the	DET
bam-10675	34	7	data	datum	NOUN
bam-10675	34	8	,	,	PUNCT
bam-10675	34	9	we	we	PRON
bam-10675	34	10	implemented	implement	VERB
bam-10675	34	11	the	the	DET
bam-10675	34	12	shapiro	shapiro	PROPN
bam-10675	34	13	-	-	PUNCT
bam-10675	34	14	wilk	wilk	NOUN
bam-10675	34	15	test	test	NOUN
bam-10675	34	16	.	.	PUNCT
bam-10675	35	1	numeric	numeric	ADJ
bam-10675	35	2	data	datum	NOUN
bam-10675	35	3	were	be	AUX
bam-10675	35	4	reported	report	VERB
bam-10675	35	5	as	as	ADP
bam-10675	35	6	frequency	frequency	NOUN
bam-10675	35	7	and	and	CCONJ
bam-10675	35	8	percentage	percentage	NOUN
bam-10675	35	9	,	,	PUNCT
bam-10675	35	10	and	and	CCONJ
bam-10675	35	11	continuous	continuous	ADJ
bam-10675	35	12	data	datum	NOUN
bam-10675	35	13	were	be	AUX
bam-10675	35	14	described	describe	VERB
bam-10675	35	15	as	as	ADP
bam-10675	35	16	mean	mean	ADJ
bam-10675	35	17	and	and	CCONJ
bam-10675	35	18	standard	standard	ADJ
bam-10675	35	19	deviation	deviation	NOUN
bam-10675	35	20	.	.	PUNCT
bam-10675	36	1	parametric	parametric	ADJ
bam-10675	36	2	numeric	numeric	ADJ
bam-10675	36	3	data	datum	NOUN
bam-10675	36	4	were	be	AUX
bam-10675	36	5	compared	compare	VERB
bam-10675	36	6	using	use	VERB
bam-10675	36	7	the	the	DET
bam-10675	36	8	χ2	χ2	PROPN
bam-10675	36	9	test	test	NOUN
bam-10675	36	10	.	.	PUNCT
bam-10675	37	1	the	the	DET
bam-10675	37	2	independent	independent	ADJ
bam-10675	37	3	sample	sample	NOUN
bam-10675	37	4	t	t	NOUN
bam-10675	37	5	-	-	PUNCT
bam-10675	37	6	test	test	NOUN
bam-10675	37	7	compared	compare	VERB
bam-10675	37	8	normally	normally	ADV
bam-10675	37	9	distributed	distribute	VERB
bam-10675	37	10	continuous	continuous	ADJ
bam-10675	37	11	variables	variable	NOUN
bam-10675	37	12	.	.	PUNCT
bam-10675	38	1	to	to	PART
bam-10675	38	2	analyze	analyze	VERB
bam-10675	38	3	the	the	DET
bam-10675	38	4	means	mean	NOUN
bam-10675	38	5	of	of	ADP
bam-10675	38	6	more	more	ADJ
bam-10675	38	7	than	than	ADP
bam-10675	38	8	two	two	NUM
bam-10675	38	9	variables	variable	NOUN
bam-10675	38	10	,	,	PUNCT
bam-10675	38	11	analysis	analysis	NOUN
bam-10675	38	12	of	of	ADP
bam-10675	38	13	variances	variance	NOUN
bam-10675	38	14	(	(	PUNCT
bam-10675	38	15	anova	anova	PROPN
bam-10675	38	16	)	)	PUNCT
bam-10675	38	17	was	be	AUX
bam-10675	38	18	used	use	VERB
bam-10675	38	19	.	.	PUNCT
bam-10675	39	1	a	a	DET
bam-10675	39	2	p	p	NOUN
bam-10675	39	3	-	-	PUNCT
bam-10675	39	4	value	value	NOUN
bam-10675	39	5	of	of	ADP
bam-10675	39	6	less	less	ADJ
bam-10675	39	7	than	than	ADP
bam-10675	39	8	0.05	0.05	NUM
bam-10675	39	9	was	be	AUX
bam-10675	39	10	considered	consider	VERB
bam-10675	39	11	statistically	statistically	ADV
bam-10675	39	12	significant	significant	ADJ
bam-10675	39	13	.	.	PUNCT
bam-10675	40	1	results	result	NOUN
bam-10675	40	2	we	we	PRON
bam-10675	40	3	included	include	VERB
bam-10675	40	4	69	69	NUM
bam-10675	40	5	participants	participant	NOUN
bam-10675	40	6	in	in	ADP
bam-10675	40	7	the	the	DET
bam-10675	40	8	study	study	NOUN
bam-10675	40	9	(	(	PUNCT
bam-10675	40	10	39	39	NUM
bam-10675	40	11	breast	breast	NOUN
bam-10675	40	12	cancer	cancer	NOUN
bam-10675	40	13	patients	patient	NOUN
bam-10675	40	14	and	and	CCONJ
bam-10675	40	15	30	30	NUM
bam-10675	40	16	control	control	NOUN
bam-10675	40	17	subjects	subject	NOUN
bam-10675	40	18	with	with	ADP
bam-10675	40	19	normal	normal	ADJ
bam-10675	40	20	mammography	mammography	NOUN
bam-10675	40	21	results	result	NOUN
bam-10675	40	22	)	)	PUNCT
bam-10675	40	23	.	.	PUNCT
bam-10675	41	1	mean	mean	NOUN
bam-10675	41	2	age	age	NOUN
bam-10675	41	3	was	be	AUX
bam-10675	41	4	55.5	55.5	NUM
bam-10675	41	5	(	(	PUNCT
bam-10675	41	6	sd	sd	NOUN
bam-10675	41	7	:	:	PUNCT
bam-10675	41	8	9.5	9.5	NUM
bam-10675	41	9	)	)	PUNCT
bam-10675	41	10	year	year	NOUN
bam-10675	41	11	-	-	PUNCT
bam-10675	41	12	old	old	ADJ
bam-10675	41	13	and	and	CCONJ
bam-10675	41	14	47.7	47.7	NUM
bam-10675	41	15	(	(	PUNCT
bam-10675	41	16	sd	sd	NOUN
bam-10675	41	17	:	:	PUNCT
bam-10675	41	18	15.0	15.0	NUM
bam-10675	41	19	)	)	PUNCT
bam-10675	41	20	year	year	NOUN
bam-10675	41	21	-	-	PUNCT
bam-10675	41	22	old	old	ADJ
bam-10675	41	23	in	in	ADP
bam-10675	41	24	the	the	DET
bam-10675	41	25	case	case	NOUN
bam-10675	41	26	and	and	CCONJ
bam-10675	41	27	control	control	NOUN
bam-10675	41	28	groups	group	NOUN
bam-10675	41	29	,	,	PUNCT
bam-10675	41	30	respectively	respectively	ADV
bam-10675	41	31	;	;	PUNCT
bam-10675	41	32	this	this	DET
bam-10675	41	33	difference	difference	NOUN
bam-10675	41	34	was	be	AUX
bam-10675	41	35	statistically	statistically	ADV
bam-10675	41	36	significant	significant	ADJ
bam-10675	41	37	(	(	PUNCT
bam-10675	41	38	p	p	NOUN
bam-10675	41	39	-	-	PUNCT
bam-10675	41	40	value	value	NOUN
bam-10675	41	41	:	:	PUNCT
bam-10675	41	42	0.016	0.016	NUM
bam-10675	41	43	)	)	PUNCT
bam-10675	41	44	.	.	PUNCT
bam-10675	42	1	as	as	SCONJ
bam-10675	42	2	table	table	NOUN
bam-10675	42	3	1	1	NUM
bam-10675	42	4	represents	represent	VERB
bam-10675	42	5	,	,	PUNCT
bam-10675	42	6	most	most	ADJ
bam-10675	42	7	patients	patient	NOUN
bam-10675	42	8	were	be	AUX
bam-10675	42	9	er	er	INTJ
bam-10675	42	10	and	and	CCONJ
bam-10675	42	11	pr	pr	X
bam-10675	42	12	positive	positive	ADJ
bam-10675	42	13	,	,	PUNCT
bam-10675	42	14	while	while	SCONJ
bam-10675	42	15	most	most	ADJ
bam-10675	42	16	of	of	ADP
bam-10675	42	17	them	they	PRON
bam-10675	42	18	were	be	AUX
bam-10675	42	19	her-2	her-2	X
bam-10675	42	20	negative	negative	ADJ
bam-10675	42	21	.	.	PUNCT
bam-10675	43	1	regarding	regard	VERB
bam-10675	43	2	the	the	DET
bam-10675	43	3	tumor	tumor	NOUN
bam-10675	43	4	staging	staging	NOUN
bam-10675	43	5	,	,	PUNCT
bam-10675	43	6	44.1	44.1	NUM
bam-10675	43	7	%	%	NOUN
bam-10675	43	8	of	of	ADP
bam-10675	43	9	patients	patient	NOUN
bam-10675	43	10	had	have	VERB
bam-10675	43	11	the	the	DET
bam-10675	43	12	tumor	tumor	NOUN
bam-10675	43	13	score	score	NOUN
bam-10675	43	14	of	of	ADP
bam-10675	43	15	two	two	NUM
bam-10675	43	16	without	without	ADP
bam-10675	43	17	any	any	DET
bam-10675	43	18	lymph	lymph	NOUN
bam-10675	43	19	node	node	NOUN
bam-10675	43	20	involvement	involvement	NOUN
bam-10675	43	21	or	or	CCONJ
bam-10675	43	22	metastasis	metastasis	NOUN
bam-10675	43	23	(	(	PUNCT
bam-10675	43	24	t2n0m0	t2n0m0	PROPN
bam-10675	43	25	)	)	PUNCT
bam-10675	43	26	.	.	PUNCT
bam-10675	44	1	there	there	PRON
bam-10675	44	2	was	be	VERB
bam-10675	44	3	a	a	DET
bam-10675	44	4	significant	significant	ADJ
bam-10675	44	5	difference	difference	NOUN
bam-10675	44	6	between	between	ADP
bam-10675	44	7	the	the	DET
bam-10675	44	8	two	two	NUM
bam-10675	44	9	groups	group	NOUN
bam-10675	44	10	concerning	concern	VERB
bam-10675	44	11	serum	serum	PROPN
bam-10675	44	12	t4	t4	PROPN
bam-10675	44	13	and	and	CCONJ
bam-10675	44	14	tsh	tsh	NOUN
bam-10675	44	15	levels	level	NOUN
bam-10675	44	16	(	(	PUNCT
bam-10675	44	17	pvalue	pvalue	NOUN
bam-10675	44	18	:	:	PUNCT
bam-10675	44	19	0.034	0.034	NUM
bam-10675	44	20	and	and	CCONJ
bam-10675	44	21	<	<	X
bam-10675	44	22	0.001	0.001	NUM
bam-10675	44	23	,	,	PUNCT
bam-10675	44	24	respectively	respectively	ADV
bam-10675	44	25	)	)	PUNCT
bam-10675	44	26	.	.	PUNCT
bam-10675	45	1	on	on	ADP
bam-10675	45	2	the	the	DET
bam-10675	45	3	other	other	ADJ
bam-10675	45	4	hand	hand	NOUN
bam-10675	45	5	,	,	PUNCT
bam-10675	45	6	serum	serum	PROPN
bam-10675	45	7	t3	t3	PROPN
bam-10675	45	8	levels	level	NOUN
bam-10675	45	9	did	do	AUX
bam-10675	45	10	not	not	PART
bam-10675	45	11	significantly	significantly	ADV
bam-10675	45	12	differ	differ	VERB
bam-10675	45	13	between	between	ADP
bam-10675	45	14	the	the	DET
bam-10675	45	15	case	case	NOUN
bam-10675	45	16	and	and	CCONJ
bam-10675	45	17	control	control	NOUN
bam-10675	45	18	groups	group	NOUN
bam-10675	45	19	(	(	PUNCT
bam-10675	45	20	p	p	NOUN
bam-10675	45	21	-	-	PUNCT
bam-10675	45	22	value	value	NOUN
bam-10675	45	23	:	:	PUNCT
bam-10675	45	24	0.177	0.177	NUM
bam-10675	45	25	)	)	PUNCT
bam-10675	45	26	.	.	PUNCT
bam-10675	46	1	the	the	DET
bam-10675	46	2	mean	mean	ADJ
bam-10675	46	3	serum	serum	NOUN
bam-10675	46	4	anti	anti	ADJ
bam-10675	46	5	-	-	ADJ
bam-10675	46	6	tpo	tpo	ADJ
bam-10675	46	7	levels	level	NOUN
bam-10675	46	8	were	be	AUX
bam-10675	46	9	65.15	65.15	NUM
bam-10675	46	10	(	(	PUNCT
bam-10675	46	11	sd	sd	NOUN
bam-10675	46	12	:	:	PUNCT
bam-10675	46	13	179.74	179.74	NUM
bam-10675	46	14	)	)	PUNCT
bam-10675	46	15	iu	iu	NOUN
bam-10675	46	16	/	/	SYM
bam-10675	46	17	ml	ml	NOUN
bam-10675	46	18	and	and	CCONJ
bam-10675	46	19	152.53	152.53	NUM
bam-10675	46	20	(	(	PUNCT
bam-10675	46	21	sd	sd	NOUN
bam-10675	46	22	:	:	PUNCT
bam-10675	46	23	317.30	317.30	NUM
bam-10675	46	24	)	)	PUNCT
bam-10675	46	25	iu	iu	ADP
bam-10675	46	26	/	/	SYM
bam-10675	46	27	ml	ml	NOUN
bam-10675	46	28	in	in	ADP
bam-10675	46	29	the	the	DET
bam-10675	46	30	case	case	NOUN
bam-10675	46	31	and	and	CCONJ
bam-10675	46	32	the	the	DET
bam-10675	46	33	control	control	NOUN
bam-10675	46	34	group	group	NOUN
bam-10675	46	35	,	,	PUNCT
bam-10675	46	36	respectively	respectively	ADV
bam-10675	46	37	.	.	PUNCT
bam-10675	47	1	however	however	ADV
bam-10675	47	2	,	,	PUNCT
bam-10675	47	3	the	the	DET
bam-10675	47	4	difference	difference	NOUN
bam-10675	47	5	in	in	ADP
bam-10675	47	6	serum	serum	NOUN
bam-10675	47	7	anti	anti	ADJ
bam-10675	47	8	-	-	ADJ
bam-10675	47	9	tpo	tpo	ADJ
bam-10675	47	10	levels	level	NOUN
bam-10675	47	11	between	between	ADP
bam-10675	47	12	the	the	DET
bam-10675	47	13	two	two	NUM
bam-10675	47	14	groups	group	NOUN
bam-10675	47	15	was	be	AUX
bam-10675	47	16	not	not	PART
bam-10675	47	17	statistically	statistically	ADV
bam-10675	47	18	significant	significant	ADJ
bam-10675	47	19	(	(	PUNCT
bam-10675	47	20	p	p	NOUN
bam-10675	47	21	-	-	PUNCT
bam-10675	47	22	value	value	NOUN
bam-10675	47	23	:	:	PUNCT
bam-10675	47	24	0.184	0.184	NUM
bam-10675	47	25	)	)	PUNCT
bam-10675	47	26	.	.	PUNCT
bam-10675	48	1	table	table	NOUN
bam-10675	48	2	1	1	NUM
bam-10675	48	3	.	.	PUNCT
bam-10675	49	1	demographic	demographic	ADJ
bam-10675	49	2	data	datum	NOUN
bam-10675	49	3	of	of	ADP
bam-10675	49	4	tumor	tumor	NOUN
bam-10675	49	5	staging	staging	NOUN
bam-10675	49	6	and	and	CCONJ
bam-10675	49	7	er	er	INTJ
bam-10675	49	8	,	,	PUNCT
bam-10675	49	9	pr	pr	NOUN
bam-10675	49	10	and	and	CCONJ
bam-10675	49	11	her2	her2	PROPN
bam-10675	49	12	.	.	PUNCT
bam-10675	50	1	number	number	NOUN
bam-10675	50	2	percentage	percentage	NOUN
bam-10675	50	3	stage	stage	NOUN
bam-10675	50	4	t1n0	t1n0	NOUN
bam-10675	50	5	5	5	NUM
bam-10675	50	6	12.8	12.8	NUM
bam-10675	50	7	t1n1	t1n1	X
bam-10675	50	8	3	3	NUM
bam-10675	50	9	7.7	7.7	NUM
bam-10675	50	10	t2n0	t2n0	SYM
bam-10675	50	11	15	15	NUM
bam-10675	50	12	38.5	38.5	NUM
bam-10675	50	13	t2n1	t2n1	ADP
bam-10675	50	14	2	2	NUM
bam-10675	50	15	5.1	5.1	NUM
bam-10675	50	16	t3n0	t3n0	NOUN
bam-10675	50	17	4	4	NUM
bam-10675	50	18	10.3	10.3	NUM
bam-10675	50	19	t3n2	t3n2	SYM
bam-10675	50	20	4	4	NUM
bam-10675	50	21	10.3	10.3	NUM
bam-10675	50	22	t4	t4	PROPN
bam-10675	50	23	1	1	NUM
bam-10675	50	24	2.6	2.6	NUM
bam-10675	50	25	missing	miss	VERB
bam-10675	50	26	data	datum	NOUN
bam-10675	50	27	5	5	NUM
bam-10675	50	28	12.8	12.8	NUM
bam-10675	50	29	er	er	INTJ
bam-10675	50	30	positive	positive	ADJ
bam-10675	50	31	25	25	NUM
bam-10675	50	32	64.1	64.1	NUM
bam-10675	50	33	negative	negative	ADJ
bam-10675	50	34	12	12	NUM
bam-10675	50	35	30.8	30.8	NUM
bam-10675	50	36	missing	miss	VERB
bam-10675	50	37	data	datum	NOUN
bam-10675	50	38	2	2	NUM
bam-10675	50	39	5.1	5.1	NUM
bam-10675	50	40	pr	pr	NOUN
bam-10675	50	41	positive	positive	ADJ
bam-10675	50	42	23	23	NUM
bam-10675	50	43	59.0	59.0	NUM
bam-10675	50	44	negative	negative	ADJ
bam-10675	50	45	13	13	NUM
bam-10675	50	46	33.3	33.3	NUM
bam-10675	50	47	missing	missing	ADJ
bam-10675	50	48	data	datum	NOUN
bam-10675	50	49	3	3	NUM
bam-10675	50	50	7.7	7.7	NUM
bam-10675	50	51	her-2	her-2	NUM
bam-10675	50	52	positive	positive	ADJ
bam-10675	50	53	(	(	PUNCT
bam-10675	50	54	3	3	NUM
bam-10675	50	55	+	+	NOUN
bam-10675	50	56	)	)	PUNCT
bam-10675	50	57	5	5	NUM
bam-10675	50	58	12.8	12.8	NUM
bam-10675	50	59	positive	positive	ADJ
bam-10675	50	60	(	(	PUNCT
bam-10675	50	61	2	2	NUM
bam-10675	50	62	+	+	NOUN
bam-10675	50	63	)	)	PUNCT
bam-10675	50	64	6	6	NUM
bam-10675	50	65	15.4	15.4	NUM
bam-10675	50	66	positive	positive	ADJ
bam-10675	50	67	(	(	PUNCT
bam-10675	50	68	1	1	NUM
bam-10675	50	69	+	+	NOUN
bam-10675	50	70	)	)	PUNCT
bam-10675	50	71	1	1	NUM
bam-10675	50	72	2.6	2.6	NUM
bam-10675	50	73	negative	negative	ADJ
bam-10675	50	74	24	24	NUM
bam-10675	50	75	61.5	61.5	NUM
bam-10675	50	76	missing	miss	VERB
bam-10675	50	77	data	datum	NOUN
bam-10675	50	78	3	3	NUM
bam-10675	50	79	7.7	7.7	NUM
bam-10675	50	80	er	er	INTJ
bam-10675	50	81	:	:	PUNCT
bam-10675	50	82	estrogen	estrogen	NOUN
bam-10675	50	83	receptor	receptor	NOUN
bam-10675	50	84	;	;	PUNCT
bam-10675	50	85	pr	pr	X
bam-10675	50	86	:	:	PUNCT
bam-10675	50	87	progesterone	progesterone	NOUN
bam-10675	50	88	receptor	receptor	NOUN
bam-10675	50	89	;	;	PUNCT
bam-10675	50	90	her-2	her-2	NUM
bam-10675	50	91	:	:	PUNCT
bam-10675	50	92	human	human	ADJ
bam-10675	50	93	epidermal	epidermal	ADJ
bam-10675	50	94	growth	growth	NOUN
bam-10675	50	95	factor	factor	NOUN
bam-10675	50	96	2	2	NUM
bam-10675	50	97	.	.	PUNCT
bam-10675	50	98	non	non	ADJ
bam-10675	51	1	-co	-co	PROPN
bam-10675	51	2	mmerc	mmerc	PROPN
bam-10675	51	3	ial	ial	PROPN
bam-10675	51	4	us	us	PROPN
bam-10675	51	5	e	e	NOUN
bam-10675	51	6	o	o	X
bam-10675	51	7	nly	nly	ADV
bam-10675	51	8	anti	anti	ADJ
bam-10675	51	9	-	-	ADJ
bam-10675	51	10	tpo	tpo	ADJ
bam-10675	51	11	antibody	antibody	NOUN
bam-10675	51	12	and	and	CCONJ
bam-10675	51	13	thyroid	thyroid	VERB
bam-10675	51	14	hormone	hormone	NOUN
bam-10675	51	15	levels	level	NOUN
bam-10675	51	16	in	in	ADP
bam-10675	51	17	breast	breast	NOUN
bam-10675	51	18	cancer	cancer	NOUN
bam-10675	51	19	eur	eur	PROPN
bam-10675	51	20	j	j	PROPN
bam-10675	51	21	transl	transl	PROPN
bam-10675	51	22	myol	myol	ADV
bam-10675	51	23	33	33	NUM
bam-10675	51	24	(	(	PUNCT
bam-10675	51	25	1	1	NUM
bam-10675	51	26	)	)	PUNCT
bam-10675	51	27	10675	10675	NUM
bam-10675	51	28	,	,	PUNCT
bam-10675	51	29	2023	2023	NUM
bam-10675	51	30	doi	doi	NOUN
bam-10675	51	31	:	:	PUNCT
bam-10675	51	32	10.4081	10.4081	NUM
bam-10675	51	33	/	/	SYM
bam-10675	51	34	ejtm.2023.10675	ejtm.2023.10675	NOUN
bam-10675	51	35	3	3	NUM
bam-10675	51	36	subgroup	subgroup	NOUN
bam-10675	51	37	analysis	analysis	NOUN
bam-10675	51	38	revealed	reveal	VERB
bam-10675	51	39	that	that	SCONJ
bam-10675	51	40	there	there	PRON
bam-10675	51	41	is	be	VERB
bam-10675	51	42	no	no	DET
bam-10675	51	43	significant	significant	ADJ
bam-10675	51	44	difference	difference	NOUN
bam-10675	51	45	between	between	ADP
bam-10675	51	46	different	different	ADJ
bam-10675	51	47	stages	stage	NOUN
bam-10675	51	48	of	of	ADP
bam-10675	51	49	breast	breast	NOUN
bam-10675	51	50	cancer	cancer	NOUN
bam-10675	51	51	in	in	ADP
bam-10675	51	52	respect	respect	NOUN
bam-10675	51	53	to	to	ADP
bam-10675	51	54	anti	anti	ADJ
bam-10675	51	55	-	-	ADJ
bam-10675	51	56	tpo	tpo	ADJ
bam-10675	51	57	levels	level	NOUN
bam-10675	51	58	(	(	PUNCT
bam-10675	51	59	p	p	NOUN
bam-10675	51	60	-	-	PUNCT
bam-10675	51	61	value	value	NOUN
bam-10675	51	62	:	:	PUNCT
bam-10675	51	63	0.343	0.343	NUM
bam-10675	51	64	)	)	PUNCT
bam-10675	51	65	.	.	PUNCT
bam-10675	52	1	likewise	likewise	ADV
bam-10675	52	2	,	,	PUNCT
bam-10675	52	3	prognostic	prognostic	ADJ
bam-10675	52	4	factors	factor	NOUN
bam-10675	52	5	(	(	PUNCT
bam-10675	52	6	er	er	INTJ
bam-10675	52	7	,	,	PUNCT
bam-10675	52	8	pr	pr	NOUN
bam-10675	52	9	,	,	PUNCT
bam-10675	52	10	her-2	her-2	NUM
bam-10675	52	11	)	)	PUNCT
bam-10675	52	12	had	have	VERB
bam-10675	52	13	no	no	DET
bam-10675	52	14	significant	significant	ADJ
bam-10675	52	15	relationship	relationship	NOUN
bam-10675	52	16	with	with	ADP
bam-10675	52	17	anti	anti	ADJ
bam-10675	52	18	-	-	ADJ
bam-10675	52	19	tpo	tpo	ADJ
bam-10675	52	20	levels	level	NOUN
bam-10675	52	21	(	(	PUNCT
bam-10675	52	22	table	table	NOUN
bam-10675	52	23	2	2	NUM
bam-10675	52	24	)	)	PUNCT
bam-10675	52	25	.	.	PUNCT
bam-10675	53	1	discussion	discussion	NOUN
bam-10675	53	2	there	there	PRON
bam-10675	53	3	has	have	AUX
bam-10675	53	4	been	be	AUX
bam-10675	53	5	a	a	DET
bam-10675	53	6	long	long	ADJ
bam-10675	53	7	debate	debate	NOUN
bam-10675	53	8	over	over	ADP
bam-10675	53	9	causal	causal	ADJ
bam-10675	53	10	relationship	relationship	NOUN
bam-10675	53	11	between	between	ADP
bam-10675	53	12	thyroid	thyroid	NOUN
bam-10675	53	13	autoimmunity	autoimmunity	NOUN
bam-10675	53	14	and	and	CCONJ
bam-10675	53	15	breast	breast	NOUN
bam-10675	53	16	cancer	cancer	NOUN
bam-10675	53	17	,	,	PUNCT
bam-10675	53	18	and	and	CCONJ
bam-10675	53	19	no	no	DET
bam-10675	53	20	consensus	consensus	NOUN
bam-10675	53	21	has	have	AUX
bam-10675	53	22	been	be	AUX
bam-10675	53	23	reached	reach	VERB
bam-10675	53	24	.	.	PUNCT
bam-10675	54	1	in	in	ADP
bam-10675	54	2	this	this	DET
bam-10675	54	3	case	case	NOUN
bam-10675	54	4	-	-	PUNCT
bam-10675	54	5	control	control	NOUN
bam-10675	54	6	study	study	NOUN
bam-10675	54	7	,	,	PUNCT
bam-10675	54	8	thyroid	thyroid	NOUN
bam-10675	54	9	hormones	hormone	NOUN
bam-10675	54	10	and	and	CCONJ
bam-10675	54	11	antitpo	antitpo	NOUN
bam-10675	54	12	antibody	antibody	NOUN
bam-10675	54	13	were	be	AUX
bam-10675	54	14	compared	compare	VERB
bam-10675	54	15	between	between	ADP
bam-10675	54	16	the	the	DET
bam-10675	54	17	groups	group	NOUN
bam-10675	54	18	.	.	PUNCT
bam-10675	55	1	significantly	significantly	ADV
bam-10675	55	2	higher	high	ADJ
bam-10675	55	3	levels	level	NOUN
bam-10675	55	4	of	of	ADP
bam-10675	55	5	tsh	tsh	NOUN
bam-10675	55	6	and	and	CCONJ
bam-10675	55	7	t4	t4	PROPN
bam-10675	55	8	were	be	AUX
bam-10675	55	9	observed	observe	VERB
bam-10675	55	10	in	in	ADP
bam-10675	55	11	breast	breast	NOUN
bam-10675	55	12	cancer	cancer	NOUN
bam-10675	55	13	group	group	NOUN
bam-10675	55	14	.	.	PUNCT
bam-10675	56	1	in	in	ADP
bam-10675	56	2	contrast	contrast	NOUN
bam-10675	56	3	,	,	PUNCT
bam-10675	56	4	we	we	PRON
bam-10675	56	5	did	do	AUX
bam-10675	56	6	not	not	PART
bam-10675	56	7	find	find	VERB
bam-10675	56	8	any	any	DET
bam-10675	56	9	significant	significant	ADJ
bam-10675	56	10	correlation	correlation	NOUN
bam-10675	56	11	between	between	ADP
bam-10675	56	12	anti	anti	ADJ
bam-10675	56	13	-	-	ADJ
bam-10675	56	14	tpo	tpo	NOUN
bam-10675	56	15	or	or	CCONJ
bam-10675	56	16	t3	t3	PROPN
bam-10675	56	17	levels	level	NOUN
bam-10675	56	18	,	,	PUNCT
bam-10675	56	19	and	and	CCONJ
bam-10675	56	20	breast	breast	NOUN
bam-10675	56	21	cancer	cancer	NOUN
bam-10675	56	22	incidence	incidence	NOUN
bam-10675	56	23	.	.	PUNCT
bam-10675	57	1	however	however	ADV
bam-10675	57	2	,	,	PUNCT
bam-10675	57	3	the	the	DET
bam-10675	57	4	large	large	ADJ
bam-10675	57	5	numerical	numerical	ADJ
bam-10675	57	6	difference	difference	NOUN
bam-10675	57	7	of	of	ADP
bam-10675	57	8	anti	anti	ADJ
bam-10675	57	9	-	-	ADJ
bam-10675	57	10	tpo	tpo	ADJ
bam-10675	57	11	levels	level	NOUN
bam-10675	57	12	between	between	ADP
bam-10675	57	13	study	study	NOUN
bam-10675	57	14	groups	group	NOUN
bam-10675	57	15	may	may	AUX
bam-10675	57	16	indicate	indicate	VERB
bam-10675	57	17	insufficient	insufficient	ADJ
bam-10675	57	18	sample	sample	NOUN
bam-10675	57	19	size	size	NOUN
bam-10675	57	20	for	for	ADP
bam-10675	57	21	determination	determination	NOUN
bam-10675	57	22	of	of	ADP
bam-10675	57	23	significance	significance	NOUN
bam-10675	57	24	.	.	PUNCT
bam-10675	58	1	consequently	consequently	ADV
bam-10675	58	2	,	,	PUNCT
bam-10675	58	3	it	it	PRON
bam-10675	58	4	can	can	AUX
bam-10675	58	5	be	be	AUX
bam-10675	58	6	inferred	infer	VERB
bam-10675	58	7	that	that	SCONJ
bam-10675	58	8	while	while	SCONJ
bam-10675	58	9	thyroid	thyroid	NOUN
bam-10675	58	10	hormone	hormone	NOUN
bam-10675	58	11	imbalance	imbalance	NOUN
bam-10675	58	12	is	be	AUX
bam-10675	58	13	more	more	ADV
bam-10675	58	14	common	common	ADJ
bam-10675	58	15	in	in	ADP
bam-10675	58	16	breast	breast	NOUN
bam-10675	58	17	cancer	cancer	NOUN
bam-10675	58	18	population	population	NOUN
bam-10675	58	19	,	,	PUNCT
bam-10675	58	20	higher	high	ADJ
bam-10675	58	21	anti	anti	ADJ
bam-10675	58	22	-	-	ADJ
bam-10675	58	23	tpo	tpo	ADJ
bam-10675	58	24	antibody	antibody	NOUN
bam-10675	58	25	levels	level	NOUN
bam-10675	58	26	is	be	AUX
bam-10675	58	27	not	not	PART
bam-10675	58	28	correlated	correlate	VERB
bam-10675	58	29	with	with	ADP
bam-10675	58	30	breast	breast	NOUN
bam-10675	58	31	cancer	cancer	NOUN
bam-10675	58	32	incidence	incidence	NOUN
bam-10675	58	33	.	.	PUNCT
bam-10675	59	1	several	several	ADJ
bam-10675	59	2	articles	article	NOUN
bam-10675	59	3	have	have	AUX
bam-10675	59	4	reported	report	VERB
bam-10675	59	5	similar	similar	ADJ
bam-10675	59	6	results	result	NOUN
bam-10675	59	7	,	,	PUNCT
bam-10675	59	8	finding	find	VERB
bam-10675	59	9	no	no	DET
bam-10675	59	10	association	association	NOUN
bam-10675	59	11	between	between	ADP
bam-10675	59	12	thyroid	thyroid	NOUN
bam-10675	59	13	autoimmunity	autoimmunity	NOUN
bam-10675	59	14	or	or	CCONJ
bam-10675	59	15	disorders	disorder	NOUN
bam-10675	59	16	and	and	CCONJ
bam-10675	59	17	breast	breast	NOUN
bam-10675	59	18	cancer	cancer	NOUN
bam-10675	59	19	.	.	PUNCT
bam-10675	60	1	in	in	ADP
bam-10675	60	2	a	a	DET
bam-10675	60	3	recent	recent	ADJ
bam-10675	60	4	meta	meta	ADJ
bam-10675	60	5	-	-	PUNCT
bam-10675	60	6	analysis	analysis	NOUN
bam-10675	60	7	by	by	ADP
bam-10675	60	8	wang	wang	PROPN
bam-10675	60	9	et	et	PROPN
bam-10675	60	10	al	al	PROPN
bam-10675	60	11	.	.	PROPN
bam-10675	60	12	(	(	PUNCT
bam-10675	60	13	2020	2020	NUM
bam-10675	60	14	)	)	PUNCT
bam-10675	60	15	,	,	PUNCT
bam-10675	60	16	by	by	ADP
bam-10675	60	17	reviewing	review	VERB
bam-10675	60	18	19	19	NUM
bam-10675	60	19	studies	study	NOUN
bam-10675	60	20	,	,	PUNCT
bam-10675	60	21	it	it	PRON
bam-10675	60	22	was	be	AUX
bam-10675	60	23	demonstrated	demonstrate	VERB
bam-10675	60	24	that	that	SCONJ
bam-10675	60	25	hypothyroidism	hypothyroidism	NOUN
bam-10675	60	26	was	be	AUX
bam-10675	60	27	not	not	PART
bam-10675	60	28	related	relate	VERB
bam-10675	60	29	to	to	ADP
bam-10675	60	30	a	a	DET
bam-10675	60	31	higher	high	ADJ
bam-10675	60	32	risk	risk	NOUN
bam-10675	60	33	of	of	ADP
bam-10675	60	34	breast	breast	NOUN
bam-10675	60	35	cancer	cancer	NOUN
bam-10675	60	36	and	and	CCONJ
bam-10675	60	37	moreover	moreover	ADV
bam-10675	60	38	,	,	PUNCT
bam-10675	60	39	in	in	ADP
bam-10675	60	40	european	european	PROPN
bam-10675	60	41	subgroup	subgroup	PROPN
bam-10675	60	42	,	,	PUNCT
bam-10675	60	43	it	it	PRON
bam-10675	60	44	may	may	AUX
bam-10675	60	45	decrease	decrease	VERB
bam-10675	60	46	this	this	DET
bam-10675	60	47	risk.14	risk.14	NOUN
bam-10675	60	48	similarly	similarly	ADV
bam-10675	60	49	,	,	PUNCT
bam-10675	60	50	a	a	DET
bam-10675	60	51	2012	2012	NUM
bam-10675	60	52	article	article	NOUN
bam-10675	60	53	by	by	ADP
bam-10675	60	54	angelousi	angelousi	PROPN
bam-10675	60	55	et	et	PROPN
bam-10675	60	56	al	al	PROPN
bam-10675	60	57	.	.	PROPN
bam-10675	60	58	,	,	PUNCT
bam-10675	60	59	reviewed	review	VERB
bam-10675	60	60	12	12	NUM
bam-10675	60	61	studies	study	NOUN
bam-10675	60	62	and	and	CCONJ
bam-10675	60	63	found	find	VERB
bam-10675	60	64	no	no	DET
bam-10675	60	65	significant	significant	ADJ
bam-10675	60	66	association	association	NOUN
bam-10675	60	67	in	in	ADP
bam-10675	60	68	this	this	DET
bam-10675	60	69	regard.15	regard.15	NOUN
bam-10675	60	70	a	a	DET
bam-10675	60	71	metaanalysis	metaanalysis	NOUN
bam-10675	60	72	by	by	ADP
bam-10675	60	73	fang	fang	PROPN
bam-10675	60	74	et	et	PROPN
bam-10675	60	75	al	al	PROPN
bam-10675	60	76	.	.	PROPN
bam-10675	60	77	has	have	AUX
bam-10675	60	78	also	also	ADV
bam-10675	60	79	shown	show	VERB
bam-10675	60	80	that	that	SCONJ
bam-10675	60	81	neither	neither	PRON
bam-10675	60	82	of	of	ADP
bam-10675	60	83	hyperor	hyperor	NOUN
bam-10675	60	84	hypothyroidism	hypothyroidism	NOUN
bam-10675	60	85	were	be	AUX
bam-10675	60	86	related	relate	VERB
bam-10675	60	87	to	to	ADP
bam-10675	60	88	the	the	DET
bam-10675	60	89	risk	risk	NOUN
bam-10675	60	90	of	of	ADP
bam-10675	60	91	breast	breast	NOUN
bam-10675	60	92	cancer.16	cancer.16	PROPN
bam-10675	60	93	on	on	ADP
bam-10675	60	94	the	the	DET
bam-10675	60	95	contrary	contrary	NOUN
bam-10675	60	96	,	,	PUNCT
bam-10675	60	97	some	some	DET
bam-10675	60	98	small	small	ADJ
bam-10675	60	99	sample	sample	NOUN
bam-10675	60	100	studies	study	NOUN
bam-10675	60	101	have	have	AUX
bam-10675	60	102	highlighted	highlight	VERB
bam-10675	60	103	a	a	DET
bam-10675	60	104	relation	relation	NOUN
bam-10675	60	105	between	between	ADP
bam-10675	60	106	thyroid	thyroid	NOUN
bam-10675	60	107	autoimmunity	autoimmunity	NOUN
bam-10675	60	108	and	and	CCONJ
bam-10675	60	109	breast	breast	NOUN
bam-10675	60	110	cancer.9,17,18	cancer.9,17,18	PROPN
bam-10675	60	111	a	a	DET
bam-10675	60	112	large	large	ADJ
bam-10675	60	113	scale	scale	NOUN
bam-10675	60	114	study	study	NOUN
bam-10675	60	115	with	with	ADP
bam-10675	60	116	103	103	NUM
bam-10675	60	117	 	 	SPACE
bam-10675	60	118	466	466	NUM
bam-10675	60	119	participants	participant	NOUN
bam-10675	60	120	has	have	AUX
bam-10675	60	121	also	also	ADV
bam-10675	60	122	revealed	reveal	VERB
bam-10675	60	123	that	that	SCONJ
bam-10675	60	124	hyper	hyper	ADJ
bam-10675	60	125	and	and	CCONJ
bam-10675	60	126	hypothyroidism	hypothyroidism	NOUN
bam-10675	60	127	have	have	VERB
bam-10675	60	128	a	a	DET
bam-10675	60	129	significantly	significantly	ADV
bam-10675	60	130	increased	increase	VERB
bam-10675	60	131	risk	risk	NOUN
bam-10675	60	132	of	of	ADP
bam-10675	60	133	breast	breast	NOUN
bam-10675	60	134	cancer	cancer	NOUN
bam-10675	60	135	regardless	regardless	ADV
bam-10675	60	136	of	of	ADP
bam-10675	60	137	treatment.6	treatment.6	PROPN
bam-10675	60	138	another	another	DET
bam-10675	60	139	2012	2012	NUM
bam-10675	60	140	meta	meta	VERB
bam-10675	60	141	-	-	PUNCT
bam-10675	60	142	analysis	analysis	NOUN
bam-10675	60	143	by	by	ADP
bam-10675	60	144	hardefeldt	hardefeldt	PROPN
bam-10675	60	145	et	et	PROPN
bam-10675	60	146	al	al	PROPN
bam-10675	60	147	.	.	PROPN
bam-10675	60	148	found	find	VERB
bam-10675	60	149	significant	significant	ADJ
bam-10675	60	150	evidence	evidence	NOUN
bam-10675	60	151	for	for	ADP
bam-10675	60	152	increased	increase	VERB
bam-10675	60	153	risk	risk	NOUN
bam-10675	60	154	of	of	ADP
bam-10675	60	155	breast	breast	NOUN
bam-10675	60	156	cancer	cancer	NOUN
bam-10675	60	157	in	in	ADP
bam-10675	60	158	autoimmune	autoimmune	ADJ
bam-10675	60	159	hypothyroid	hypothyroid	ADJ
bam-10675	60	160	population.19	population.19	NOUN
bam-10675	60	161	furthermore	furthermore	ADV
bam-10675	60	162	,	,	PUNCT
bam-10675	60	163	analysis	analysis	NOUN
bam-10675	60	164	did	do	AUX
bam-10675	60	165	not	not	PART
bam-10675	60	166	reveal	reveal	VERB
bam-10675	60	167	any	any	DET
bam-10675	60	168	significant	significant	ADJ
bam-10675	60	169	association	association	NOUN
bam-10675	60	170	between	between	ADP
bam-10675	60	171	anti	anti	ADJ
bam-10675	60	172	-	-	ADJ
bam-10675	60	173	tpo	tpo	ADJ
bam-10675	60	174	antibody	antibody	NOUN
bam-10675	60	175	levels	level	NOUN
bam-10675	60	176	and	and	CCONJ
bam-10675	60	177	different	different	ADJ
bam-10675	60	178	cancer	cancer	NOUN
bam-10675	60	179	stages	stage	NOUN
bam-10675	60	180	,	,	PUNCT
bam-10675	60	181	different	different	ADJ
bam-10675	60	182	hormone	hormone	NOUN
bam-10675	60	183	receptor	receptor	NOUN
bam-10675	60	184	expressions	expression	NOUN
bam-10675	60	185	,	,	PUNCT
bam-10675	60	186	and	and	CCONJ
bam-10675	60	187	her2	her2	PROPN
bam-10675	60	188	status	status	NOUN
bam-10675	60	189	.	.	PUNCT
bam-10675	61	1	this	this	PRON
bam-10675	61	2	was	be	AUX
bam-10675	61	3	similar	similar	ADJ
bam-10675	61	4	to	to	ADP
bam-10675	61	5	the	the	DET
bam-10675	61	6	results	result	NOUN
bam-10675	61	7	of	of	ADP
bam-10675	61	8	a	a	DET
bam-10675	61	9	study	study	NOUN
bam-10675	61	10	where	where	SCONJ
bam-10675	61	11	by	by	ADP
bam-10675	61	12	analyzing	analyze	VERB
bam-10675	61	13	143	143	NUM
bam-10675	61	14	breast	breast	NOUN
bam-10675	61	15	cancer	cancer	NOUN
bam-10675	61	16	patients	patient	NOUN
bam-10675	61	17	,	,	PUNCT
bam-10675	61	18	no	no	DET
bam-10675	61	19	relationship	relationship	NOUN
bam-10675	61	20	between	between	ADP
bam-10675	61	21	er	er	INTJ
bam-10675	61	22	and	and	CCONJ
bam-10675	61	23	pr	pr	NOUN
bam-10675	61	24	status	status	NOUN
bam-10675	61	25	,	,	PUNCT
bam-10675	61	26	and	and	CCONJ
bam-10675	61	27	the	the	DET
bam-10675	61	28	presence	presence	NOUN
bam-10675	61	29	of	of	ADP
bam-10675	61	30	serum	serum	NOUN
bam-10675	61	31	thyroid	thyroid	NOUN
bam-10675	61	32	autoantibodies	autoantibody	NOUN
bam-10675	61	33	was	be	AUX
bam-10675	61	34	observed.13	observed.13	PRON
bam-10675	61	35	interestingly	interestingly	ADV
bam-10675	61	36	,	,	PUNCT
bam-10675	61	37	in	in	ADP
bam-10675	61	38	another	another	DET
bam-10675	61	39	study	study	NOUN
bam-10675	61	40	where	where	SCONJ
bam-10675	61	41	er	er	INTJ
bam-10675	61	42	status	status	NOUN
bam-10675	61	43	and	and	CCONJ
bam-10675	61	44	thyroid	thyroid	VERB
bam-10675	61	45	autoantibodies	autoantibody	NOUN
bam-10675	61	46	(	(	PUNCT
bam-10675	61	47	anti	anti	ADJ
bam-10675	61	48	-	-	ADJ
bam-10675	61	49	tpo	tpo	NOUN
bam-10675	61	50	and	and	CCONJ
bam-10675	61	51	anti	anti	ADJ
bam-10675	61	52	-	-	ADJ
bam-10675	61	53	thyroglobulin	thyroglobulin	ADJ
bam-10675	61	54	antibodies	antibodie	VERB
bam-10675	61	55	)	)	PUNCT
bam-10675	61	56	had	have	VERB
bam-10675	61	57	no	no	DET
bam-10675	61	58	association	association	NOUN
bam-10675	61	59	,	,	PUNCT
bam-10675	61	60	it	it	PRON
bam-10675	61	61	was	be	AUX
bam-10675	61	62	demonstrated	demonstrate	VERB
bam-10675	61	63	that	that	SCONJ
bam-10675	61	64	er	er	INTJ
bam-10675	61	65	positivity	positivity	NOUN
bam-10675	61	66	and	and	CCONJ
bam-10675	61	67	higher	high	ADJ
bam-10675	61	68	levels	level	NOUN
bam-10675	61	69	thyroid	thyroid	VERB
bam-10675	61	70	autoantibodies	autoantibody	NOUN
bam-10675	61	71	were	be	AUX
bam-10675	61	72	correlated	correlate	VERB
bam-10675	61	73	with	with	ADP
bam-10675	61	74	better	well	ADJ
bam-10675	61	75	survival.20	survival.20	NOUN
bam-10675	61	76	in	in	ADP
bam-10675	61	77	contrast	contrast	NOUN
bam-10675	61	78	,	,	PUNCT
bam-10675	61	79	a	a	DET
bam-10675	61	80	large	large	ADJ
bam-10675	61	81	scale	scale	NOUN
bam-10675	61	82	study	study	NOUN
bam-10675	61	83	did	do	AUX
bam-10675	61	84	not	not	PART
bam-10675	61	85	find	find	VERB
bam-10675	61	86	any	any	DET
bam-10675	61	87	prognostic	prognostic	ADJ
bam-10675	61	88	value	value	NOUN
bam-10675	61	89	for	for	ADP
bam-10675	61	90	anti	anti	ADJ
bam-10675	61	91	-	-	ADJ
bam-10675	61	92	tpo	tpo	NOUN
bam-10675	61	93	antibodies	antibodie	VERB
bam-10675	61	94	in	in	ADP
bam-10675	61	95	breast	breast	NOUN
bam-10675	61	96	cancer	cancer	NOUN
bam-10675	61	97	patients.21	patients.21	NOUN
bam-10675	61	98	on	on	ADP
bam-10675	61	99	the	the	DET
bam-10675	61	100	other	other	ADJ
bam-10675	61	101	hand	hand	NOUN
bam-10675	61	102	,	,	PUNCT
bam-10675	61	103	in	in	ADP
bam-10675	61	104	a	a	DET
bam-10675	61	105	case	case	NOUN
bam-10675	61	106	-	-	PUNCT
bam-10675	61	107	control	control	NOUN
bam-10675	61	108	study	study	NOUN
bam-10675	61	109	,	,	PUNCT
bam-10675	61	110	saraiva	saraiva	NOUN
bam-10675	61	111	et	et	PROPN
bam-10675	61	112	al	al	PROPN
bam-10675	61	113	.	.	PROPN
bam-10675	61	114	found	find	VERB
bam-10675	61	115	significantly	significantly	ADV
bam-10675	61	116	higher	high	ADJ
bam-10675	61	117	concentrations	concentration	NOUN
bam-10675	61	118	of	of	ADP
bam-10675	61	119	tsh	tsh	NOUN
bam-10675	61	120	in	in	ADP
bam-10675	61	121	premenopausal	premenopausal	NOUN
bam-10675	61	122	breast	breast	NOUN
bam-10675	61	123	cancer	cancer	NOUN
bam-10675	61	124	patients	patient	NOUN
bam-10675	61	125	.	.	PUNCT
bam-10675	62	1	menopausal	menopausal	ADJ
bam-10675	62	2	patients	patient	NOUN
bam-10675	62	3	were	be	AUX
bam-10675	62	4	diagnosed	diagnose	VERB
bam-10675	62	5	with	with	ADP
bam-10675	62	6	higher	high	ADJ
bam-10675	62	7	levels	level	NOUN
bam-10675	62	8	of	of	ADP
bam-10675	62	9	free	free	ADJ
bam-10675	62	10	t4	t4	PROPN
bam-10675	62	11	and	and	CCONJ
bam-10675	62	12	lower	low	ADJ
bam-10675	62	13	tsh	tsh	NOUN
bam-10675	62	14	,	,	PUNCT
bam-10675	62	15	consistent	consistent	ADJ
bam-10675	62	16	with	with	ADP
bam-10675	62	17	subclinical	subclinical	ADJ
bam-10675	62	18	hyperthyroidism	hyperthyroidism	NOUN
bam-10675	62	19	in	in	ADP
bam-10675	62	20	this	this	DET
bam-10675	62	21	study.22	study.22	NOUN
bam-10675	62	22	some	some	DET
bam-10675	62	23	studies	study	NOUN
bam-10675	62	24	have	have	AUX
bam-10675	62	25	also	also	ADV
bam-10675	62	26	reported	report	VERB
bam-10675	62	27	higher	high	ADJ
bam-10675	62	28	t4,23	t4,23	NOUN
bam-10675	62	29	or	or	CCONJ
bam-10675	62	30	t3	t3	PROPN
bam-10675	62	31	and	and	CCONJ
bam-10675	62	32	t4.24	t4.24	PROPN
bam-10675	62	33	levels	level	NOUN
bam-10675	62	34	in	in	ADP
bam-10675	62	35	breast	breast	NOUN
bam-10675	62	36	cancer	cancer	NOUN
bam-10675	62	37	patients	patient	NOUN
bam-10675	62	38	,	,	PUNCT
bam-10675	62	39	while	while	SCONJ
bam-10675	62	40	finding	find	VERB
bam-10675	62	41	no	no	DET
bam-10675	62	42	significant	significant	ADJ
bam-10675	62	43	difference	difference	NOUN
bam-10675	62	44	for	for	ADP
bam-10675	62	45	tsh	tsh	NOUN
bam-10675	62	46	.	.	PUNCT
bam-10675	63	1	on	on	ADP
bam-10675	63	2	the	the	DET
bam-10675	63	3	table	table	NOUN
bam-10675	63	4	2	2	NUM
bam-10675	63	5	.	.	PUNCT
bam-10675	63	6	sub	sub	ADJ
bam-10675	63	7	-	-	ADJ
bam-10675	63	8	group	group	NOUN
bam-10675	63	9	analysis	analysis	NOUN
bam-10675	63	10	of	of	ADP
bam-10675	63	11	serum	serum	NOUN
bam-10675	63	12	anti	anti	ADJ
bam-10675	63	13	-	-	ADJ
bam-10675	63	14	tpo	tpo	ADJ
bam-10675	63	15	levels	level	NOUN
bam-10675	63	16	.	.	PUNCT
bam-10675	64	1	mean	mean	VERB
bam-10675	64	2	±sd	±sd	PRON
bam-10675	64	3	p	p	ADJ
bam-10675	64	4	-	-	PUNCT
bam-10675	64	5	value	value	NOUN
bam-10675	64	6	stage	stage	NOUN
bam-10675	65	1	t1n0	t1n0	X
bam-10675	65	2	133.2±278.8	133.2±278.8	NOUN
bam-10675	65	3	0.343	0.343	NUM
bam-10675	65	4	t1n1	t1n1	X
bam-10675	65	5	185.3±264.0	185.3±264.0	NUM
bam-10675	65	6	t2n0	t2n0	PUNCT
bam-10675	65	7	12.0±14.6	12.0±14.6	NUM
bam-10675	65	8	t2n1	t2n1	ADP
bam-10675	65	9	10.0±0.00	10.0±0.00	NUM
bam-10675	65	10	t3n0	t3n0	NOUN
bam-10675	65	11	38.1±41.6	38.1±41.6	NUM
bam-10675	65	12	t3n2	t3n2	PRON
bam-10675	65	13	15.9±7.4	15.9±7.4	NUM
bam-10675	65	14	t4	t4	PROPN
bam-10675	65	15	10.0±0	10.0±0	PROPN
bam-10675	65	16	er	er	INTJ
bam-10675	65	17	positive	positive	ADJ
bam-10675	65	18	39.9±124.1	39.9±124.1	NUM
bam-10675	65	19	0.373	0.373	NUM
bam-10675	65	20	negative	negative	ADJ
bam-10675	65	21	55.3±139.1	55.3±139.1	NUM
bam-10675	65	22	pr	pr	NOUN
bam-10675	65	23	positive	positive	ADJ
bam-10675	65	24	41.9±129.5	41.9±129.5	NUM
bam-10675	65	25	0.808	0.808	NUM
bam-10675	65	26	negative	negative	ADJ
bam-10675	65	27	53.0±133.5	53.0±133.5	PROPN
bam-10675	65	28	her-2	her-2	NUM
bam-10675	65	29	positive	positive	ADJ
bam-10675	65	30	(	(	PUNCT
bam-10675	65	31	3	3	NUM
bam-10675	65	32	+	+	NOUN
bam-10675	65	33	)	)	PUNCT
bam-10675	65	34	112.0±210.6	112.0±210.6	NOUN
bam-10675	65	35	0.179	0.179	NUM
bam-10675	65	36	positive	positive	ADJ
bam-10675	65	37	(	(	PUNCT
bam-10675	65	38	2	2	NUM
bam-10675	65	39	+	+	NOUN
bam-10675	65	40	)	)	PUNCT
bam-10675	65	41	122.0±250.5	122.0±250.5	NUM
bam-10675	65	42	positive	positive	ADJ
bam-10675	65	43	(	(	PUNCT
bam-10675	65	44	1	1	NUM
bam-10675	65	45	+	+	NOUN
bam-10675	65	46	)	)	PUNCT
bam-10675	65	47	10.0±0	10.0±0	NUM
bam-10675	65	48	negative	negative	ADJ
bam-10675	65	49	14.5±21.3	14.5±21.3	PROPN
bam-10675	65	50	er	er	INTJ
bam-10675	65	51	:	:	PUNCT
bam-10675	65	52	estrogen	estrogen	NOUN
bam-10675	65	53	receptor	receptor	NOUN
bam-10675	65	54	;	;	PUNCT
bam-10675	65	55	pr	pr	X
bam-10675	65	56	:	:	PUNCT
bam-10675	65	57	progesterone	progesterone	NOUN
bam-10675	65	58	receptor	receptor	NOUN
bam-10675	65	59	;	;	PUNCT
bam-10675	65	60	her-2	her-2	NUM
bam-10675	65	61	:	:	PUNCT
bam-10675	65	62	human	human	ADJ
bam-10675	65	63	epidermal	epidermal	ADJ
bam-10675	65	64	growth	growth	NOUN
bam-10675	65	65	factor	factor	NOUN
bam-10675	65	66	2	2	NUM
bam-10675	65	67	.	.	PUNCT
bam-10675	65	68	non	non	ADJ
bam-10675	66	1	-co	-co	PROPN
bam-10675	66	2	mmerc	mmerc	PROPN
bam-10675	66	3	ial	ial	PROPN
bam-10675	66	4	us	us	PROPN
bam-10675	66	5	e	e	NOUN
bam-10675	66	6	o	o	X
bam-10675	66	7	nly	nly	ADV
bam-10675	66	8	anti	anti	ADJ
bam-10675	66	9	-	-	ADJ
bam-10675	66	10	tpo	tpo	ADJ
bam-10675	66	11	antibody	antibody	NOUN
bam-10675	66	12	and	and	CCONJ
bam-10675	66	13	thyroid	thyroid	VERB
bam-10675	66	14	hormone	hormone	NOUN
bam-10675	66	15	levels	level	NOUN
bam-10675	66	16	in	in	ADP
bam-10675	66	17	breast	breast	NOUN
bam-10675	66	18	cancer	cancer	NOUN
bam-10675	66	19	eur	eur	PROPN
bam-10675	66	20	j	j	PROPN
bam-10675	66	21	transl	transl	PROPN
bam-10675	66	22	myol	myol	ADV
bam-10675	66	23	33	33	NUM
bam-10675	66	24	(	(	PUNCT
bam-10675	66	25	1	1	NUM
bam-10675	66	26	)	)	PUNCT
bam-10675	66	27	10675	10675	NUM
bam-10675	66	28	,	,	PUNCT
bam-10675	66	29	2023	2023	NUM
bam-10675	66	30	doi	doi	NOUN
bam-10675	66	31	:	:	PUNCT
bam-10675	66	32	10.4081	10.4081	NUM
bam-10675	66	33	/	/	SYM
bam-10675	66	34	ejtm.2023.10675	ejtm.2023.10675	NOUN
bam-10675	66	35	4	4	NUM
bam-10675	66	36	other	other	ADJ
bam-10675	66	37	hand	hand	NOUN
bam-10675	66	38	,	,	PUNCT
bam-10675	66	39	some	some	DET
bam-10675	66	40	studies	study	NOUN
bam-10675	66	41	have	have	AUX
bam-10675	66	42	found	find	VERB
bam-10675	66	43	that	that	SCONJ
bam-10675	66	44	low	low	ADJ
bam-10675	66	45	t4	t4	PROPN
bam-10675	66	46	might	might	AUX
bam-10675	66	47	be	be	AUX
bam-10675	66	48	associated	associate	VERB
bam-10675	66	49	with	with	ADP
bam-10675	66	50	higher	high	ADJ
bam-10675	66	51	risk	risk	NOUN
bam-10675	66	52	of	of	ADP
bam-10675	66	53	breast	breast	NOUN
bam-10675	66	54	cancer.8	cancer.8	NOUN
bam-10675	66	55	the	the	DET
bam-10675	66	56	main	main	ADJ
bam-10675	66	57	shortcoming	shortcoming	NOUN
bam-10675	66	58	of	of	ADP
bam-10675	66	59	this	this	DET
bam-10675	66	60	study	study	NOUN
bam-10675	66	61	was	be	AUX
bam-10675	66	62	small	small	ADJ
bam-10675	66	63	sample	sample	NOUN
bam-10675	66	64	size	size	NOUN
bam-10675	66	65	which	which	PRON
bam-10675	66	66	might	might	AUX
bam-10675	66	67	limit	limit	VERB
bam-10675	66	68	the	the	DET
bam-10675	66	69	generalizability	generalizability	NOUN
bam-10675	66	70	of	of	ADP
bam-10675	66	71	our	our	PRON
bam-10675	66	72	results	result	NOUN
bam-10675	66	73	.	.	PUNCT
bam-10675	67	1	implementation	implementation	NOUN
bam-10675	67	2	of	of	ADP
bam-10675	67	3	age	age	NOUN
bam-10675	67	4	matching	match	VERB
bam-10675	67	5	in	in	ADP
bam-10675	67	6	control	control	NOUN
bam-10675	67	7	group	group	NOUN
bam-10675	67	8	selection	selection	NOUN
bam-10675	67	9	could	could	AUX
bam-10675	67	10	have	have	AUX
bam-10675	67	11	omitted	omit	VERB
bam-10675	67	12	age	age	NOUN
bam-10675	67	13	difference	difference	NOUN
bam-10675	67	14	as	as	ADP
bam-10675	67	15	a	a	DET
bam-10675	67	16	confounding	confound	VERB
bam-10675	67	17	factor	factor	NOUN
bam-10675	67	18	.	.	PUNCT
bam-10675	68	1	classification	classification	NOUN
bam-10675	68	2	of	of	ADP
bam-10675	68	3	samples	sample	NOUN
bam-10675	68	4	into	into	ADP
bam-10675	68	5	pre	pre	ADJ
bam-10675	68	6	and	and	CCONJ
bam-10675	68	7	postmenopausal	postmenopausal	ADJ
bam-10675	68	8	groups	group	NOUN
bam-10675	68	9	was	be	AUX
bam-10675	68	10	considered	consider	VERB
bam-10675	68	11	initially	initially	ADV
bam-10675	68	12	but	but	CCONJ
bam-10675	68	13	due	due	ADP
bam-10675	68	14	to	to	ADP
bam-10675	68	15	the	the	DET
bam-10675	68	16	limited	limited	ADJ
bam-10675	68	17	sample	sample	NOUN
bam-10675	68	18	size	size	NOUN
bam-10675	68	19	it	it	PRON
bam-10675	68	20	was	be	AUX
bam-10675	68	21	not	not	PART
bam-10675	68	22	carried	carry	VERB
bam-10675	68	23	out	out	ADP
bam-10675	68	24	in	in	ADP
bam-10675	68	25	order	order	NOUN
bam-10675	68	26	to	to	PART
bam-10675	68	27	maintain	maintain	VERB
bam-10675	68	28	study	study	NOUN
bam-10675	68	29	power	power	NOUN
bam-10675	68	30	.	.	PUNCT
bam-10675	69	1	additional	additional	ADJ
bam-10675	69	2	multicentric	multicentric	ADJ
bam-10675	69	3	multiethnic	multiethnic	ADJ
bam-10675	69	4	studies	study	NOUN
bam-10675	69	5	with	with	ADP
bam-10675	69	6	greater	great	ADJ
bam-10675	69	7	sample	sample	NOUN
bam-10675	69	8	size	size	NOUN
bam-10675	69	9	are	be	AUX
bam-10675	69	10	needed	need	VERB
bam-10675	69	11	to	to	PART
bam-10675	69	12	draw	draw	VERB
bam-10675	69	13	more	more	ADV
bam-10675	69	14	precise	precise	ADJ
bam-10675	69	15	conclusions	conclusion	NOUN
bam-10675	69	16	.	.	PUNCT
bam-10675	70	1	in	in	ADP
bam-10675	70	2	conclusion	conclusion	NOUN
bam-10675	70	3	,	,	PUNCT
bam-10675	70	4	this	this	DET
bam-10675	70	5	case	case	NOUN
bam-10675	70	6	-	-	PUNCT
bam-10675	70	7	control	control	NOUN
bam-10675	70	8	study	study	NOUN
bam-10675	70	9	,	,	PUNCT
bam-10675	70	10	which	which	PRON
bam-10675	70	11	was	be	AUX
bam-10675	70	12	carried	carry	VERB
bam-10675	70	13	for	for	ADP
bam-10675	70	14	the	the	DET
bam-10675	70	15	first	first	ADJ
bam-10675	70	16	time	time	NOUN
bam-10675	70	17	in	in	ADP
bam-10675	70	18	iranian	iranian	ADJ
bam-10675	70	19	population	population	NOUN
bam-10675	70	20	,	,	PUNCT
bam-10675	70	21	it	it	PRON
bam-10675	70	22	was	be	AUX
bam-10675	70	23	demonstrated	demonstrate	VERB
bam-10675	70	24	that	that	SCONJ
bam-10675	70	25	while	while	SCONJ
bam-10675	70	26	breast	breast	NOUN
bam-10675	70	27	cancer	cancer	NOUN
bam-10675	70	28	was	be	AUX
bam-10675	70	29	not	not	PART
bam-10675	70	30	associated	associate	VERB
bam-10675	70	31	with	with	ADP
bam-10675	70	32	t3	t3	PROPN
bam-10675	70	33	and	and	CCONJ
bam-10675	70	34	anti	anti	ADJ
bam-10675	70	35	-	-	ADJ
bam-10675	70	36	tpo	tpo	NOUN
bam-10675	70	37	levels	level	NOUN
bam-10675	70	38	,	,	PUNCT
bam-10675	70	39	t4	t4	PROPN
bam-10675	70	40	and	and	CCONJ
bam-10675	70	41	tsh	tsh	NOUN
bam-10675	70	42	levels	level	NOUN
bam-10675	70	43	were	be	AUX
bam-10675	70	44	higher	high	ADJ
bam-10675	70	45	in	in	ADP
bam-10675	70	46	patient	patient	ADJ
bam-10675	70	47	group	group	NOUN
bam-10675	70	48	.	.	PUNCT
bam-10675	71	1	this	this	PRON
bam-10675	71	2	can	can	AUX
bam-10675	71	3	serve	serve	VERB
bam-10675	71	4	as	as	ADP
bam-10675	71	5	preliminary	preliminary	ADJ
bam-10675	71	6	evidence	evidence	NOUN
bam-10675	71	7	that	that	PRON
bam-10675	71	8	thyroid	thyroid	NOUN
bam-10675	71	9	autoimmunity	autoimmunity	NOUN
bam-10675	71	10	is	be	AUX
bam-10675	71	11	not	not	PART
bam-10675	71	12	correlated	correlate	VERB
bam-10675	71	13	with	with	ADP
bam-10675	71	14	breast	breast	NOUN
bam-10675	71	15	cancer	cancer	NOUN
bam-10675	71	16	.	.	PUNCT
bam-10675	72	1	however	however	ADV
bam-10675	72	2	,	,	PUNCT
bam-10675	72	3	additional	additional	ADJ
bam-10675	72	4	studies	study	NOUN
bam-10675	72	5	with	with	ADP
bam-10675	72	6	larger	large	ADJ
bam-10675	72	7	sample	sample	NOUN
bam-10675	72	8	sizes	size	NOUN
bam-10675	72	9	are	be	AUX
bam-10675	72	10	required	require	VERB
bam-10675	72	11	for	for	ADP
bam-10675	72	12	more	more	ADV
bam-10675	72	13	conclusive	conclusive	ADJ
bam-10675	72	14	evidence	evidence	NOUN
bam-10675	72	15	.	.	PUNCT
bam-10675	73	1	list	list	NOUN
bam-10675	73	2	of	of	ADP
bam-10675	73	3	acronyms	acronym	NOUN
bam-10675	73	4	anti	anti	ADJ
bam-10675	73	5	-	-	ADJ
bam-10675	73	6	tpo	tpo	ADJ
bam-10675	73	7	anti	anti	ADJ
bam-10675	73	8	-	-	ADJ
bam-10675	73	9	thyroid	thyroid	ADJ
bam-10675	73	10	peroxidase	peroxidase	NOUN
bam-10675	73	11	er	er	INTJ
bam-10675	73	12	estrogen	estrogen	NOUN
bam-10675	73	13	receptors	receptor	NOUN
bam-10675	73	14	her2	her2	VERB
bam-10675	73	15	-human	-human	ADJ
bam-10675	73	16	epidermal	epidermal	ADJ
bam-10675	73	17	growth	growth	NOUN
bam-10675	73	18	factor	factor	NOUN
bam-10675	73	19	receptor	receptor	NOUN
bam-10675	73	20	2	2	NUM
bam-10675	73	21	pr	pr	NOUN
bam-10675	73	22	progesterone	progesterone	NOUN
bam-10675	73	23	receptors	receptor	NOUN
bam-10675	73	24	tsh	tsh	NOUN
bam-10675	73	25	thyroid	thyroid	NOUN
bam-10675	73	26	stimulating	stimulate	VERB
bam-10675	73	27	hormone	hormone	NOUN
bam-10675	73	28	contributions	contribution	NOUN
bam-10675	73	29	of	of	ADP
bam-10675	73	30	authors	author	NOUN
bam-10675	73	31	se	se	PROPN
bam-10675	73	32	contributed	contribute	VERB
bam-10675	73	33	in	in	ADP
bam-10675	73	34	the	the	DET
bam-10675	73	35	conception	conception	NOUN
bam-10675	73	36	of	of	ADP
bam-10675	73	37	the	the	DET
bam-10675	73	38	work	work	NOUN
bam-10675	73	39	,	,	PUNCT
bam-10675	73	40	conducting	conduct	VERB
bam-10675	73	41	the	the	DET
bam-10675	73	42	study	study	NOUN
bam-10675	73	43	,	,	PUNCT
bam-10675	73	44	revising	revise	VERB
bam-10675	73	45	the	the	DET
bam-10675	73	46	draft	draft	NOUN
bam-10675	73	47	.	.	PUNCT
bam-10675	74	1	sf	sf	NOUN
bam-10675	74	2	contributed	contribute	VERB
bam-10675	74	3	in	in	ADP
bam-10675	74	4	analysis	analysis	NOUN
bam-10675	74	5	,	,	PUNCT
bam-10675	74	6	or	or	CCONJ
bam-10675	74	7	interpretation	interpretation	NOUN
bam-10675	74	8	of	of	ADP
bam-10675	74	9	data	datum	NOUN
bam-10675	74	10	,	,	PUNCT
bam-10675	74	11	drafting	draft	VERB
bam-10675	74	12	the	the	DET
bam-10675	74	13	work	work	NOUN
bam-10675	74	14	and	and	CCONJ
bam-10675	74	15	revising	revise	VERB
bam-10675	74	16	it	it	PRON
bam-10675	74	17	critically	critically	ADV
bam-10675	74	18	for	for	ADP
bam-10675	74	19	important	important	ADJ
bam-10675	74	20	intellectual	intellectual	ADJ
bam-10675	74	21	content	content	NOUN
bam-10675	74	22	.	.	PUNCT
bam-10675	75	1	sat	sat	AUX
bam-10675	75	2	contributed	contribute	VERB
bam-10675	75	3	in	in	ADP
bam-10675	75	4	draft	draft	NOUN
bam-10675	75	5	and	and	CCONJ
bam-10675	75	6	critical	critical	ADJ
bam-10675	75	7	revision	revision	NOUN
bam-10675	75	8	for	for	ADP
bam-10675	75	9	important	important	ADJ
bam-10675	75	10	intellectual	intellectual	ADJ
bam-10675	75	11	content	content	NOUN
bam-10675	75	12	.	.	PUNCT
bam-10675	76	1	zr	zr	PROPN
bam-10675	76	2	contributed	contribute	VERB
bam-10675	76	3	substantially	substantially	ADV
bam-10675	76	4	to	to	ADP
bam-10675	76	5	the	the	DET
bam-10675	76	6	conception	conception	NOUN
bam-10675	76	7	,	,	PUNCT
bam-10675	76	8	design	design	NOUN
bam-10675	76	9	and	and	CCONJ
bam-10675	76	10	drafting	draft	VERB
bam-10675	76	11	the	the	DET
bam-10675	76	12	work	work	NOUN
bam-10675	76	13	.	.	PUNCT
bam-10675	77	1	all	all	DET
bam-10675	77	2	authors	author	NOUN
bam-10675	77	3	read	read	VERB
bam-10675	77	4	and	and	CCONJ
bam-10675	77	5	approved	approve	VERB
bam-10675	77	6	the	the	DET
bam-10675	77	7	final	final	ADJ
bam-10675	77	8	edited	edited	ADJ
bam-10675	77	9	typescript	typescript	NOUN
bam-10675	77	10	.	.	PUNCT
bam-10675	78	1	acknowledgments	acknowledgment	NOUN
bam-10675	78	2	research	research	NOUN
bam-10675	78	3	reported	report	VERB
bam-10675	78	4	in	in	ADP
bam-10675	78	5	this	this	DET
bam-10675	78	6	publication	publication	NOUN
bam-10675	78	7	was	be	AUX
bam-10675	78	8	supported	support	VERB
bam-10675	78	9	by	by	ADP
bam-10675	78	10	a	a	DET
bam-10675	78	11	grant	grant	NOUN
bam-10675	78	12	[	[	X
bam-10675	78	13	ref	ref	NOUN
bam-10675	78	14	.	.	PUNCT
bam-10675	79	1	no	no	INTJ
bam-10675	79	2	.	.	PUNCT
bam-10675	80	1	:	:	PUNCT
bam-10675	80	2	1764	1764	NUM
bam-10675	80	3	and	and	CCONJ
bam-10675	80	4	ethical	ethical	ADJ
bam-10675	80	5	number	number	NOUN
bam-10675	80	6	:	:	PUNCT
bam-10675	81	1	irsemums.rfc.13990068	irsemums.rfc.13990068	ADJ
bam-10675	81	2	]	]	PUNCT
bam-10675	81	3	from	from	ADP
bam-10675	81	4	semnan	semnan	PROPN
bam-10675	81	5	university	university	PROPN
bam-10675	81	6	of	of	ADP
bam-10675	81	7	medical	medical	ADJ
bam-10675	81	8	sciences	sciences	PROPN
bam-10675	81	9	,	,	PUNCT
bam-10675	81	10	semnan	semnan	NOUN
bam-10675	81	11	,	,	PUNCT
bam-10675	81	12	iran	iran	PROPN
bam-10675	81	13	.	.	PUNCT
bam-10675	82	1	we	we	PRON
bam-10675	82	2	would	would	AUX
bam-10675	82	3	like	like	VERB
bam-10675	82	4	to	to	PART
bam-10675	82	5	thank	thank	VERB
bam-10675	82	6	the	the	DET
bam-10675	82	7	semnan	semnan	PROPN
bam-10675	82	8	university	university	PROPN
bam-10675	82	9	of	of	ADP
bam-10675	82	10	medical	medical	ADJ
bam-10675	82	11	sciences	sciences	PROPN
bam-10675	82	12	and	and	CCONJ
bam-10675	82	13	mri	mri	NOUN
bam-10675	82	14	center	center	NOUN
bam-10675	82	15	of	of	ADP
bam-10675	82	16	semnan	semnan	PROPN
bam-10675	82	17	(	(	PUNCT
bam-10675	82	18	imam	imam	PROPN
bam-10675	82	19	ali	ali	PROPN
bam-10675	82	20	)	)	PUNCT
bam-10675	82	21	for	for	ADP
bam-10675	82	22	providing	provide	VERB
bam-10675	82	23	facilities	facility	NOUN
bam-10675	82	24	to	to	ADP
bam-10675	82	25	this	this	DET
bam-10675	82	26	work	work	NOUN
bam-10675	82	27	.	.	PUNCT
bam-10675	83	1	funding	fund	VERB
bam-10675	83	2	this	this	DET
bam-10675	83	3	study	study	NOUN
bam-10675	83	4	was	be	AUX
bam-10675	83	5	granted	grant	VERB
bam-10675	83	6	by	by	ADP
bam-10675	83	7	semnan	semnan	PROPN
bam-10675	83	8	university	university	PROPN
bam-10675	83	9	of	of	ADP
bam-10675	83	10	medical	medical	ADJ
bam-10675	83	11	sciences	science	NOUN
bam-10675	83	12	.	.	PUNCT
bam-10675	84	1	conflict	conflict	NOUN
bam-10675	84	2	of	of	ADP
bam-10675	84	3	interest	interest	NOUN
bam-10675	84	4	the	the	DET
bam-10675	84	5	authors	author	NOUN
bam-10675	84	6	declare	declare	VERB
bam-10675	84	7	no	no	DET
bam-10675	84	8	conflict	conflict	NOUN
bam-10675	84	9	of	of	ADP
bam-10675	84	10	interests	interest	NOUN
bam-10675	84	11	.	.	PUNCT
bam-10675	85	1	ethical	ethical	ADJ
bam-10675	85	2	publication	publication	NOUN
bam-10675	85	3	statement	statement	NOUN
bam-10675	85	4	we	we	PRON
bam-10675	85	5	confirm	confirm	VERB
bam-10675	85	6	that	that	SCONJ
bam-10675	85	7	we	we	PRON
bam-10675	85	8	have	have	AUX
bam-10675	85	9	read	read	VERB
bam-10675	85	10	the	the	DET
bam-10675	85	11	journal	journal	NOUN
bam-10675	85	12	’s	’s	PART
bam-10675	85	13	position	position	NOUN
bam-10675	85	14	on	on	ADP
bam-10675	85	15	issues	issue	NOUN
bam-10675	85	16	involved	involve	VERB
bam-10675	85	17	in	in	ADP
bam-10675	85	18	ethical	ethical	ADJ
bam-10675	85	19	publication	publication	NOUN
bam-10675	85	20	and	and	CCONJ
bam-10675	85	21	affirm	affirm	NOUN
bam-10675	85	22	that	that	SCONJ
bam-10675	85	23	this	this	DET
bam-10675	85	24	report	report	NOUN
bam-10675	85	25	is	be	AUX
bam-10675	85	26	consistent	consistent	ADJ
bam-10675	85	27	with	with	ADP
bam-10675	85	28	those	those	DET
bam-10675	85	29	guidelines	guideline	NOUN
bam-10675	85	30	.	.	PUNCT
bam-10675	86	1	corresponding	correspond	VERB
bam-10675	86	2	author	author	PROPN
bam-10675	86	3	elahe	elahe	PROPN
bam-10675	86	4	jandaghi	jandaghi	PROPN
bam-10675	86	5	,	,	PUNCT
bam-10675	86	6	department	department	NOUN
bam-10675	86	7	of	of	ADP
bam-10675	86	8	internal	internal	ADJ
bam-10675	86	9	medicine	medicine	NOUN
bam-10675	86	10	,	,	PUNCT
bam-10675	86	11	semnan	semnan	PROPN
bam-10675	86	12	university	university	PROPN
bam-10675	86	13	of	of	ADP
bam-10675	86	14	medical	medical	ADJ
bam-10675	86	15	sciences	sciences	PROPN
bam-10675	86	16	,	,	PUNCT
bam-10675	86	17	semnan	semnan	NOUN
bam-10675	86	18	,	,	PUNCT
bam-10675	86	19	iran	iran	PROPN
bam-10675	86	20	iran	iran	PROPN
bam-10675	86	21	.	.	PUNCT
bam-10675	87	1	orcid	orcid	NOUN
bam-10675	88	1	i	i	PRON
bam-10675	88	2	d	d	NOUN
bam-10675	88	3	:	:	PUNCT
bam-10675	88	4	0000	0000	NUM
bam-10675	88	5	-	-	PUNCT
bam-10675	88	6	0002	0002	NUM
bam-10675	88	7	-	-	PUNCT
bam-10675	88	8	6477	6477	NUM
bam-10675	88	9	-	-	PUNCT
bam-10675	88	10	6356	6356	NUM
bam-10675	88	11	e	e	NOUN
bam-10675	88	12	-	-	NOUN
bam-10675	88	13	mail	mail	NOUN
bam-10675	88	14	:	:	PUNCT
bam-10675	88	15	dr.ejandaghi@semums.ac.ir	dr.ejandaghi@semums.ac.ir	VERB
bam-10675	88	16	e	e	NOUN
bam-10675	88	17	-	-	NOUN
bam-10675	88	18	mails	mail	NOUN
bam-10675	88	19	and	and	CCONJ
bam-10675	88	20	orcid	orcid	NOUN
bam-10675	89	1	i	i	INTJ
bam-10675	89	2	d	d	PROPN
bam-10675	89	3	of	of	ADP
bam-10675	89	4	co	co	NOUN
bam-10675	89	5	-	-	NOUN
bam-10675	89	6	authors	author	NOUN
bam-10675	89	7	farahnaz	farahnaz	PROPN
bam-10675	89	8	ghahremanfard	ghahremanfard	PROPN
bam-10675	89	9	:	:	PUNCT
bam-10675	89	10	f_ghahremanfard@yahoo.com	f_ghahremanfard@yahoo.com	NOUN
bam-10675	89	11	0000	0000	NUM
bam-10675	89	12	-	-	PUNCT
bam-10675	89	13	0003	0003	NUM
bam-10675	89	14	-	-	PUNCT
bam-10675	89	15	2620	2620	NUM
bam-10675	89	16	-	-	PUNCT
bam-10675	89	17	3378	3378	NUM
bam-10675	89	18	rahimi	rahimi	ADJ
bam-10675	89	19	ghobad	ghobad	NOUN
bam-10675	89	20	:	:	PUNCT
bam-10675	89	21	suntzu1370@gmail.com	suntzu1370@gmail.com	X
bam-10675	90	1	orcid	orcid	NOUN
bam-10675	91	1	i	i	PRON
bam-10675	91	2	d	d	NOUN
bam-10675	91	3	:	:	PUNCT
bam-10675	91	4	0000	0000	NUM
bam-10675	91	5	-	-	PUNCT
bam-10675	91	6	0001	0001	NUM
bam-10675	91	7	-	-	PUNCT
bam-10675	91	8	7439	7439	NUM
bam-10675	91	9	-	-	PUNCT
bam-10675	91	10	8160	8160	NUM
bam-10675	91	11	majid	majid	PROPN
bam-10675	91	12	mirmohammadkhani	mirmohammadkhani	PROPN
bam-10675	91	13	:	:	PUNCT
bam-10675	92	1	majidmirmohammadkhani@yahoo.com	majidmirmohammadkhani@yahoo.com	X
bam-10675	92	2	orcid	orcid	NOUN
bam-10675	93	1	i	i	PRON
bam-10675	93	2	d	d	NOUN
bam-10675	93	3	:	:	PUNCT
bam-10675	93	4	0000	0000	NUM
bam-10675	93	5	-	-	PUNCT
bam-10675	93	6	0001	0001	NUM
bam-10675	93	7	-	-	PUNCT
bam-10675	93	8	6251	6251	NUM
bam-10675	93	9	-	-	PUNCT
bam-10675	93	10	7484	7484	NUM
bam-10675	93	11	mohamadamir	mohamadamir	NOUN
bam-10675	93	12	sarabi	sarabi	NOUN
bam-10675	93	13	:	:	PUNCT
bam-10675	93	14	crdu@semums.ac.ir	crdu@semums.ac.ir	ADJ
bam-10675	93	15	orcid	orcid	NOUN
bam-10675	93	16	i	i	NOUN
bam-10675	93	17	d	d	NOUN
bam-10675	93	18	:	:	PUNCT
bam-10675	93	19	0000	0000	NUM
bam-10675	93	20	-	-	PUNCT
bam-10675	93	21	0003	0003	NUM
bam-10675	93	22	-	-	PUNCT
bam-10675	93	23	1510	1510	NUM
bam-10675	93	24	-	-	SYM
bam-10675	93	25	5553	5553	NUM
bam-10675	93	26	references	reference	NOUN
bam-10675	93	27	1	1	NUM
bam-10675	93	28	.	.	PUNCT
bam-10675	93	29	sancho	sancho	PROPN
bam-10675	93	30	-	-	PUNCT
bam-10675	93	31	garnier	garnier	PROPN
bam-10675	93	32	h	h	PROPN
bam-10675	93	33	,	,	PUNCT
bam-10675	93	34	colonna	colonna	NOUN
bam-10675	93	35	m.	m.	NOUN
bam-10675	93	36	épidémiologie	épidémiologie	NOUN
bam-10675	93	37	des	des	PROPN
bam-10675	93	38	cancers	cancer	NOUN
bam-10675	93	39	du	du	AUX
bam-10675	93	40	sein	sein	PROPN
bam-10675	93	41	[	[	X
bam-10675	93	42	breast	breast	NOUN
bam-10675	93	43	cancer	cancer	NOUN
bam-10675	93	44	epidemiology	epidemiology	NOUN
bam-10675	93	45	]	]	PUNCT
bam-10675	93	46	.	.	PUNCT
bam-10675	94	1	presse	presse	PROPN
bam-10675	94	2	med	med	PROPN
bam-10675	94	3	.	.	PROPN
bam-10675	95	1	2019	2019	NUM
bam-10675	95	2	oct;48(10):1076	oct;48(10):1076	NOUN
bam-10675	95	3	-	-	SYM
bam-10675	95	4	1084	1084	NUM
bam-10675	95	5	.	.	PUNCT
bam-10675	96	1	french	french	PROPN
bam-10675	96	2	.	.	PUNCT
bam-10675	97	1	doi	doi	NOUN
bam-10675	97	2	:	:	PUNCT
bam-10675	97	3	10.1016	10.1016	NUM
bam-10675	97	4	/	/	SYM
bam-10675	97	5	j.lpm.2019.09.022	j.lpm.2019.09.022	NOUN
bam-10675	97	6	.	.	PUNCT
bam-10675	98	1	epub	epub	PROPN
bam-10675	98	2	2019	2019	NUM
bam-10675	98	3	nov	nov	PROPN
bam-10675	98	4	6	6	NUM
bam-10675	98	5	.	.	NOUN
bam-10675	98	6	2	2	NUM
bam-10675	98	7	.	.	X
bam-10675	98	8	nafissi	nafissi	PROPN
bam-10675	98	9	n	n	CCONJ
bam-10675	98	10	,	,	PUNCT
bam-10675	98	11	khayamzadeh	khayamzadeh	PROPN
bam-10675	98	12	m	m	PROPN
bam-10675	98	13	,	,	PUNCT
bam-10675	98	14	zeinali	zeinali	PROPN
bam-10675	98	15	z	z	PROPN
bam-10675	98	16	,	,	PUNCT
bam-10675	98	17	pazooki	pazooki	PROPN
bam-10675	98	18	d	d	PROPN
bam-10675	98	19	,	,	PUNCT
bam-10675	98	20	hosseini	hosseini	PROPN
bam-10675	98	21	m	m	PROPN
bam-10675	98	22	,	,	PUNCT
bam-10675	98	23	akbari	akbari	PROPN
bam-10675	98	24	me	i	PRON
bam-10675	98	25	.	.	PUNCT
bam-10675	99	1	epidemiology	epidemiology	NOUN
bam-10675	99	2	and	and	CCONJ
bam-10675	99	3	histopathology	histopathology	NOUN
bam-10675	99	4	of	of	ADP
bam-10675	99	5	breast	breast	NOUN
bam-10675	99	6	cancer	cancer	NOUN
bam-10675	99	7	in	in	ADP
bam-10675	99	8	iran	iran	PROPN
bam-10675	99	9	versus	versus	ADP
bam-10675	99	10	other	other	ADJ
bam-10675	99	11	middle	middle	ADJ
bam-10675	99	12	eastern	eastern	ADJ
bam-10675	99	13	countries	country	NOUN
bam-10675	99	14	.	.	PUNCT
bam-10675	100	1	middle	middle	PROPN
bam-10675	100	2	east	east	PROPN
bam-10675	100	3	journal	journal	PROPN
bam-10675	100	4	of	of	ADP
bam-10675	100	5	cancer	cancer	NOUN
bam-10675	100	6	.	.	PUNCT
bam-10675	101	1	2018;9(3):243	2018;9(3):243	NUM
bam-10675	101	2	-	-	PUNCT
bam-10675	101	3	51	51	NUM
bam-10675	101	4	.	.	PUNCT
bam-10675	101	5	doi:10.30476	doi:10.30476	ADJ
bam-10675	101	6	/	/	SYM
bam-10675	101	7	mejc	mejc	NOUN
bam-10675	101	8	.	.	PUNCT
bam-10675	102	1	2018.42130	2018.42130	X
bam-10675	102	2	.	.	PUNCT
bam-10675	103	1	https://mejc.sums.ac.ir/article_42130.html	https://mejc.sums.ac.ir/article_42130.html	PROPN
bam-10675	103	2	3	3	NUM
bam-10675	103	3	.	.	PROPN
bam-10675	103	4	kamińska	kamińska	PROPN
bam-10675	103	5	m	m	PROPN
bam-10675	103	6	,	,	PUNCT
bam-10675	103	7	ciszewski	ciszewski	PROPN
bam-10675	103	8	t	t	PROPN
bam-10675	103	9	,	,	PUNCT
bam-10675	103	10	łopacka	łopacka	NOUN
bam-10675	103	11	-	-	PUNCT
bam-10675	103	12	szatan	szatan	PROPN
bam-10675	103	13	k	k	PROPN
bam-10675	103	14	,	,	PUNCT
bam-10675	103	15	miotła	miotła	PROPN
bam-10675	103	16	p	p	X
bam-10675	103	17	,	,	PUNCT
bam-10675	103	18	starosławska	starosławska	PROPN
bam-10675	103	19	e.	e.	PROPN
bam-10675	103	20	breast	breast	PROPN
bam-10675	103	21	cancer	cancer	NOUN
bam-10675	103	22	risk	risk	NOUN
bam-10675	103	23	factors	factor	NOUN
bam-10675	103	24	.	.	PUNCT
bam-10675	104	1	prz	prz	PROPN
bam-10675	104	2	menopauzalny	menopauzalny	PROPN
bam-10675	104	3	.	.	PUNCT
bam-10675	105	1	2015	2015	NUM
bam-10675	105	2	sep;14(3):196202	sep;14(3):196202	PROPN
bam-10675	105	3	.	.	PUNCT
bam-10675	105	4	doi	doi	PROPN
bam-10675	105	5	:	:	PUNCT
bam-10675	105	6	10.5114	10.5114	NUM
bam-10675	105	7	/	/	SYM
bam-10675	105	8	pm.2015.54346	pm.2015.54346	ADJ
bam-10675	105	9	.	.	PUNCT
bam-10675	106	1	epub	epub	NOUN
bam-10675	106	2	2015	2015	NUM
bam-10675	106	3	sep	sep	PROPN
bam-10675	106	4	30	30	NUM
bam-10675	106	5	.	.	PUNCT
bam-10675	107	1	4	4	NUM
bam-10675	107	2	.	.	X
bam-10675	107	3	ito	ito	PROPN
bam-10675	107	4	k	k	PROPN
bam-10675	107	5	,	,	PUNCT
bam-10675	107	6	maruchi	maruchi	PROPN
bam-10675	107	7	n.	n.	PROPN
bam-10675	107	8	breast	breast	NOUN
bam-10675	107	9	cancer	cancer	NOUN
bam-10675	107	10	in	in	ADP
bam-10675	107	11	patients	patient	NOUN
bam-10675	107	12	with	with	ADP
bam-10675	107	13	hashimoto	hashimoto	NOUN
bam-10675	107	14	's	's	PART
bam-10675	107	15	thyroiditis	thyroiditis	NOUN
bam-10675	107	16	.	.	PUNCT
bam-10675	108	1	lancet	lancet	PROPN
bam-10675	108	2	.	.	PUNCT
bam-10675	109	1	1975	1975	NUM
bam-10675	109	2	dec	dec	PROPN
bam-10675	109	3	6;2(7945):1119	6;2(7945):1119	PROPN
bam-10675	109	4	-	-	SYM
bam-10675	109	5	21	21	NUM
bam-10675	109	6	.	.	PUNCT
bam-10675	110	1	doi	doi	NOUN
bam-10675	110	2	:	:	PUNCT
bam-10675	110	3	10.1016	10.1016	NUM
bam-10675	110	4	/	/	SYM
bam-10675	110	5	s01406736(75)91006	s01406736(75)91006	PROPN
bam-10675	110	6	-	-	PUNCT
bam-10675	110	7	5	5	NUM
bam-10675	110	8	.	.	NOUN
bam-10675	110	9	5	5	NUM
bam-10675	110	10	.	.	PUNCT
bam-10675	110	11	singh	singh	PROPN
bam-10675	110	12	l	l	PROPN
bam-10675	110	13	,	,	PUNCT
bam-10675	110	14	lall	lall	PROPN
bam-10675	110	15	b	b	PROPN
bam-10675	110	16	,	,	PUNCT
bam-10675	110	17	agarwall	agarwall	PROPN
bam-10675	110	18	g.	g.	PROPN
bam-10675	110	19	thyroid	thyroid	NOUN
bam-10675	110	20	in	in	ADP
bam-10675	110	21	breast	breast	NOUN
bam-10675	110	22	cancer	cancer	NOUN
bam-10675	110	23	.	.	PUNCT
bam-10675	111	1	asian	asian	PROPN
bam-10675	111	2	med	med	PROPN
bam-10675	111	3	j.	j.	PROPN
bam-10675	111	4	1982;25:157	1982;25:157	PROPN
bam-10675	111	5	-	-	SYM
bam-10675	111	6	63	63	NUM
bam-10675	111	7	.	.	PUNCT
bam-10675	112	1	6	6	NUM
bam-10675	112	2	.	.	X
bam-10675	112	3	weng	weng	PROPN
bam-10675	112	4	ch	ch	PROPN
bam-10675	112	5	,	,	PUNCT
bam-10675	112	6	chen	chen	PROPN
bam-10675	112	7	yh	yh	PROPN
bam-10675	112	8	,	,	PUNCT
bam-10675	112	9	lin	lin	PROPN
bam-10675	112	10	ch	ch	PROPN
bam-10675	112	11	,	,	PUNCT
bam-10675	112	12	luo	luo	PROPN
bam-10675	112	13	x	x	PROPN
bam-10675	112	14	,	,	PUNCT
bam-10675	112	15	lin	lin	PROPN
bam-10675	112	16	th	th	PROPN
bam-10675	112	17	.	.	PUNCT
bam-10675	112	18	thyroid	thyroid	NOUN
bam-10675	112	19	disorders	disorder	NOUN
bam-10675	112	20	and	and	CCONJ
bam-10675	112	21	breast	breast	NOUN
bam-10675	112	22	cancer	cancer	NOUN
bam-10675	112	23	risk	risk	NOUN
bam-10675	112	24	in	in	ADP
bam-10675	112	25	asian	asian	ADJ
bam-10675	112	26	population	population	NOUN
bam-10675	112	27	:	:	PUNCT
bam-10675	112	28	a	a	DET
bam-10675	112	29	nationwide	nationwide	ADJ
bam-10675	112	30	population	population	NOUN
bam-10675	112	31	-	-	PUNCT
bam-10675	112	32	based	base	VERB
bam-10675	112	33	casecontrol	casecontrol	NOUN
bam-10675	112	34	study	study	NOUN
bam-10675	112	35	in	in	ADP
bam-10675	112	36	taiwan	taiwan	PROPN
bam-10675	112	37	.	.	PUNCT
bam-10675	113	1	bmj	bmj	PROPN
bam-10675	113	2	open	open	ADJ
bam-10675	113	3	.	.	PUNCT
bam-10675	114	1	2018	2018	NUM
bam-10675	114	2	mar	mar	PROPN
bam-10675	114	3	30;8(3):e020194	30;8(3):e020194	NUM
bam-10675	114	4	.	.	PUNCT
bam-10675	115	1	doi	doi	NOUN
bam-10675	115	2	:	:	PUNCT
bam-10675	115	3	10.1136	10.1136	NUM
bam-10675	115	4	/	/	SYM
bam-10675	115	5	bmjopen-2017020194	bmjopen-2017020194	NOUN
bam-10675	115	6	.	.	PUNCT
bam-10675	116	1	7	7	NUM
bam-10675	116	2	.	.	NUM
bam-10675	116	3	rasmusson	rasmusson	PROPN
bam-10675	116	4	b	b	PROPN
bam-10675	116	5	,	,	PUNCT
bam-10675	116	6	feldt	feldt	PROPN
bam-10675	116	7	-	-	PUNCT
bam-10675	116	8	rasmussen	rasmussen	PROPN
bam-10675	116	9	u	u	PROPN
bam-10675	116	10	,	,	PUNCT
bam-10675	116	11	hegedüs	hegedüs	PROPN
bam-10675	116	12	l	l	PROPN
bam-10675	116	13	,	,	PUNCT
bam-10675	116	14	perrild	perrild	ADJ
bam-10675	116	15	h	h	NOUN
bam-10675	116	16	,	,	PUNCT
bam-10675	116	17	bech	bech	PROPN
bam-10675	116	18	k	k	PROPN
bam-10675	116	19	,	,	PUNCT
bam-10675	116	20	høier	høier	PROPN
bam-10675	116	21	-	-	PUNCT
bam-10675	116	22	madsen	madsen	PROPN
bam-10675	116	23	m.	m.	PROPN
bam-10675	116	24	thyroid	thyroid	PROPN
bam-10675	116	25	function	function	VERB
bam-10675	116	26	in	in	ADP
bam-10675	116	27	patients	patient	NOUN
bam-10675	116	28	with	with	ADP
bam-10675	116	29	breast	breast	NOUN
bam-10675	116	30	cancer	cancer	NOUN
bam-10675	116	31	.	.	PUNCT
bam-10675	117	1	eur	eur	PROPN
bam-10675	117	2	j	j	PROPN
bam-10675	117	3	cancer	cancer	PROPN
bam-10675	117	4	clin	clin	PROPN
bam-10675	117	5	oncol	oncol	PROPN
bam-10675	117	6	.	.	PUNCT
bam-10675	118	1	1987	1987	NUM
bam-10675	118	2	may;23(5):553	may;23(5):553	PROPN
bam-10675	118	3	-	-	PUNCT
bam-10675	118	4	6	6	NUM
bam-10675	118	5	.	.	PUNCT
bam-10675	118	6	doi	doi	NOUN
bam-10675	118	7	:	:	PUNCT
bam-10675	118	8	10.1016/0277	10.1016/0277	NUM
bam-10675	118	9	-	-	SYM
bam-10675	118	10	5379(87)90319	5379(87)90319	NUM
bam-10675	118	11	-	-	PUNCT
bam-10675	118	12	1	1	NUM
bam-10675	118	13	.	.	NOUN
bam-10675	118	14	8	8	NUM
bam-10675	118	15	.	.	X
bam-10675	118	16	kuijpens	kuijpens	PROPN
bam-10675	118	17	jl	jl	PROPN
bam-10675	118	18	,	,	PUNCT
bam-10675	118	19	nyklíctek	nyklíctek	PROPN
bam-10675	118	20	i	i	PROPN
bam-10675	118	21	,	,	PUNCT
bam-10675	118	22	louwman	louwman	PROPN
bam-10675	118	23	mw	mw	PROPN
bam-10675	118	24	,	,	PUNCT
bam-10675	118	25	weetman	weetman	PROPN
bam-10675	118	26	ta	ta	PROPN
bam-10675	118	27	,	,	PUNCT
bam-10675	118	28	pop	pop	VERB
bam-10675	118	29	vj	vj	NOUN
bam-10675	118	30	,	,	PUNCT
bam-10675	118	31	coebergh	coebergh	PROPN
bam-10675	118	32	jw	jw	PROPN
bam-10675	118	33	.	.	PROPN
bam-10675	118	34	hypothyroidism	hypothyroidism	PROPN
bam-10675	118	35	might	might	AUX
bam-10675	118	36	be	be	AUX
bam-10675	118	37	related	relate	VERB
bam-10675	118	38	to	to	ADP
bam-10675	118	39	breast	breast	NOUN
bam-10675	118	40	cancer	cancer	NOUN
bam-10675	118	41	in	in	ADP
bam-10675	118	42	post	post	ADJ
bam-10675	118	43	-	-	ADJ
bam-10675	118	44	menopausal	menopausal	ADJ
bam-10675	118	45	women	woman	NOUN
bam-10675	118	46	.	.	PUNCT
bam-10675	119	1	thyroid	thyroid	PROPN
bam-10675	119	2	.	.	PUNCT
bam-10675	120	1	2005	2005	NUM
bam-10675	120	2	nov;15(11):1253	nov;15(11):1253	ADJ
bam-10675	120	3	-	-	PUNCT
bam-10675	120	4	9	9	NUM
bam-10675	120	5	.	.	PUNCT
bam-10675	120	6	doi	doi	NOUN
bam-10675	120	7	:	:	PUNCT
bam-10675	120	8	10.1089	10.1089	NUM
bam-10675	120	9	/	/	SYM
bam-10675	120	10	thy.2005.15.1253	thy.2005.15.1253	PROPN
bam-10675	120	11	.	.	PUNCT
bam-10675	120	12	non	non	PROPN
bam-10675	121	1	-co	-co	PROPN
bam-10675	121	2	mmerc	mmerc	PROPN
bam-10675	121	3	ial	ial	PROPN
bam-10675	121	4	us	us	PROPN
bam-10675	121	5	e	e	NOUN
bam-10675	121	6	o	o	NOUN
bam-10675	121	7	nly	nly	ADV
bam-10675	121	8	mailto:dr.ejandaghi@semums.ac.ir	mailto:dr.ejandaghi@semums.ac.ir	VERB
bam-10675	121	9	mailto:f_ghahremanfard@yahoo.com	mailto:f_ghahremanfard@yahoo.com	PROPN
bam-10675	121	10	mailto:suntzu1370@gmail.com	mailto:suntzu1370@gmail.com	PROPN
bam-10675	121	11	mailto:majidmirmohammadkhani@yahoo.com	mailto:majidmirmohammadkhani@yahoo.com	PROPN
bam-10675	121	12	mailto:crdu@semums.ac.ir	mailto:crdu@semums.ac.ir	VERB
bam-10675	121	13	anti	anti	ADJ
bam-10675	121	14	-	-	ADJ
bam-10675	121	15	tpo	tpo	ADJ
bam-10675	121	16	antibody	antibody	NOUN
bam-10675	121	17	and	and	CCONJ
bam-10675	121	18	thyroid	thyroid	VERB
bam-10675	121	19	hormone	hormone	NOUN
bam-10675	121	20	levels	level	NOUN
bam-10675	121	21	in	in	ADP
bam-10675	121	22	breast	breast	NOUN
bam-10675	121	23	cancer	cancer	NOUN
bam-10675	121	24	eur	eur	PROPN
bam-10675	121	25	j	j	PROPN
bam-10675	121	26	transl	transl	PROPN
bam-10675	121	27	myol	myol	ADV
bam-10675	121	28	33	33	NUM
bam-10675	121	29	(	(	PUNCT
bam-10675	121	30	1	1	NUM
bam-10675	121	31	)	)	PUNCT
bam-10675	121	32	10675	10675	NUM
bam-10675	121	33	,	,	PUNCT
bam-10675	121	34	2023	2023	NUM
bam-10675	121	35	doi	doi	NOUN
bam-10675	121	36	:	:	PUNCT
bam-10675	121	37	10.4081	10.4081	NUM
bam-10675	121	38	/	/	SYM
bam-10675	121	39	ejtm.2023.10675	ejtm.2023.10675	NOUN
bam-10675	121	40	5	5	NUM
bam-10675	121	41	9	9	NUM
bam-10675	121	42	.	.	PUNCT
bam-10675	122	1	jiskra	jiskra	PROPN
bam-10675	122	2	j	j	PROPN
bam-10675	122	3	,	,	PUNCT
bam-10675	122	4	barkmanova	barkmanova	PROPN
bam-10675	122	5	j	j	PROPN
bam-10675	122	6	,	,	PUNCT
bam-10675	122	7	limanova	limanova	PROPN
bam-10675	123	1	z	z	X
bam-10675	123	2	,	,	PUNCT
bam-10675	123	3	lánská	lánská	PROPN
bam-10675	123	4	v	v	NOUN
bam-10675	123	5	,	,	PUNCT
bam-10675	123	6	smutek	smutek	X
bam-10675	123	7	d	d	X
bam-10675	123	8	,	,	PUNCT
bam-10675	123	9	potlukova	potlukova	PROPN
bam-10675	123	10	e	e	NOUN
bam-10675	123	11	,	,	PUNCT
bam-10675	123	12	antosova	antosova	PROPN
bam-10675	123	13	m.	m.	PROPN
bam-10675	123	14	thyroid	thyroid	PROPN
bam-10675	123	15	autoimmunity	autoimmunity	NOUN
bam-10675	123	16	occurs	occur	VERB
bam-10675	123	17	more	more	ADV
bam-10675	123	18	frequently	frequently	ADV
bam-10675	123	19	in	in	ADP
bam-10675	123	20	women	woman	NOUN
bam-10675	123	21	with	with	ADP
bam-10675	123	22	breast	breast	NOUN
bam-10675	123	23	cancer	cancer	NOUN
bam-10675	123	24	compared	compare	VERB
bam-10675	123	25	to	to	ADP
bam-10675	123	26	women	woman	NOUN
bam-10675	123	27	with	with	ADP
bam-10675	123	28	colorectal	colorectal	ADJ
bam-10675	123	29	cancer	cancer	NOUN
bam-10675	123	30	and	and	CCONJ
bam-10675	123	31	controls	control	NOUN
bam-10675	123	32	but	but	CCONJ
bam-10675	123	33	it	it	PRON
bam-10675	123	34	has	have	VERB
bam-10675	123	35	no	no	DET
bam-10675	123	36	impact	impact	NOUN
bam-10675	123	37	on	on	ADP
bam-10675	123	38	relapse	relapse	NOUN
bam-10675	123	39	-	-	PUNCT
bam-10675	123	40	free	free	ADJ
bam-10675	123	41	and	and	CCONJ
bam-10675	123	42	overall	overall	ADJ
bam-10675	123	43	survival	survival	NOUN
bam-10675	123	44	.	.	PUNCT
bam-10675	124	1	oncol	oncol	PROPN
bam-10675	124	2	rep	rep	PROPN
bam-10675	124	3	.	.	PROPN
bam-10675	124	4	2007	2007	NUM
bam-10675	124	5	dec;18(6):1603	dec;18(6):1603	PROPN
bam-10675	124	6	-	-	PUNCT
bam-10675	124	7	11	11	NUM
bam-10675	124	8	.	.	PUNCT
bam-10675	125	1	10	10	NUM
bam-10675	125	2	.	.	X
bam-10675	126	1	cristofanilli	cristofanilli	PROPN
bam-10675	126	2	m	m	PROPN
bam-10675	126	3	,	,	PUNCT
bam-10675	126	4	yamamura	yamamura	PROPN
bam-10675	126	5	y	y	PROPN
bam-10675	126	6	,	,	PUNCT
bam-10675	126	7	kau	kau	PROPN
bam-10675	126	8	sw	sw	PROPN
bam-10675	126	9	,	,	PUNCT
bam-10675	126	10	bevers	bevers	PROPN
bam-10675	126	11	t	t	PROPN
bam-10675	126	12	,	,	PUNCT
bam-10675	126	13	strom	strom	PROPN
bam-10675	126	14	s	s	PROPN
bam-10675	126	15	,	,	PUNCT
bam-10675	126	16	patangan	patangan	PROPN
bam-10675	126	17	m	m	PROPN
bam-10675	126	18	,	,	PUNCT
bam-10675	126	19	hsu	hsu	PROPN
bam-10675	126	20	l	l	PROPN
bam-10675	126	21	,	,	PUNCT
bam-10675	126	22	krishnamurthy	krishnamurthy	PROPN
bam-10675	126	23	s	s	PROPN
bam-10675	126	24	,	,	PUNCT
bam-10675	126	25	theriault	theriault	VERB
bam-10675	126	26	rl	rl	X
bam-10675	126	27	,	,	PUNCT
bam-10675	126	28	hortobagyi	hortobagyi	PROPN
bam-10675	126	29	gn	gn	PROPN
bam-10675	126	30	.	.	PROPN
bam-10675	126	31	thyroid	thyroid	PROPN
bam-10675	126	32	hormone	hormone	NOUN
bam-10675	126	33	and	and	CCONJ
bam-10675	126	34	breast	breast	NOUN
bam-10675	126	35	carcinoma	carcinoma	NOUN
bam-10675	126	36	.	.	PUNCT
bam-10675	127	1	primary	primary	ADJ
bam-10675	127	2	hypothyroidism	hypothyroidism	NOUN
bam-10675	127	3	is	be	AUX
bam-10675	127	4	associated	associate	VERB
bam-10675	127	5	with	with	ADP
bam-10675	127	6	a	a	DET
bam-10675	127	7	reduced	reduced	ADJ
bam-10675	127	8	incidence	incidence	NOUN
bam-10675	127	9	of	of	ADP
bam-10675	127	10	primary	primary	ADJ
bam-10675	127	11	breast	breast	NOUN
bam-10675	127	12	carcinoma	carcinoma	NOUN
bam-10675	127	13	.	.	PUNCT
bam-10675	128	1	cancer	cancer	NOUN
bam-10675	128	2	.	.	PUNCT
bam-10675	129	1	2005	2005	NUM
bam-10675	129	2	mar	mar	PROPN
bam-10675	129	3	15;103(6):1122	15;103(6):1122	NUM
bam-10675	129	4	-	-	SYM
bam-10675	129	5	8	8	NUM
bam-10675	129	6	.	.	PUNCT
bam-10675	129	7	doi	doi	NOUN
bam-10675	129	8	:	:	PUNCT
bam-10675	129	9	10.1002	10.1002	NUM
bam-10675	129	10	/	/	SYM
bam-10675	129	11	cncr.20881	cncr.20881	NOUN
bam-10675	129	12	.	.	PROPN
bam-10675	129	13	11	11	NUM
bam-10675	129	14	.	.	PUNCT
bam-10675	130	1	søgaard	søgaard	PROPN
bam-10675	130	2	m	m	PROPN
bam-10675	130	3	,	,	PUNCT
bam-10675	130	4	farkas	farkas	PROPN
bam-10675	130	5	dk	dk	PROPN
bam-10675	130	6	,	,	PUNCT
bam-10675	130	7	ehrenstein	ehrenstein	PROPN
bam-10675	130	8	v	v	NOUN
bam-10675	130	9	,	,	PUNCT
bam-10675	130	10	jørgensen	jørgensen	PROPN
bam-10675	130	11	jo	jo	PROPN
bam-10675	130	12	,	,	PUNCT
bam-10675	130	13	dekkers	dekkers	PROPN
bam-10675	130	14	om	om	PROPN
bam-10675	130	15	,	,	PUNCT
bam-10675	130	16	sørensen	sørensen	PROPN
bam-10675	130	17	ht	ht	PROPN
bam-10675	130	18	.	.	PROPN
bam-10675	130	19	hypothyroidism	hypothyroidism	PROPN
bam-10675	130	20	and	and	CCONJ
bam-10675	130	21	hyperthyroidism	hyperthyroidism	NOUN
bam-10675	130	22	and	and	CCONJ
bam-10675	130	23	breast	breast	NOUN
bam-10675	130	24	cancer	cancer	NOUN
bam-10675	130	25	risk	risk	NOUN
bam-10675	130	26	:	:	PUNCT
bam-10675	130	27	a	a	DET
bam-10675	130	28	nationwide	nationwide	ADJ
bam-10675	130	29	cohort	cohort	NOUN
bam-10675	130	30	study	study	NOUN
bam-10675	130	31	.	.	PUNCT
bam-10675	131	1	eur	eur	PROPN
bam-10675	131	2	j	j	PROPN
bam-10675	131	3	endocrinol	endocrinol	NOUN
bam-10675	131	4	.	.	PUNCT
bam-10675	132	1	2016	2016	NUM
bam-10675	132	2	apr;174(4):409	apr;174(4):409	NOUN
bam-10675	132	3	-	-	PUNCT
bam-10675	132	4	14	14	NUM
bam-10675	132	5	.	.	PUNCT
bam-10675	133	1	doi	doi	NOUN
bam-10675	133	2	:	:	PUNCT
bam-10675	133	3	10.1530	10.1530	NUM
bam-10675	133	4	/	/	SYM
bam-10675	133	5	eje-15	eje-15	NOUN
bam-10675	133	6	-	-	PUNCT
bam-10675	133	7	0989	0989	NUM
bam-10675	133	8	.	.	PUNCT
bam-10675	134	1	12	12	NUM
bam-10675	134	2	.	.	PUNCT
bam-10675	135	1	maruchi	maruchi	PROPN
bam-10675	135	2	n	n	CCONJ
bam-10675	135	3	,	,	PUNCT
bam-10675	135	4	annegers	annegers	PROPN
bam-10675	135	5	jf	jf	PROPN
bam-10675	135	6	,	,	PUNCT
bam-10675	135	7	kurland	kurland	PROPN
bam-10675	135	8	lt	lt	PROPN
bam-10675	135	9	.	.	PROPN
bam-10675	135	10	hashimoto	hashimoto	PROPN
bam-10675	135	11	's	's	PART
bam-10675	135	12	thyroiditis	thyroiditis	NOUN
bam-10675	135	13	and	and	CCONJ
bam-10675	135	14	breast	breast	NOUN
bam-10675	135	15	cancer	cancer	NOUN
bam-10675	135	16	.	.	PUNCT
bam-10675	136	1	mayo	mayo	PROPN
bam-10675	136	2	clin	clin	PROPN
bam-10675	136	3	proc	proc	PROPN
bam-10675	136	4	.	.	PUNCT
bam-10675	137	1	1976	1976	NUM
bam-10675	137	2	may;51(5):263	may;51(5):263	PROPN
bam-10675	137	3	-	-	PUNCT
bam-10675	137	4	5	5	NUM
bam-10675	137	5	.	.	NOUN
bam-10675	137	6	13	13	NUM
bam-10675	137	7	.	.	PUNCT
bam-10675	138	1	michalaki	michalaki	NOUN
bam-10675	138	2	v	v	NOUN
bam-10675	138	3	,	,	PUNCT
bam-10675	138	4	kondi	kondi	NOUN
bam-10675	138	5	-	-	PUNCT
bam-10675	138	6	pafiti	pafiti	PROPN
bam-10675	138	7	a	a	PRON
bam-10675	138	8	,	,	PUNCT
bam-10675	138	9	gennatas	gennatas	PROPN
bam-10675	138	10	s	s	PROPN
bam-10675	138	11	,	,	PUNCT
bam-10675	138	12	antoniou	antoniou	PROPN
bam-10675	138	13	a	a	NOUN
bam-10675	138	14	,	,	PUNCT
bam-10675	138	15	primetis	primetis	PROPN
bam-10675	138	16	h	h	NOUN
bam-10675	138	17	,	,	PUNCT
bam-10675	138	18	gennatas	gennatas	PROPN
bam-10675	138	19	c.	c.	PROPN
bam-10675	138	20	breast	breast	NOUN
bam-10675	138	21	cancer	cancer	NOUN
bam-10675	138	22	in	in	ADP
bam-10675	138	23	association	association	NOUN
bam-10675	138	24	with	with	ADP
bam-10675	138	25	thyroid	thyroid	NOUN
bam-10675	138	26	disorders	disorder	NOUN
bam-10675	138	27	.	.	PUNCT
bam-10675	139	1	j	j	PROPN
bam-10675	139	2	buon	buon	NOUN
bam-10675	139	3	.	.	PUNCT
bam-10675	140	1	2009	2009	NUM
bam-10675	140	2	jul	jul	NOUN
bam-10675	140	3	-	-	PUNCT
bam-10675	140	4	sep;14(3):425	sep;14(3):425	NOUN
bam-10675	140	5	-	-	PUNCT
bam-10675	140	6	8	8	NUM
bam-10675	140	7	.	.	PUNCT
bam-10675	141	1	14	14	NUM
bam-10675	141	2	.	.	PUNCT
bam-10675	142	1	wang	wang	PROPN
bam-10675	142	2	b	b	PROPN
bam-10675	142	3	,	,	PUNCT
bam-10675	142	4	lu	lu	PROPN
bam-10675	142	5	z	z	PROPN
bam-10675	142	6	,	,	PUNCT
bam-10675	142	7	huang	huang	PROPN
bam-10675	142	8	y	y	PROPN
bam-10675	142	9	,	,	PUNCT
bam-10675	142	10	li	li	PROPN
bam-10675	142	11	r	r	PROPN
bam-10675	142	12	,	,	PUNCT
bam-10675	142	13	lin	lin	PROPN
bam-10675	142	14	t.	t.	PROPN
bam-10675	142	15	does	do	AUX
bam-10675	142	16	hypothyroidism	hypothyroidism	NOUN
bam-10675	142	17	increase	increase	VERB
bam-10675	142	18	the	the	DET
bam-10675	142	19	risk	risk	NOUN
bam-10675	142	20	of	of	ADP
bam-10675	142	21	breast	breast	NOUN
bam-10675	142	22	cancer	cancer	NOUN
bam-10675	142	23	:	:	PUNCT
bam-10675	142	24	evidence	evidence	NOUN
bam-10675	142	25	from	from	ADP
bam-10675	142	26	a	a	DET
bam-10675	142	27	meta	meta	ADJ
bam-10675	142	28	-	-	PUNCT
bam-10675	142	29	analysis	analysis	NOUN
bam-10675	142	30	.	.	PUNCT
bam-10675	143	1	bmc	bmc	NOUN
bam-10675	143	2	cancer	cancer	NOUN
bam-10675	143	3	.	.	PUNCT
bam-10675	144	1	2020	2020	NUM
bam-10675	144	2	aug	aug	PROPN
bam-10675	144	3	6;20(1):733	6;20(1):733	NUM
bam-10675	144	4	.	.	PUNCT
bam-10675	145	1	doi	doi	NOUN
bam-10675	145	2	:	:	PUNCT
bam-10675	145	3	10.1186	10.1186	NUM
bam-10675	145	4	/	/	SYM
bam-10675	145	5	s12885	s12885	NOUN
bam-10675	145	6	-	-	PUNCT
bam-10675	145	7	020	020	NUM
bam-10675	145	8	-	-	PUNCT
bam-10675	145	9	072304	072304	NUM
bam-10675	145	10	.	.	PUNCT
bam-10675	146	1	pmid	pmid	NOUN
bam-10675	146	2	:	:	PUNCT
bam-10675	146	3	32762667	32762667	NUM
bam-10675	146	4	;	;	PUNCT
bam-10675	146	5	pmcid	pmcid	PROPN
bam-10675	146	6	:	:	PUNCT
bam-10675	146	7	pmc7409635	pmc7409635	NOUN
bam-10675	146	8	.	.	PUNCT
bam-10675	147	1	15	15	NUM
bam-10675	147	2	.	.	X
bam-10675	147	3	angelousi	angelousi	PROPN
bam-10675	147	4	ag	ag	PROPN
bam-10675	147	5	,	,	PUNCT
bam-10675	147	6	anagnostou	anagnostou	PROPN
bam-10675	147	7	vk	vk	PROPN
bam-10675	147	8	,	,	PUNCT
bam-10675	147	9	stamatakos	stamatakos	PROPN
bam-10675	147	10	mk	mk	PROPN
bam-10675	147	11	,	,	PUNCT
bam-10675	147	12	georgiopoulos	georgiopoulos	PROPN
bam-10675	147	13	ga	ga	PROPN
bam-10675	147	14	,	,	PUNCT
bam-10675	147	15	kontzoglou	kontzoglou	PROPN
bam-10675	147	16	kc	kc	PROPN
bam-10675	147	17	.	.	PROPN
bam-10675	147	18	mechanisms	mechanism	NOUN
bam-10675	147	19	in	in	ADP
bam-10675	147	20	endocrinology	endocrinology	NOUN
bam-10675	147	21	:	:	PUNCT
bam-10675	147	22	primary	primary	ADJ
bam-10675	147	23	ht	ht	NOUN
bam-10675	147	24	and	and	CCONJ
bam-10675	147	25	risk	risk	NOUN
bam-10675	147	26	for	for	ADP
bam-10675	147	27	breast	breast	NOUN
bam-10675	147	28	cancer	cancer	NOUN
bam-10675	147	29	:	:	PUNCT
bam-10675	147	30	a	a	DET
bam-10675	147	31	systematic	systematic	ADJ
bam-10675	147	32	review	review	NOUN
bam-10675	147	33	and	and	CCONJ
bam-10675	147	34	meta	meta	ADJ
bam-10675	147	35	-	-	PUNCT
bam-10675	147	36	analysis	analysis	NOUN
bam-10675	147	37	.	.	PUNCT
bam-10675	148	1	eur	eur	PROPN
bam-10675	148	2	j	j	PROPN
bam-10675	148	3	endocrinol	endocrinol	NOUN
bam-10675	148	4	.	.	PUNCT
bam-10675	149	1	2012	2012	NUM
bam-10675	149	2	mar;166(3):373	mar;166(3):373	NOUN
bam-10675	149	3	-	-	PUNCT
bam-10675	149	4	81	81	NUM
bam-10675	149	5	.	.	PUNCT
bam-10675	150	1	doi	doi	NOUN
bam-10675	150	2	:	:	PUNCT
bam-10675	150	3	10.1530	10.1530	NUM
bam-10675	150	4	/	/	SYM
bam-10675	150	5	eje-11	eje-11	NOUN
bam-10675	150	6	-	-	PUNCT
bam-10675	150	7	0838	0838	NUM
bam-10675	150	8	.	.	PUNCT
bam-10675	151	1	epub	epub	PROPN
bam-10675	151	2	2011	2011	NUM
bam-10675	151	3	oct	oct	NOUN
bam-10675	151	4	24	24	NUM
bam-10675	151	5	.	.	PUNCT
bam-10675	151	6	16	16	NUM
bam-10675	151	7	.	.	PUNCT
bam-10675	152	1	fang	fang	PROPN
bam-10675	152	2	y	y	PROPN
bam-10675	152	3	,	,	PUNCT
bam-10675	152	4	yao	yao	PROPN
bam-10675	152	5	l	l	NOUN
bam-10675	152	6	,	,	PUNCT
bam-10675	152	7	sun	sun	PROPN
bam-10675	152	8	j	j	PROPN
bam-10675	152	9	,	,	PUNCT
bam-10675	152	10	yang	yang	PROPN
bam-10675	152	11	r	r	PROPN
bam-10675	152	12	,	,	PUNCT
bam-10675	152	13	chen	chen	PROPN
bam-10675	152	14	y	y	PROPN
bam-10675	152	15	,	,	PUNCT
bam-10675	152	16	tian	tian	PROPN
bam-10675	152	17	j	j	PROPN
bam-10675	152	18	,	,	PUNCT
bam-10675	152	19	yang	yang	PROPN
bam-10675	152	20	k	k	PROPN
bam-10675	152	21	,	,	PUNCT
bam-10675	152	22	tian	tian	PROPN
bam-10675	152	23	l.	l.	PROPN
bam-10675	152	24	does	do	AUX
bam-10675	152	25	thyroid	thyroid	VERB
bam-10675	152	26	dysfunction	dysfunction	NOUN
bam-10675	152	27	increase	increase	VERB
bam-10675	152	28	the	the	DET
bam-10675	152	29	risk	risk	NOUN
bam-10675	152	30	of	of	ADP
bam-10675	152	31	breast	breast	NOUN
bam-10675	152	32	cancer	cancer	NOUN
bam-10675	152	33	?	?	PUNCT
bam-10675	153	1	a	a	DET
bam-10675	153	2	systematic	systematic	ADJ
bam-10675	153	3	review	review	NOUN
bam-10675	153	4	and	and	CCONJ
bam-10675	153	5	meta	meta	ADJ
bam-10675	153	6	-	-	PUNCT
bam-10675	153	7	analysis	analysis	NOUN
bam-10675	153	8	.	.	PUNCT
bam-10675	154	1	j	j	PROPN
bam-10675	154	2	endocrinol	endocrinol	NOUN
bam-10675	154	3	invest	inv	ADJ
bam-10675	154	4	.	.	PUNCT
bam-10675	155	1	2017	2017	NUM
bam-10675	155	2	oct;40(10):1035	oct;40(10):1035	NOUN
bam-10675	155	3	-	-	SYM
bam-10675	155	4	1047	1047	NUM
bam-10675	155	5	.	.	PUNCT
bam-10675	156	1	doi	doi	NOUN
bam-10675	156	2	:	:	PUNCT
bam-10675	156	3	10.1007	10.1007	NUM
bam-10675	156	4	/	/	SYM
bam-10675	156	5	s40618	s40618	NOUN
bam-10675	156	6	-	-	PUNCT
bam-10675	156	7	0170679	0170679	NUM
bam-10675	156	8	-	-	PUNCT
bam-10675	156	9	x.	x.	NOUN
bam-10675	156	10	epub	epub	NOUN
bam-10675	156	11	2017	2017	NUM
bam-10675	156	12	may	may	PROPN
bam-10675	156	13	17	17	NUM
bam-10675	156	14	.	.	PUNCT
bam-10675	157	1	pmid	pmid	NOUN
bam-10675	157	2	:	:	PUNCT
bam-10675	157	3	28516372	28516372	NUM
bam-10675	157	4	.	.	PUNCT
bam-10675	158	1	17	17	NUM
bam-10675	158	2	.	.	PUNCT
bam-10675	158	3	gogas	gogas	PROPN
bam-10675	158	4	j	j	PROPN
bam-10675	158	5	,	,	PUNCT
bam-10675	158	6	kouskos	kouskos	PROPN
bam-10675	158	7	e	e	PROPN
bam-10675	158	8	,	,	PUNCT
bam-10675	158	9	tseleni	tseleni	NOUN
bam-10675	158	10	-	-	PUNCT
bam-10675	158	11	balafouta	balafouta	NOUN
bam-10675	158	12	s	s	PROPN
bam-10675	158	13	,	,	PUNCT
bam-10675	158	14	markopoulos	markopoulos	PROPN
bam-10675	158	15	c	c	PROPN
bam-10675	158	16	,	,	PUNCT
bam-10675	158	17	revenas	revenas	VERB
bam-10675	158	18	k	k	PROPN
bam-10675	158	19	,	,	PUNCT
bam-10675	158	20	gogas	gogas	NOUN
bam-10675	158	21	g	g	NOUN
bam-10675	158	22	,	,	PUNCT
bam-10675	158	23	kostakis	kostaki	NOUN
bam-10675	158	24	a.	a.	PROPN
bam-10675	158	25	autoimmune	autoimmune	PROPN
bam-10675	158	26	thyroid	thyroid	NOUN
bam-10675	158	27	disease	disease	NOUN
bam-10675	158	28	in	in	ADP
bam-10675	158	29	women	woman	NOUN
bam-10675	158	30	with	with	ADP
bam-10675	158	31	breast	breast	NOUN
bam-10675	158	32	carcinoma	carcinoma	NOUN
bam-10675	158	33	.	.	PUNCT
bam-10675	159	1	eur	eur	PROPN
bam-10675	159	2	j	j	PROPN
bam-10675	159	3	surg	surg	PROPN
bam-10675	159	4	oncol	oncol	PROPN
bam-10675	159	5	.	.	PUNCT
bam-10675	160	1	2001	2001	NUM
bam-10675	161	1	nov;27(7):62630	nov;27(7):62630	PROPN
bam-10675	161	2	.	.	PUNCT
bam-10675	161	3	doi	doi	PROPN
bam-10675	161	4	:	:	PUNCT
bam-10675	161	5	10.1053	10.1053	NUM
bam-10675	161	6	/	/	SYM
bam-10675	161	7	ejso.2001.1204	ejso.2001.1204	NOUN
bam-10675	161	8	.	.	PUNCT
bam-10675	162	1	pmid	pmid	NOUN
bam-10675	162	2	:	:	PUNCT
bam-10675	162	3	11669589	11669589	NUM
bam-10675	162	4	.	.	PUNCT
bam-10675	163	1	18	18	NUM
bam-10675	163	2	.	.	PUNCT
bam-10675	163	3	giustarini	giustarini	PROPN
bam-10675	163	4	e	e	PROPN
bam-10675	163	5	,	,	PUNCT
bam-10675	163	6	pinchera	pinchera	PROPN
bam-10675	163	7	a	a	NOUN
bam-10675	163	8	,	,	PUNCT
bam-10675	163	9	fierabracci	fierabracci	PROPN
bam-10675	163	10	p	p	NOUN
bam-10675	163	11	,	,	PUNCT
bam-10675	163	12	roncella	roncella	NOUN
bam-10675	163	13	m	m	NOUN
bam-10675	163	14	,	,	PUNCT
bam-10675	163	15	fustaino	fustaino	PROPN
bam-10675	163	16	l	l	NOUN
bam-10675	163	17	,	,	PUNCT
bam-10675	163	18	mammoli	mammoli	PROPN
bam-10675	163	19	c	c	X
bam-10675	163	20	,	,	PUNCT
bam-10675	163	21	giani	giani	PROPN
bam-10675	163	22	c.	c.	PROPN
bam-10675	163	23	thyroid	thyroid	PROPN
bam-10675	163	24	autoimmunity	autoimmunity	NOUN
bam-10675	163	25	in	in	ADP
bam-10675	163	26	patients	patient	NOUN
bam-10675	163	27	with	with	ADP
bam-10675	163	28	malignant	malignant	ADJ
bam-10675	163	29	and	and	CCONJ
bam-10675	163	30	benign	benign	ADJ
bam-10675	163	31	breast	breast	NOUN
bam-10675	163	32	diseases	disease	NOUN
bam-10675	163	33	before	before	ADP
bam-10675	163	34	surgery	surgery	NOUN
bam-10675	163	35	.	.	PUNCT
bam-10675	164	1	eur	eur	PROPN
bam-10675	164	2	j	j	PROPN
bam-10675	164	3	endocrinol	endocrinol	NOUN
bam-10675	164	4	.	.	PUNCT
bam-10675	165	1	2006	2006	NUM
bam-10675	165	2	may;154(5):645	may;154(5):645	NOUN
bam-10675	165	3	-	-	PUNCT
bam-10675	165	4	9	9	NUM
bam-10675	165	5	.	.	PUNCT
bam-10675	165	6	doi	doi	NOUN
bam-10675	165	7	:	:	PUNCT
bam-10675	165	8	10.1530	10.1530	NUM
bam-10675	165	9	/	/	SYM
bam-10675	165	10	eje.1.02108	eje.1.02108	PROPN
bam-10675	165	11	.	.	PUNCT
bam-10675	166	1	19	19	NUM
bam-10675	166	2	.	.	X
bam-10675	166	3	hardefeldt	hardefeldt	PROPN
bam-10675	166	4	pj	pj	PROPN
bam-10675	166	5	,	,	PUNCT
bam-10675	166	6	eslick	eslick	NOUN
bam-10675	166	7	gd	gd	PROPN
bam-10675	166	8	,	,	PUNCT
bam-10675	166	9	edirimanne	edirimanne	PROPN
bam-10675	166	10	s.	s.	PROPN
bam-10675	166	11	benign	benign	PROPN
bam-10675	166	12	thyroid	thyroid	NOUN
bam-10675	166	13	disease	disease	NOUN
bam-10675	166	14	is	be	AUX
bam-10675	166	15	associated	associate	VERB
bam-10675	166	16	with	with	ADP
bam-10675	166	17	breast	breast	NOUN
bam-10675	166	18	cancer	cancer	NOUN
bam-10675	166	19	:	:	PUNCT
bam-10675	166	20	a	a	DET
bam-10675	166	21	meta	meta	ADJ
bam-10675	166	22	-	-	PUNCT
bam-10675	166	23	analysis	analysis	NOUN
bam-10675	166	24	.	.	PUNCT
bam-10675	167	1	breast	breast	NOUN
bam-10675	167	2	cancer	cancer	NOUN
bam-10675	167	3	res	re	NOUN
bam-10675	167	4	treat	treat	NOUN
bam-10675	167	5	.	.	PUNCT
bam-10675	168	1	2012	2012	NUM
bam-10675	168	2	jun;133(3):1169	jun;133(3):1169	PROPN
bam-10675	168	3	-	-	SYM
bam-10675	168	4	77	77	NUM
bam-10675	168	5	.	.	PUNCT
bam-10675	169	1	doi	doi	NOUN
bam-10675	169	2	:	:	PUNCT
bam-10675	169	3	10.1007	10.1007	NUM
bam-10675	169	4	/	/	SYM
bam-10675	169	5	s10549	s10549	PROPN
bam-10675	169	6	-	-	PUNCT
bam-10675	169	7	0122019	0122019	NUM
bam-10675	169	8	-	-	PUNCT
bam-10675	169	9	3	3	NUM
bam-10675	169	10	.	.	PUNCT
bam-10675	170	1	epub	epub	NOUN
bam-10675	170	2	2012	2012	NUM
bam-10675	170	3	mar	mar	PROPN
bam-10675	170	4	21	21	NUM
bam-10675	170	5	.	.	PROPN
bam-10675	170	6	20	20	NUM
bam-10675	170	7	.	.	PUNCT
bam-10675	171	1	fiore	fiore	NOUN
bam-10675	171	2	e	e	NOUN
bam-10675	171	3	,	,	PUNCT
bam-10675	171	4	giustarini	giustarini	NOUN
bam-10675	171	5	e	e	PROPN
bam-10675	171	6	,	,	PUNCT
bam-10675	171	7	mammoli	mammoli	PROPN
bam-10675	171	8	c	c	NOUN
bam-10675	171	9	,	,	PUNCT
bam-10675	171	10	fragomeni	fragomeni	PROPN
bam-10675	171	11	f	f	PROPN
bam-10675	171	12	,	,	PUNCT
bam-10675	171	13	campani	campani	PROPN
bam-10675	171	14	d	d	PROPN
bam-10675	171	15	,	,	PUNCT
bam-10675	171	16	muller	muller	PROPN
bam-10675	171	17	i	i	PROPN
bam-10675	171	18	,	,	PUNCT
bam-10675	171	19	pinchera	pinchera	PROPN
bam-10675	171	20	a	a	PROPN
bam-10675	171	21	,	,	PUNCT
bam-10675	171	22	giani	giani	PROPN
bam-10675	171	23	c.	c.	PROPN
bam-10675	171	24	favorable	favorable	ADJ
bam-10675	171	25	predictive	predictive	ADJ
bam-10675	171	26	value	value	NOUN
bam-10675	171	27	of	of	ADP
bam-10675	171	28	thyroid	thyroid	NOUN
bam-10675	171	29	autoimmunity	autoimmunity	NOUN
bam-10675	171	30	in	in	ADP
bam-10675	171	31	high	high	ADJ
bam-10675	171	32	aggressive	aggressive	ADJ
bam-10675	171	33	breast	breast	NOUN
bam-10675	171	34	cancer	cancer	NOUN
bam-10675	171	35	.	.	PUNCT
bam-10675	172	1	j	j	PROPN
bam-10675	172	2	endocrinol	endocrinol	NOUN
bam-10675	172	3	invest	inv	ADJ
bam-10675	172	4	.	.	PUNCT
bam-10675	173	1	2007	2007	NUM
bam-10675	174	1	oct;30(9):734	oct;30(9):734	NUM
bam-10675	174	2	-	-	SYM
bam-10675	174	3	8	8	NUM
bam-10675	175	1	.	.	PUNCT
bam-10675	175	2	doi	doi	NOUN
bam-10675	175	3	:	:	PUNCT
bam-10675	175	4	10.1007	10.1007	NUM
bam-10675	175	5	/	/	SYM
bam-10675	175	6	bf03350810	bf03350810	PROPN
bam-10675	175	7	.	.	PUNCT
bam-10675	176	1	21	21	NUM
bam-10675	176	2	.	.	PUNCT
bam-10675	177	1	muller	muller	PROPN
bam-10675	177	2	i	i	PROPN
bam-10675	177	3	,	,	PUNCT
bam-10675	177	4	kilburn	kilburn	PROPN
bam-10675	177	5	ls	ls	PROPN
bam-10675	177	6	,	,	PUNCT
bam-10675	177	7	taylor	taylor	PROPN
bam-10675	177	8	pn	pn	PROPN
bam-10675	177	9	,	,	PUNCT
bam-10675	177	10	barrett	barrett	PROPN
bam-10675	177	11	-	-	PUNCT
bam-10675	177	12	lee	lee	PROPN
bam-10675	177	13	pj	pj	PROPN
bam-10675	177	14	,	,	PUNCT
bam-10675	177	15	bliss	bliss	PROPN
bam-10675	177	16	jm	jm	PROPN
bam-10675	177	17	,	,	PUNCT
bam-10675	177	18	ellis	ellis	PROPN
bam-10675	177	19	p	p	X
bam-10675	177	20	,	,	PUNCT
bam-10675	177	21	ludgate	ludgate	VERB
bam-10675	177	22	me	i	PRON
bam-10675	177	23	,	,	PUNCT
bam-10675	177	24	dayan	dayan	PROPN
bam-10675	177	25	cm	cm	PROPN
bam-10675	177	26	.	.	PUNCT
bam-10675	178	1	tpoab	tpoab	PROPN
bam-10675	178	2	and	and	CCONJ
bam-10675	178	3	thyroid	thyroid	NOUN
bam-10675	178	4	function	function	NOUN
bam-10675	178	5	are	be	AUX
bam-10675	178	6	not	not	PART
bam-10675	178	7	associated	associate	VERB
bam-10675	178	8	with	with	ADP
bam-10675	178	9	breast	breast	NOUN
bam-10675	178	10	cancer	cancer	NOUN
bam-10675	178	11	outcome	outcome	NOUN
bam-10675	178	12	:	:	PUNCT
bam-10675	178	13	evidence	evidence	NOUN
bam-10675	178	14	from	from	ADP
bam-10675	178	15	a	a	DET
bam-10675	178	16	largescale	largescale	NOUN
bam-10675	178	17	study	study	NOUN
bam-10675	178	18	using	use	VERB
bam-10675	178	19	data	datum	NOUN
bam-10675	178	20	from	from	ADP
bam-10675	178	21	the	the	DET
bam-10675	178	22	taxotere	taxotere	PROPN
bam-10675	178	23	as	as	ADP
bam-10675	178	24	adjuvant	adjuvant	ADJ
bam-10675	178	25	chemotherapy	chemotherapy	NOUN
bam-10675	178	26	trial	trial	NOUN
bam-10675	178	27	(	(	PUNCT
bam-10675	178	28	tact	tact	ADJ
bam-10675	178	29	,	,	PUNCT
bam-10675	178	30	cruk01/001	cruk01/001	PROPN
bam-10675	178	31	)	)	PUNCT
bam-10675	178	32	.	.	PUNCT
bam-10675	179	1	eur	eur	PROPN
bam-10675	179	2	thyroid	thyroid	NOUN
bam-10675	179	3	j.	j.	PROPN
bam-10675	179	4	2017	2017	NUM
bam-10675	179	5	jul;6(4):197207	jul;6(4):197207	NOUN
bam-10675	179	6	.	.	PUNCT
bam-10675	180	1	doi	doi	NOUN
bam-10675	180	2	:	:	PUNCT
bam-10675	180	3	10.1159/000460246	10.1159/000460246	NUM
bam-10675	180	4	.	.	PUNCT
bam-10675	181	1	epub	epub	PROPN
bam-10675	181	2	2017	2017	NUM
bam-10675	181	3	apr	apr	NOUN
bam-10675	181	4	4	4	NUM
bam-10675	181	5	.	.	NOUN
bam-10675	181	6	22	22	NUM
bam-10675	181	7	.	.	PUNCT
bam-10675	182	1	saraiva	saraiva	NOUN
bam-10675	182	2	pp	pp	ADV
bam-10675	182	3	,	,	PUNCT
bam-10675	182	4	figueiredo	figueiredo	PROPN
bam-10675	182	5	nb	nb	PROPN
bam-10675	182	6	,	,	PUNCT
bam-10675	182	7	padovani	padovani	PROPN
bam-10675	182	8	cr	cr	PROPN
bam-10675	182	9	,	,	PUNCT
bam-10675	182	10	brentani	brentani	PROPN
bam-10675	182	11	mm	mm	PROPN
bam-10675	182	12	,	,	PUNCT
bam-10675	182	13	nogueira	nogueira	PROPN
bam-10675	182	14	cr	cr	PROPN
bam-10675	182	15	.	.	PUNCT
bam-10675	183	1	profile	profile	PROPN
bam-10675	183	2	of	of	ADP
bam-10675	183	3	thyroid	thyroid	NOUN
bam-10675	183	4	hormones	hormone	NOUN
bam-10675	183	5	in	in	ADP
bam-10675	183	6	breast	breast	NOUN
bam-10675	183	7	cancer	cancer	NOUN
bam-10675	183	8	patients	patient	NOUN
bam-10675	183	9	.	.	PUNCT
bam-10675	184	1	braz	braz	PROPN
bam-10675	184	2	j	j	PROPN
bam-10675	184	3	med	med	PROPN
bam-10675	184	4	biol	biol	PROPN
bam-10675	184	5	res	re	NOUN
bam-10675	184	6	.	.	PUNCT
bam-10675	184	7	2005	2005	NUM
bam-10675	184	8	may;38(5):761	may;38(5):761	NOUN
bam-10675	184	9	-	-	SYM
bam-10675	184	10	5	5	NUM
bam-10675	184	11	.	.	PUNCT
bam-10675	184	12	doi	doi	NOUN
bam-10675	184	13	:	:	PUNCT
bam-10675	184	14	10.1590	10.1590	NUM
bam-10675	184	15	/	/	SYM
bam-10675	184	16	s0100879x2005000500014	s0100879x2005000500014	NOUN
bam-10675	184	17	.	.	PUNCT
bam-10675	185	1	epub	epub	PROPN
bam-10675	185	2	2005	2005	NUM
bam-10675	185	3	may	may	AUX
bam-10675	185	4	25	25	NUM
bam-10675	185	5	.	.	PUNCT
bam-10675	186	1	23	23	NUM
bam-10675	186	2	.	.	PUNCT
bam-10675	187	1	ortega	ortega	PROPN
bam-10675	187	2	-	-	PUNCT
bam-10675	187	3	olvera	olvera	PROPN
bam-10675	187	4	c	c	PROPN
bam-10675	187	5	,	,	PUNCT
bam-10675	187	6	ulloa	ulloa	NOUN
bam-10675	187	7	-	-	PUNCT
bam-10675	187	8	aguirre	aguirre	PROPN
bam-10675	187	9	a	a	PROPN
bam-10675	187	10	,	,	PUNCT
bam-10675	187	11	ángelesllerenas	ángelesllerenas	PROPN
bam-10675	187	12	a	a	NOUN
bam-10675	187	13	,	,	PUNCT
bam-10675	187	14	mainero	mainero	NOUN
bam-10675	187	15	-	-	PUNCT
bam-10675	187	16	ratchelous	ratchelous	ADJ
bam-10675	187	17	fe	fe	PROPN
bam-10675	187	18	,	,	PUNCT
bam-10675	187	19	gonzálezacevedo	gonzálezacevedo	PROPN
bam-10675	187	20	ce	ce	PROPN
bam-10675	187	21	,	,	PUNCT
bam-10675	187	22	hernández	hernández	PROPN
bam-10675	187	23	-	-	PUNCT
bam-10675	187	24	blanco	blanco	PROPN
bam-10675	187	25	ml	ml	PROPN
bam-10675	187	26	,	,	PUNCT
bam-10675	187	27	ziv	ziv	PROPN
bam-10675	187	28	e	e	PROPN
bam-10675	187	29	,	,	PUNCT
bam-10675	187	30	avilés	avilés	NOUN
bam-10675	187	31	-	-	PUNCT
bam-10675	187	32	santa	santa	PROPN
bam-10675	187	33	l	l	PROPN
bam-10675	187	34	,	,	PUNCT
bam-10675	187	35	pérez	pérez	NOUN
bam-10675	187	36	-	-	PUNCT
bam-10675	187	37	rodríguez	rodríguez	NOUN
bam-10675	187	38	e	e	NOUN
bam-10675	187	39	,	,	PUNCT
bam-10675	187	40	torres	torre	NOUN
bam-10675	187	41	-	-	PUNCT
bam-10675	187	42	mejía	mejía	NOUN
bam-10675	187	43	g.	g.	PROPN
bam-10675	187	44	thyroid	thyroid	PROPN
bam-10675	187	45	hormones	hormones	PROPN
bam-10675	187	46	and	and	CCONJ
bam-10675	187	47	breast	breast	NOUN
bam-10675	187	48	cancer	cancer	NOUN
bam-10675	187	49	association	association	NOUN
bam-10675	187	50	according	accord	VERB
bam-10675	187	51	to	to	ADP
bam-10675	187	52	menopausal	menopausal	ADJ
bam-10675	187	53	status	status	NOUN
bam-10675	187	54	and	and	CCONJ
bam-10675	187	55	body	body	NOUN
bam-10675	187	56	mass	mass	PROPN
bam-10675	187	57	index	index	NOUN
bam-10675	187	58	.	.	PUNCT
bam-10675	188	1	breast	breast	NOUN
bam-10675	188	2	cancer	cancer	NOUN
bam-10675	188	3	res	re	NOUN
bam-10675	188	4	.	.	PROPN
bam-10675	188	5	2018	2018	NUM
bam-10675	188	6	aug	aug	PROPN
bam-10675	188	7	9;20(1):94	9;20(1):94	NUM
bam-10675	188	8	.	.	PUNCT
bam-10675	189	1	doi	doi	NOUN
bam-10675	189	2	:	:	PUNCT
bam-10675	189	3	10.1186	10.1186	NUM
bam-10675	189	4	/	/	SYM
bam-10675	189	5	s13058	s13058	PROPN
bam-10675	189	6	-	-	PUNCT
bam-10675	189	7	018	018	NUM
bam-10675	189	8	-	-	PUNCT
bam-10675	189	9	1017	1017	NUM
bam-10675	189	10	-	-	SYM
bam-10675	189	11	8	8	NUM
bam-10675	189	12	.	.	NUM
bam-10675	190	1	24	24	NUM
bam-10675	190	2	.	.	PUNCT
bam-10675	191	1	ditsch	ditsch	NUM
bam-10675	191	2	n	n	CCONJ
bam-10675	191	3	,	,	PUNCT
bam-10675	191	4	liebhardt	liebhardt	PROPN
bam-10675	191	5	s	s	PROPN
bam-10675	191	6	,	,	PUNCT
bam-10675	191	7	von	von	PROPN
bam-10675	191	8	koch	koch	PROPN
bam-10675	191	9	f	f	PROPN
bam-10675	191	10	,	,	PUNCT
bam-10675	191	11	lenhard	lenhard	PROPN
bam-10675	191	12	m	m	PROPN
bam-10675	191	13	,	,	PUNCT
bam-10675	191	14	vogeser	vogeser	PROPN
bam-10675	191	15	m	m	PROPN
bam-10675	191	16	,	,	PUNCT
bam-10675	191	17	spitzweg	spitzweg	VERB
bam-10675	191	18	c	c	NOUN
bam-10675	191	19	,	,	PUNCT
bam-10675	191	20	gallwas	gallwas	PROPN
bam-10675	191	21	j	j	PROPN
bam-10675	191	22	,	,	PUNCT
bam-10675	191	23	toth	toth	PROPN
bam-10675	191	24	b.	b.	PROPN
bam-10675	191	25	thyroid	thyroid	PROPN
bam-10675	191	26	function	function	NOUN
bam-10675	191	27	in	in	ADP
bam-10675	191	28	breast	breast	NOUN
bam-10675	191	29	cancer	cancer	NOUN
bam-10675	191	30	patients	patient	NOUN
bam-10675	191	31	.	.	PUNCT
bam-10675	192	1	anticancer	anticancer	NOUN
bam-10675	192	2	res	re	NOUN
bam-10675	192	3	.	.	PUNCT
bam-10675	193	1	2010	2010	NUM
bam-10675	193	2	may;30(5):1713	may;30(5):1713	PROPN
bam-10675	193	3	-	-	PUNCT
bam-10675	193	4	7	7	PROPN
bam-10675	193	5	.	.	PUNCT
bam-10675	193	6	disclaimer	disclaimer	NOUN
bam-10675	193	7	all	all	DET
bam-10675	193	8	claims	claim	NOUN
bam-10675	193	9	expressed	express	VERB
bam-10675	193	10	in	in	ADP
bam-10675	193	11	this	this	DET
bam-10675	193	12	article	article	NOUN
bam-10675	193	13	are	be	AUX
bam-10675	193	14	solely	solely	ADV
bam-10675	193	15	those	those	PRON
bam-10675	193	16	of	of	ADP
bam-10675	193	17	the	the	DET
bam-10675	193	18	authors	author	NOUN
bam-10675	193	19	and	and	CCONJ
bam-10675	193	20	do	do	AUX
bam-10675	193	21	not	not	PART
bam-10675	193	22	necessarily	necessarily	ADV
bam-10675	193	23	represent	represent	VERB
bam-10675	193	24	those	those	PRON
bam-10675	193	25	of	of	ADP
bam-10675	193	26	their	their	PRON
bam-10675	193	27	affiliated	affiliated	ADJ
bam-10675	193	28	organizations	organization	NOUN
bam-10675	193	29	,	,	PUNCT
bam-10675	193	30	or	or	CCONJ
bam-10675	193	31	those	those	PRON
bam-10675	193	32	of	of	ADP
bam-10675	193	33	the	the	DET
bam-10675	193	34	publisher	publisher	NOUN
bam-10675	193	35	,	,	PUNCT
bam-10675	193	36	the	the	DET
bam-10675	193	37	editors	editor	NOUN
bam-10675	193	38	and	and	CCONJ
bam-10675	193	39	the	the	DET
bam-10675	193	40	reviewers	reviewer	NOUN
bam-10675	193	41	.	.	PUNCT
bam-10675	194	1	any	any	DET
bam-10675	194	2	product	product	NOUN
bam-10675	194	3	that	that	PRON
bam-10675	194	4	may	may	AUX
bam-10675	194	5	be	be	AUX
bam-10675	194	6	evaluated	evaluate	VERB
bam-10675	194	7	in	in	ADP
bam-10675	194	8	this	this	DET
bam-10675	194	9	article	article	NOUN
bam-10675	194	10	or	or	CCONJ
bam-10675	194	11	claim	claim	NOUN
bam-10675	194	12	that	that	PRON
bam-10675	194	13	may	may	AUX
bam-10675	194	14	be	be	AUX
bam-10675	194	15	made	make	VERB
bam-10675	194	16	by	by	ADP
bam-10675	194	17	its	its	PRON
bam-10675	194	18	manufacturer	manufacturer	NOUN
bam-10675	194	19	is	be	AUX
bam-10675	194	20	not	not	PART
bam-10675	194	21	guaranteed	guarantee	VERB
bam-10675	194	22	or	or	CCONJ
bam-10675	194	23	endorsed	endorse	VERB
bam-10675	194	24	by	by	ADP
bam-10675	194	25	the	the	DET
bam-10675	194	26	publisher	publisher	NOUN
bam-10675	194	27	.	.	PUNCT
bam-10675	195	1	submission	submission	NOUN
bam-10675	195	2	:	:	PUNCT
bam-10675	195	3	june	june	PROPN
bam-10675	195	4	13	13	NUM
bam-10675	195	5	,	,	PUNCT
bam-10675	195	6	2022	2022	NUM
bam-10675	195	7	revision	revision	NOUN
bam-10675	195	8	received	receive	VERB
bam-10675	195	9	:	:	PUNCT
bam-10675	195	10	june	june	PROPN
bam-10675	195	11	30	30	NUM
bam-10675	195	12	,	,	PUNCT
bam-10675	195	13	2022	2022	NUM
bam-10675	195	14	accepted	accept	VERB
bam-10675	195	15	for	for	ADP
bam-10675	195	16	publication	publication	NOUN
bam-10675	195	17	:	:	PUNCT
bam-10675	195	18	june	june	PROPN
bam-10675	195	19	30	30	NUM
bam-10675	195	20	,	,	PUNCT
bam-10675	195	21	2022	2022	NUM
bam-10675	195	22	non	non	ADJ
bam-10675	195	23	-co	-co	PROPN
bam-10675	195	24	mmerc	mmerc	PROPN
bam-10675	195	25	ial	ial	PROPN
bam-10675	195	26	us	us	PROPN
bam-10675	195	27	e	e	NOUN
bam-10675	195	28	o	o	NOUN
bam-10675	195	29	nly	nly	ADV